studies on the synthesis, … on the synthesis, characterisation and antimicrobial applications of...
TRANSCRIPT
STUDIES ON THE SYNTHESIS, CHARACTERISATION AND ANTIMICROBIAL
APPLICATIONS OF RARE EARTH METAL SCHIFF BASE COMPLEXES
A THESIS
Submitted by
LEKHA L.
Under the guidance of
Dr. D. EASWARAMOORTHY
in partial fulfillment for the award of the degree of
DOCTOR OF PHILOSOPHY
in CHEMISTRY
B.S.ABDUR RAHMAN UNIVERSITY (B.S. ABDUR RAHMAN INSTITUTE OF SCIENCE & TECHNOLOGY)
(Estd. u/s 3 of the UGC Act. 1956)
www.bsauniv.ac.in
JUNE 2014
ii
B.S.ABDUR RAHMAN UNIVERSITY (B.S. ABDUR RAHMAN INSTITUTE OF SCIENCE & TECHNOLOGY)
(Estd. u/s 3 of the UGC Act. 1956) www.bsauniv.ac.in
BONAFIDE CERTIFICATE
Certified that this thesis report STUDIES ON THE SYNTHESIS,
CHARACTERISATION AND ANTIMICROBIAL APPLICATIONS OF RARE
EARTH METAL SCHIFF BASE COMPLEXES is the bonafide work of
LEKHA L. (RRN: 1091212) who carried out the thesis work under my
supervision. Certified further, that to the best of my knowledge the work
reported herein does not form part of any other thesis report or dissertation
on the basis of which a degree or award was conferred on an earlier
occasion on this or any other candidate.
Dr. D. EASWARAMOORTHY
RESEARCH SUPERVISOR
Professor & Head
Department of Chemistry
B.S. Abdur Rahman University
Vandalur, Chennai – 600 048.
iii
B.S.ABDUR RAHMAN UNIVERSITY (B.S. ABDUR RAHMAN INSTITUTE OF SCIENCE & TECHNOLOGY)
(Estd. u/s 3 of the UGC Act. 1956) www.bsauniv.ac.in
CERTIFICATE
This is to certify that my Ph.D student Ms. L.Lekha
(RRN: 1091212), has incorporated all the corrections suggested by the
examiners in her thesis report entitled STUDIES ON THE SYNTHESIS,
CHARACTERISATION AND ANTIMICROBIAL APPLICATIONS OF RARE
EARTH METAL SCHIFF BASE COMPLEXES.
Dr. D. EASWARAMOORTHY
RESEARCH SUPERVISOR
Professor & Head
Department of Chemistry
B.S. Abdur Rahman University
Vandalur, Chennai – 600 048.
iv
v
ABSTRACT
Condensation of carbonyl compounds with primary amines is one
of the traditional reactions in chemistry, leading to the formation of Schiff
base compounds. Rare earth metal complexes having N, O donor Schiff
bases play a vital role in pharmaceutical, biological and industrial chemistry,
due to their diverse applications as contrast enhancing agents in NMR
imaging, luminescent probes in medicine and biology, radiometal-labeled
agents for diagnostic imaging, catalyst, supramolecular assemblies with
enhanced physiochemical properties and even for rare earth separation.
With these objectives in mind, Schiff base rare earth metal
complexes are synthesised and characterised. In addition, the Schiff base
ligands and their rare earth metal complexes are screened for their invitro
antimicrobial activities against Escherichia coli, Pseudomonas aeruginosa,
Staphylococcus aureus, Streptococcus agalactiae, Candida and Aspergillus
species and also for catalytic activities.
The experimental part of this thesis includes, the synthesis of
Schiff base ligands like, Sodium 2-(5-bromo-2-hydroxybenzylideneamino)-3-
hydroxypropanoate (SeBrS denoted as L1), Sodium 2-(5-bromo-2-
hydroxybenzylideneamino)-3-hydroxybutanoate (ThBrS as denoted L2) and
Sodium 2-(5-bromo-2-hydroxybenzylidene amino)-4-methylpentanoate (LBrS
denoted as L3 and their corresponding rare earth metal complexes like
Gd (III), Pr (III), Er (III), Sm (III), Tb (III) and Yb(III) Schiff base complexes.
The typical procedure and experimental setup for anti-bacterial, antifungal
studies and aniline oxidation has been incorporated in chapter 3. The results
and discussion part of the thesis describe the characterisation and
application of these newly synthesised complexes. The following
observations have been made based on the spectral and analytical data:
vi
Spectral study and thermal data of the rare earth metal Schiff base
complexes derived from serine showed that two nitrate groups are bound in
a bidentate manner to the central Ln (III) ions in the coordination sphere
while another nitrate is in the outer coordination sphere in complexes. The
fluorescence data reveals that the Sm (III), Tb (III) and Er (III) Schiff base
complexes exhibit characteristic luminescence of corresponding +3 ions,
which indicates that the ligand (L1) is a good organic chelator to absorb and
transfer energy to Sm (III), Tb (III) and Er (III) ions. The synthesised rare
earth Schiff base complexes derived from leucine exhibits the coordination of
the ligand with the central Ln (III) ion through phenolic oxygen, azomethine
nitrogen and the carboxylic oxygen with 1:1 stoichiometry. The samarium
and terbium Schiff base complexes show interesting fluorescence properties.
The in vitro antibacterial activity results showed that most of the
synthesised complexes using serine, threonine and leucine based Schiff
bases, possess good antibacterial activity against bacteria like Escherichia
coli, Proteus, Staphylococcus aureus and Pseudomonas aeruginosa. The
rare earth Schiff base complexes were found to possess enhanced
antimicrobial activity than the corresponding free Schiff base ligands. In
addition, antifungal activity of the complexes is higher than that of the
antibacterial activity of the complexes.
The above complexes possess good catalytic ability for the
oxidation of aniline under mild conditions and Gd (III) Schiff base complex
derived from leucine was utilised to check the generality and efficiency of
oxidation of various substituted anilines. The result herein reveals that the
leucine based rare earth Schiff base complexes are good catalysts for
reactions of commercial importance and suitable to catalyse aniline oxidation
reaction under mild experimental conditions. The catalytic study could be
further extended for other newly synthesised complexes. Further, research
and developments in the application of this Schiff base rare earth metal
complexes would be highly useful to industries and academic world.
vii
ACKNOWLEDGEMENT
At this moment of accomplishment, first of all I pay respect to my guide, Dr. D. Easwaramoorthy, Head & Professor of chemistry department,
B.S.Abdhur Rhaman University, Vandalur. This work would not have been possible without his guidance, support and encouragement.
I am also extremely indebted to Dr. I.Mohammed Bilal, COE,
B.S.Abdhur Rhaman University, for his valuable suggestions and corrections during the review of my thesis progress. I warmly thank Dr. S.Kutti Rani, for her valuable advice, constructive criticism and her extensive discussion around my work.
I gratefully acknowledge Dr. G. Rajagopal and Dr. K.K. Balasubramaniam for their encouragement and personal attention
during my Ph.D. tenure. I also thank my Doctoral committee members, Dr. Riyazuddin and Dr. J. Herbert Mabel for their helpful suggestions and comments.
I am indebted to my student colleagues Mr. R. Mohanraj, Mr. K. Devaraj, Mr. M. Saminathan, Mr. S.Dhivakar, Mr. M. Saravanan, Mr. V. Thiruvengadam and Ms. M. Sasikala for their constant support.
It’s my fortune to gratefully acknowledge the support of some special individuals. Words may fail me to express my gratitude to Dr. K. Kanmani Raja for his support, generous care towards my research
programme. He uses to motivate me during my hard moments and gave a good shape in formatting my thesis. Thanks doesn’t seem sufficient to Dr. K. Shivasankari, Dr. R. Hariharan and Dr. M. Sathish for their support,
care, understanding and precious friendship.
Last but not least, I would like to pay high regards to my lovable husband Mr. V.S. Babu and my ward L. Kaushick Babu who has been a moral support and all of my family members for their continuous
encouragement and inspiration. I thank them all whole heartedly.
L. LEKHA
viii
TABLE OF CONTENTS
CHAPTER NO. TITLE PAGE NO.
ABSTRACT v
ACKNOWLEDGEMENT vii
LIST OF TABLES xiii
LIST OF FIGURES xv
LIST OF SCHEMES xxvi
LIST OF ABBREVIATIONS xxvii
LIST OF SYMBOLS xxviii
1. INTRODUCTION 1
1.1 SCHIFF BASE 3
1.1.1 Amino Acid Schiff Base 5
1.2 RARE EARTH METAL CHEMISTRY 6
1.2.1 General Characteristics 6
1.2.2 Magnetic Properties 7
1.2.3 Coordination Chemistry 7
1.2.4 Photophysical Properties 8
1.3 DONORS 9
1.4 SCHIFF BASE – RARE EARTH METAL
COMPLEXES
10
1.5 BIOLOGICAL IMPORTANCE 11
1.5.1 Antimicrobial Activities 11
1.6 CATALYTIC ACTIVITIES 12
1.7 METALLO – ELEMENTS UNDER
INVESTIGATION
13
1.7.1 Praseodymium 13
1.7.2 Gadolinium 14
ix
CHAPTER NO. TITLE PAGE NO.
1.7.3 Samarium 14
1.7.4 Terbium 15
1.7.5 Erbium 16
1.7.6 Ytterbium 16
2. LITERATURE OVERVIEW 21
2.1 INTRODUCTION 21
2.2 ANTIMICROBIAL PROPERTIES 21
2.3 LUMINESCENT PROPERTIES 25
2.4 CATALYTIC PROPERTIES 28
2.5 AIM AND OBJECTIVE 28
2.6 OUTLINE OF THE THESIS 28
3. EXPERIMENTAL METHODS AND TECHNIQUES
31
3.1 MATERIALS EMPLOYED 31
3.2 SOLVENTS 31
3.3 EXPERIMENTAL METHODS 32
3.3.1 Synthesis of Schiff Base Ligand [l1] 32
3.3.2 Synthesis of [Ln(L1)(NO3)2(H2O)]NO3
Complexes
32
3.3.3 Synthesis of Schiff Base Ligand [l2] 34
3.3.4 Synthesis of [Ln(L2)(NO3)2(H2O)]NO3
Complex
35
3.3.5 Synthesis of Schiff Base Ligand 36
3.3.6 Synthesis of [Ln(L3)(NO3)2(H2O)]NO3
Complex
37
3.3.7 In vitro Antibacterial Study 38
3.3.8 In vitro Antifungal Study 39
3.3.9 Catalytic Oxidation of Aniline 40
x
CHAPTER NO. TITLE PAGE NO.
3.4 ANALYTICAL METHODS 40
3.4.1 Microanalysis 40
3.4.2 Molecular Weight Determination 40
3.5 INSTRUMENTAL METHODS 41
3.5.1 Infrared Spectra 41
3.5.2 Electronic Spectra 41
3.5.3 NMR Spectra 42
4. SCHIFF BASE DERIVED FROM SERINE AND ITS LANTHANIDE (III) COMPLEXES
43
4.1 INTRODUCTION 43
4.2 RESULTS AND DISCUSSION 44
4.2.1 Elemental Analysis 45
4.2.2 Mass Spectra 46
4.2.3 Molar Conductance 55
4.2.4 Thermo Gravimetric Analysis 55
4.2.5 1H NMR Spectra 64
4.2.6 IR Spectra 66
4.2.7 Electronic Spectroscopy 75
4.2.8 Fluorescence Studies 81
4.2.9 Antibacterial Studies 83
4.2.10 Antifungal Studies 89
4.3 CONCLUSION 93
5. SCHIFF BASE DERIVED FROM THREONINE AND ITS LANTHANIDE (III) COMPLEXES
94
5.1 INTRODUCTION 94
5.2 RESULTS AND DISCUSSION 95
5.2.1 Elemental Analysis 96
xi
CHAPTER NO. TITLE PAGE NO.
5.2.2 Mass Spectra 98
5.2.3 Molar Conductance 107
5.2.4 Thermo Gravimetric Analysis 107
5.2.5 1H NMR Spectra 116
5.2.6 IR Spectra 118
5.2.7 Electronic Spectroscopy 128
5.2.8 Fluorescence Study 134
5.2.9 Antibacterial Studies 136
5.2.10 Antifungal Studies 141
5.3 CONCLUSION 145
6. SCHIFF BASE DERIVED FROM LEUCINE AND ITS LANTHANIDE (III) COMPLEXES
146
6.1 INTRODUCTION 146
6.2 RESULTS AND DISCUSSION 147
6.2.1 Elemental Analysis 148
6.2.2 Mass Spectra 150
6.2.3 Molar Conductance 159
6.2.4 Thermo Gravimetric Analysis 159
6.2.5 1H NMR Spectra 168
6.2.6 IR Spectra 170
6.2.7 Electronic Spectroscopy 180
6.2.8 Fluorescence Studies 186
6.2.9 Antibacterial Studies 189
6.2.10 Antifungal Studies 194
6.3 CONCLUSION 198
7. CATALYTIC ACTIVITY OF LANTHANIDE (III) SCHIFF BASE COMPLEXES DERIVED
199
xii
CHAPTER NO. TITLE PAGE NO.
FROM LEUCINE
7.1 INTRODUCTION 199
7.2 CATALYTIC OXIDATION OF ANILINE AND
SUBSTITUTED ANILINES
200
7.3 CONCLUSION 217
8. SUMMARY AND CONCLUSION 218
8.1 Ln (III) SCHIFF BASE (L1) COMPLEXES 218
8.2 Ln (III) SCHIFF BASE (L2) COMPLEXES 218
8.3 Ln (III) SCHIFF BASE (L3) COMPLEXES 219
8.4 CATALYTIC ACTIVITY OF Ln (III) SCHIFF
BASE (L3) COMPLEXES
220
9. SCOPE FOR FUTURE WORK 221
10. REFERENCES 222
LIST OF PUBLICATIONS 250
TECHNICAL BIOGRAPHY
252
xiii
LIST OF TABLES
TABLE NO. TITLE PAGE NO.
3.1 Physical properties and the percentage yield of
the Schiff base ligand [L1] and its Ln (III)
complexes 34
3.2 Physical properties and the percentage yield of
the Schiff base ligand [L2] and its Ln (III)
complexes 36
3.3 Physical properties and the percentage yield of
the Schiff base ligand [L3] and its Ln (III)
complexes 38
4.1 Elemental Analysis of the ligand [L1] and Ln (III)
Schiff base complexes in DMF 46
4.2 Molar conductance of the ligand [L1] and Ln (III)
Schiff base complexes 55
4.3 Infrared spectral data for the ligand [L1] and the
Ln (III) complexes 67
4.4 UV-visible Spectral Data max. (nm) for the ligand
[L1] and the Ln (III) complexes 81
4.5 Antibacterial results of the Schiff base ligand [L1]
and their Ln (III) complexes for maximum
concentration 85
4.6 Antifungal results of the Schiff base ligand [L1]
and their Ln (III) complexes for maximum
concentration 90
5.1 Elemental Analysis of the ligand [L2] and Ln (III)
Schiff base complexes in DMF 97
5.2 Molar conductance of the ligand [L2] and Ln (III)
Schiff base complexes 107
xiv
TABLE NO. TITLE PAGE NO.
5.3 Infrared spectral data for the ligand [L2] and the
Ln (III) complexes 120
5.4 UV-visible Spectral Data max. (nm) for the ligand
[L2] and the Ln (III) complexes 133
5.5 Antibacterial results of the Schiff base ligand [L2]
and their Ln (III) complexes for maximum
concentration 137
5.6 Antifungal results of the Schiff base ligand [L2]
and their Ln (III) complexes for maximum
concentration 142
6.1 Elemental Analysis of the ligand [L3] and Ln (III)
Schiff base complexes in DMF 149
6.2 Molar conductance of the ligand [L3] and Ln (III)
Schiff base complexes 159
6.3 Infrared spectral data for the ligand [L3] and the
Ln (III) complexes 172
6.4 UV-visible Spectral Data max. (nm) for the ligand
[L3] and the Ln (III) complexes 181
6.5 Antibacterial results of the Schiff base ligand [L3]
and their Ln (III) complexes for maximum
concentration 190
6.6 Antifungal results of the Schiff base ligand [L3]
and their Ln (III) complexes for maximum
concentration 195
7.1 Oxidation of aniline catalysed by various Ln (III)
complexes in CH2Cl2 at RT 202
7.2 Oxidation of aniline and substituted anilines
catalysed by Gd (III) complex in CH2Cl2 at RT
203
xv
LIST OF FIGURES
FIGURE NO. TITLE PAGE NO.
2.1 Emission spectrum of the complex
[TbL(NO3)2(H2O)2](NO3) 26
2.2 The Fluorescence spectra of (a) Tb (III) and (b)
Sm (III) complexes 27
4.1 Sodium salt of the Schiff base ligand [L1] 44
4.2 Mass Spectrum of the Schiff base ligand [L1] 47
4.3 Mass Spectrum of the [Pr(L1)(NO3)2(H2O)]NO3
complex 48
4.4 Mass Spectrum of the
[Sm(L1)(NO3)2(H2O)]NO3 complex 49
4.5 Mass Spectrum of the [Gd(L1)(NO3)2(H2O)]NO3
complex 50
4.6 Mass Spectrum of the [Tb(L1)(NO3)2(H2O)]NO3
complex 51
4.7 Mass Spectrum of the [Er(L1)(NO3)2(H2O)]NO3
complex 52
4.8 Mass Spectrum of the [Yb(L1)(NO3)2(H2O)]NO3
complex 53
4.9 HR-MS of the [Pr(L1)(NO3)2(H2O)]NO3 complex 54
4.10 TG / DTA curves of Schiff base ligand [L1] 57
4.11 TG/DTA curves of the [Pr(L1)(NO3)2H2O].NO3
complex 58
4.12 TG/DTA curves of the [Sm(L1)(NO3)2H2O].NO3
complex 59
4.13 TG/DTA curves of the [Gd(L1)(NO3)2H2O].NO3
complex 60
xvi
FIGURE NO. TITLE PAGE NO.
4.14 TG/DTA curves of the [Tb(L1)(NO3)2H2O].NO3
complex 61
4.15 TG/DTA curves of the [Er(L1)(NO3)2H2O].NO3
complex 62
4.16 TG/DTA curves of the [Yb(L1)(NO3)2H2O].NO3
complex 63
4.17 1H NMR spectrum of the Schiff base ligand [L1] 65
4.18 IR spectrum of the Schiff base ligand [L1] 68
4.19 IR spectrum of the
[Pr(L1)(NO3)2H2O].NO3complex 69
4.20 IR spectrum of the
[Sm(L1)(NO3)2H2O].NO3complex 70
4.21 IR spectrum of the
[Gd(L1)(NO3)2H2O].NO3complex 71
4.22 IR spectrum of the
[Tb(L1)(NO3)2H2O].NO3complex 72
4.23 IR spectrum of the
[Er(L1)(NO3)2H2O].NO3complex 73
4.24 IR spectrum of the
[Yb(L1)(NO3)2H2O].NO3complex 74
4.25 UV-visible spectrum of the Schiff base ligand
[L1] in DMF solution (1.0 10-6 M) at room
temperature. 76
4.26 UV-visible spectrum of the
[Pr(L1)(NO3)2H2O].NO3complex in DMF
solution (1.0 10-6 M) at room temperature. 77
4.27 UV-visible spectrum of the
[Sm(L1)(NO3)2H2O].NO3complex in DMF
solution (1.0 10-6 M) at room temperature. 77
xvii
FIGURE NO. TITLE PAGE NO.
4.28 UV-visible spectrum of the
[Gd(L1)(NO3)2H2O].NO3complex in DMF
solution (1.0 10-6 M) at room temperature. 78
4.29 UV-visible spectrum of the
[Tb(L1)(NO3)2H2O].NO3complex in DMF
solution (1.0 10-6 M) at room temperature. 78
4.30 UV-visible spectrum of the
[Er(L1)(NO3)2H2O].NO3complex in DMF
solution (1.0 10-6 M) at room temperature. 79
4.31 UV-visible spectrum of the
[Yb(L1)(NO3)2H2O].NO3complex in DMF
solution (1.0 10-6 M) at room temperature. 79
4.32 Comparative UV-visible spectra of the Schiff
base ligand [L1] and Ln (III) Schiff base
complexes in DMF solution (1.0 10-6 M) at
room temperature. 80
4.33 Emission spectra of Sm (III) and Tb (III) Schiff
base complexes in DMF solution (1.0 10-6 M)
at room temperature. Emission spectrum is
obtained with exc. = 360 nm. 83
4.34 Zone of inhibition of a. Sm (III) b.Sm (III) c. Er
(III) complexes of L1 Ligand for bacterial
species 86
4.35 Percentage Inhibition of Schiff base ligand [L1]
and their Ln (III) Schiff base complexes against
Escherichia coli 87
4.36 Percentage Inhibition of Schiff base ligand [L1]
and their Ln (III) Schiff base complexes against
Proteus 87
xviii
FIGURE NO. TITLE PAGE NO.
4.37 Percentage Inhibition of Schiff base ligand [L1]
and their Ln (III) Schiff base complexes against
Pseudomonas aeruginosa
88
4.38 Percentage Inhibition of Schiff base ligand [L1]
and their Ln (III) Schiff base complexes against
Staphylococcus aureus 88
4.39 Zone of inhibition of Tb (III) complex of L1
Ligand for fungal species 91
4.40 Percentage Inhibition of Schiff base ligand [L1]
and their Ln (III) Schiff base complexes against
Candida 92
4.41 Percentage Inhibition of Schiff base ligand [L1]
and their Ln (III) Schiff base complexes against
Aspergillus 92
5.1 Sodium salt of the Schiff base ligand [L2] 95
5.2 Mass Spectrum of the Schiff base ligand [L2] 99
5.3 Mass Spectrum of the [Pr(L2)(NO3)2(H2O)]NO3
complex 100
5.4 Mass Spectrum of the
[Sm(L2)(NO3)2(H2O)]NO3 complex 101
5.5 Mass Spectrum of the [Gd(L2)(NO3)2(H2O)]NO3
complex 102
5.6 Mass Spectrum of the [Tb(L2)(NO3)2(H2O)]NO3
complex 103
5.7 Mass Spectrum of the [Er(L2)(NO3)2(H2O)]NO3
complex 104
5.8 Mass Spectrum of the [Yb(L2)(NO3)2(H2O)]NO3
complex 105
5.9 HR-MS of the [Pr(L2)(NO3)2(H2O)]NO3 complex 106
5.10 TG / DTA curves of Schiff base ligand [L2] 109
xix
FIGURE NO. TITLE PAGE NO.
5.11 TG/DTA curves of the [Pr(L2)(NO3)2H2O]NO3
complex 110
5.12 TG/DTA curves of the [Sm(L2)(NO3)2H2O]NO3
complex 111
5.13 TG/DTA curves of the [Gd(L2)(NO3)2H2O]NO3
complex 112
5.14 TG/DTA curves of the [Tb(L2)(NO3)2H2O]NO3
complex 113
5.15 TG/DTA curves of the [Er(L2)(NO3)2H2O]NO3
complex 114
5.16 TG/DTA curves of the [Yb(L2)(NO3)2H2O]NO3
complex 115
5.17 1H NMR spectrum of the Schiff base ligand [L2] 117
5.18 IR spectrum of the Schiff base ligand [L2] 121
5.19 IR spectrum of the [Pr(L2)(NO3)2H2O]NO3
complex 122
5.20 IR spectrum of the [Sm(L2)(NO3)2H2O]NO3
complex 123
5.21 IR spectrum of the [Gd(L2)(NO3)2H2O]NO3
complex 124
5.22 IR spectrum of the [Tb(L2)(NO3)2H2O]NO3
complex 125
5.23 IR spectrum of the [Er(L2)(NO3)2H2O]NO3
complex 126
5.24 IR spectrum of the [Yb(L2)(NO3)2H2O] NO3
complex 127
5.25 UV-visible spectrum of the Schiff base ligand
[L2] in DMF solution (1.0 10-6 M) at room
temperature. 129
xx
FIGURE NO. TITLE PAGE NO.
5.26 UV-visible spectrum of the
[Pr(L2)(NO3)2H2O].NO3 complex in DMF
solution (1.0 10-6 M) at room temperature
129
5.27 UV-visible spectrum of the [Sm(L2)(NO3)2H2O]
NO3complex in DMF solution (1.0 10-6 M) at
room temperature. 130
5.28 UV-visible spectrum of the [Gd(L2)(NO3)2H2O]
NO3complex in DMF solution (1.0 10-6 M) at
room temperature. 130
5.29 UV-visible spectrum of the [Tb(L2)(NO3)2H2O]
NO3complex in DMF solution (1.0 10-6 M) at
room temperature. 131
5.30 UV-visible spectrum of the [Er(L2)(NO3)2H2O]
NO3complex in DMF solution (1.0 10-6 M) at
room temperature. 131
5.31 UV-visible spectrum of the [Yb(L2)(NO3)2H2O]
NO3complex in DMF solution (1.0 10-6 M) at
room temperature. 132
5.32 Comparative UV-visible spectra of the Schiff
base ligand [L2] and Ln (III) Schiff base
complexes in DMF solution (1.0 10-6 M) at
room temperature. 132
5.33 Emission spectra of Sm (III) and Tb (III) Schiff
base complexes in DMF solution (1.0 10-6 M)
at room temperature. Emission spectrum is
obtained with exc. = 360 nm. 135
5.34 Zone of inhibition of a. Gd (III) b.Gd (III)
c. Yb (III) d. Er (III) complex of L2 Ligand for
bacterial species 138
xxi
FIGURE NO. TITLE PAGE NO.
5.35 Percentage Inhibition of Schiff base ligand [L2]
and their Ln (III) Schiff base complexes against
Escherichia coli
139
5.36 Percentage Inhibition of Schiff base ligand [L2]
and their Ln (III) Schiff base complexes against
Streptococcus agalactiae 139
5.37 Percentage Inhibition of Schiff base ligand [L2]
and their Ln (III) Schiff base complexes against
Pseudomonas aeruginosa 140
5.38 Percentage Inhibition of Schiff base ligand [L2]
and their Ln (III) Schiff base complexes against
Staphylococcus aureus 140
5.39 Zone of inhibition of a. Gd (III) b. Sm
(III) complex of L2 Ligand for fungal species 143
5.40 Percentage Inhibition of Schiff base ligand [L2]
and their Ln (III) Schiff base complexes against
Candida 144
5.41 Percentage Inhibition of Schiff base ligand [L2]
and their Ln (III) Schiff base complexes against
Aspergillus 144
6.1 Sodium salt of the Schiff base ligand [L3] 147
6.2 Mass Spectrum of the Schiff base ligand [L3] 151
6.3 Mass Spectrum of the [Pr(L3)(NO3)2(H2O)]NO3
complex 152
6.4 Mass Spectrum of the
[Sm(L3)(NO3)2(H2O)]NO3 complex 153
6.5 Mass Spectrum of the [Gd(L3)(NO3)2(H2O)]NO3
complex 154
6.6 Mass Spectrum of the [Tb(L3)(NO3)2(H2O)]NO3
complex 155
xxii
FIGURE NO. TITLE PAGE NO.
6.7 Mass Spectrum of the [Er(L3)(NO3)2(H2O)]NO3
complex 156
6.8 Mass Spectrum of the [Yb(L3)(NO3)2(H2O)]NO3
complex 157
6.9 HR-MS of the [Pr(L3)(NO3)2(H2O)]NO3 complex 158
6.10 TG / DTA curves of Schiff base ligand [L3] 161
6.11 TG/DTA curves of the [Pr(L3)(NO3)2H2O]NO3
complex 162
6.12 TG/DTA curves of the [Sm(L3)(NO3)2H2O]NO3
complex 163
6.13 TG/DTA curves of the [Gd(L3)(NO3)2H2O]NO3
complex 164
6.14 TG/DTA curves of the [Tb(L3)(NO3)2H2O]NO3
complex 165
6.15 TG/DTA curves of the [Er(L3)(NO3)2H2O]NO3
complex 166
6.16 TG/DTA curves of the [Yb(L3)(NO3)2H2O]NO3
complex 167
6.17 1H NMR spectrum of the Schiff base ligand [L3] 169
6.18 IR spectrum of the Schiff base ligand [L3] 173
6.19 IR spectrum of the [Pr(L3)(NO3)2H2O]NO3
complex 174
6.20 IR spectrum of the [Sm(L3)(NO3)2H2O]NO3
complex 175
6.21 IR spectrum of the [Gd(L3)(NO3)2H2O]NO3
complex 176
6.22 IR spectrum of the [Tb(L3)(NO3)2H2O]NO3
complex 177
6.23 IR spectrum of the [Er(L3)(NO3)2H2O]NO3
complex 178
xxiii
FIGURE NO. TITLE PAGE NO.
6.24 IR spectrum of the [Yb(L3)(NO3)2H2O]NO3
complex 179
6.25 UV-visible spectrum of the Schiff base ligand
[L3] in DMF solution (1.0 10-6 M) at room
temperature
182
6.26 UV-visible spectrum of the [Pr(L3)(NO3)2H2O]NO3 complex in DMF
solution (1.0 10-6 M) at room temperature 182
6.27 UV-visible spectrum of the
[Sm(L3)(NO3)2H2O]NO3 complex in DMF
solution (1.0 10-6 M) at room temperature. 183
6.28 UV-visible spectrum of the [Gd(L3)(NO3)2H2O]NO3 complex in DMF
solution (1.0 10-6 M) at room temperature. 183
6.29 UV-visible spectrum of the [Tb(L3)(NO3)2H2O]NO3 complex in DMF
solution (1.0 10-6 M) at room temperature. 184
6.30 UV-visible spectrum of the [Er(L3)(NO3)2H2O]NO3 complex in DMF solution
(1.0 10-6 M) at room temperature. 184
6.31 UV-visible spectrum of the [Yb(L3)(NO3)2H2O].NO3complex in DMF
solution (1.0 10-6 M) at room temperature. 185
6.32 Comparative UV-visible spectra of the Schiff base ligand [L3] and Ln (III) Schiff base
complexes in DMF solution (1.0 10-6 M) at
room temperature. 185
6.33 Emission spectra of Sm (III) and Tb (III) Schiff
base complexes in DMF solution (1.0 10-6 M)
at room temperature. Emission spectrum is obtained with exc. = 395 nm. 188
xxiv
FIGURE NO. TITLE PAGE NO.
6.34 Zone of inhibition of a. Tb (III) b. Tb (III) c. Gd
(III) d. Tb (III) complexes of L3 Ligand for
bacterial species 191
6.35 Percentage Inhibition of Schiff base ligand [L3]
and their Ln (III) Schiff base complexes against
Escherichia coli 192
6.36 Percentage Inhibition of Schiff base ligand [L3]
and their Ln (III) Schiff base complexes against
Streptococcus agalactiae 192
6.37 Percentage Inhibition of Schiff base ligand [L3]
and their Ln(III) Schiff base complexes against
Pseudomonas aeruginosa 193
6.38 Percentage Inhibition of Schiff base ligand [L3]
and their Ln (III) Schiff base complexes against
Staphylococcus aureus 193
6.39 Zone of inhibition of Tb (III) complex of L3
Ligand for fungal species 196
6.40 Percentage Inhibition of Schiff base ligand [L3]
and their Ln (III) Schiff base complexes against
Candida 197
6.41 Percentage Inhibition of Schiff base ligand [L3]
and their Ln (III) Schiff base complexes against
Aspergillus 197
7.1 1H NMR spectrum of Diphenyl-diazene 205
7.2 1H NMR spectrum of Di-p-tolyl-diazene 206
7.3 1H NMR spectrum of Bis-(4-chloro-phenyl)-
diazene 207
7.4 1H NMR spectrum of Bis-(4-nitro-phenyl)-
diazene 208
xxv
FIGURE NO. TITLE PAGE NO.
7.5 1H NMR spectrum of Bis-(4-methoxy-phenyl)-
diazene
209
7.6 1H NMR spectrum of Bis-(3-nitro-phenyl)-
diazene 210
7.7 1H NMR spectrum of Bis-(3-methoxy-phenyl)-
diazene
211
7.8 1H NMR spectrum of Bis-(3-chloro-phenyl)-
diazene 212
7.9 1H NMR spectrum of Di-m-tolyl-diazene 213
7.10 1H NMR spectrum of Bis-(2-chloro-phenyl)-
diazene 214
7.11 1H NMR spectrum of Bis-(2-methoxy-phenyl)-
diazene 215
7.12 1H NMR spectrum of Azodibenzoicacid 216
xxvi
LIST OF SCHEMES
SCHEME NO. TITLE PAGE NO.
1.1 Process of condensation of aldehyde and
primary amine 3
1.2 Process of formation of Schiff base with
carbinolamine intermediate 4
2.1 Catalytic oxidation of aniline using hydrogen
peroxide 26
2.2 Catalytic oxidation of 4-methoxyaniline 26
2.3 Oxidation of anilines with hydrogen peroxide
over Si-Co 27
3.1 Synthesis of Schiff base ligand [L1] 32
3.2 Synthesis of rare earth metal Schiff base [L1]
complexes. 33
3.3 Synthesis of Schiff base ligand [L2] 35
3.4 Synthesis of rare earth metal Schiff base [L2]
complexes. 36
3.5 Synthesis of Schiff base ligand [L3] 37
3.6 Synthesis of rare earth metal Schiff base [L3]
complexes. 38
3.7 Catalytic oxidation of aniline 40
4.1 Synthesis of Schiff base ligand [L1] and Ln (III)
Schiff base complex 45
5.1 Synthesis of Schiff base ligand [L2] and Ln (III)
Schiff base complexes 96
6.1 Synthesis of Schiff base ligand [L3] and Ln (III)
Schiff base Complexes 148
xxvii
LIST OF ABBREVIATIONS
CDCl3 - Deuterated Chloroform
cm-1 - Per centimeter oC - Degree Celsius
DCM - Dichloromethane
DMF - Dimethyl Formamide
DMSO - Dimethyl Sulfoxide
DPPH - 2,2-diphenyl-1-picrylhydrazyl.
EtOH - Ethanol
FTIR - Fourier Transform Infrared Spectroscopy
h - Hour
HPLC - High Performance Liquid Chromatography
HRMS - High Resolution Mass Spectroscopy
M - Molar
MeOH - Methanol mg - Milligram
MHz - Mega Hertz
mL - Millilitre
mol - Mole
µgmL-1 - Microgram per millilitre
nm - Nanometer
NMR - Nuclear Magnetic Resonance Spectroscopy
pH - potence Hydrogen
ppm - Parts Per Million
RT - Room Temperature
SCm2mol-1 - Siemens Square Centimeter per mole
TG/DTA - Thermogravimetric / Differential Thermogravimetric
Analysis
TLC - Thin Layer Chromatography
TMS - Tetramethylsilane
xxviii
LIST OF SYMBOLS
* - Anti-bonding pi orbital
- Chemical shift
- Epsilon
- Equivalent conductance
µ - micro
% - Percentage
- Pi orbital
E2 - Second order elimination
- Wavelength
- Wavenumber
1
1. INTRODUCTION
The accomplishment of antimicrobial agents, ranging from direct
killing of invading pathogens to immune response modulation and other
complex biological responses, has stimulated research and clinical interest
for more than two decades. However the area is still flourishing due to
emerging discoveries in the functions, roles and regulation of antimicrobial
agents. An antimicrobial agent kills microorganisms or inhibit their growth
and they can be grouped according to the microorganisms against which
they act on; antibacterial are used against bacteria and antifungal are used
against fungi.
There are several indications that new approaches are required to
combat emerging infections and the global spread of drug-resistant
pathogens. There is no doubting the need for new strategies and new
molecules to treat pathogens that are resistant to nearly the full array of
contemporary antibiotics [1]. We are at a critical point, not seen since the
pre-antibiotic era, at which infections caused by some bacterial pathogens
are untreatable. Treatment of bacterial, fungal, and viral infections selects for
the emergence of resistant organisms that may be rare in the initial
population but become increasingly prevalent under selective drug pressure.
In fact, the presence of an antibiotic can accelerate mutation and
recombination in bacterial populations and contribute directly to its own
obsolescence.
Design of strategies for novel antimicrobial calls for the exploration
of antimicrobials which fight against the infectious microbes that exploits the
beneficial and commensal microbes in sites where normal microbiota reside.
Recently, the lanthanide Schiff base complexes have acquired special
2
attention in medicinal and pharmaceutical field since they show excellent
biological activities.
Some of the lanthanide complexes are used in biomedical analysis
as MRI contrast agents [2]. Because of special, photophysical and biological
properties, lanthanide complexes can be used as biological probes in the
areas of clinical chemistry and molecular biology [3]. Due to their special
electronic configuration, lanthanide complexes have inspired many efforts on
the design and synthesis as potential anticancer and antibacterial agents [4-
7]. Polydentate ligands such as Schiff bases, assisted by metal ions, provide
highly organised supramolecular metal complexes. Such complexes possess
binding sites and cavities for various cations, anions and organic molecules
[8].
The versatile nature of the lanthanide Schiff base complexes,
make them an important candidate in catalysis of numerous organic
transformations like oxidation of amines to their corresponding oxygen
containing derivatives. . Some of the Schiff base complexes containing N
and O donor atoms are effective stereospecific catalysts for oxidation [9],
reduction [10], hydrolysis [11], biological activities [12,13], and other organic
and inorganic transformations. These organic transformations are
environmentally friendly and hence they are highly desirable for the
treatment of waste water which contains toxic organic pollutants. Aniline one
such pollutant, is used in the manufacturing of dyes, polymers, which
includes rubber, herbicides, pesticides, fungicides, and pharmaceuticals, is
released into environment from these industries. Aniline is also found in the
effluents of petroleum refinery plants. Aniline containing chemicals find wider
applications in various arenas. Because of its toxic and unmanageable
nature it is considered to be an increasing threat to both the environment
and human health. Therefore, aniline has aroused great attention and is
classified as a persistent organic pollutant. So there is an urgent need to
develop efficient and economical methods to remove this pollutant from
wastewater.
3
Several solutions have been proposed in this regard, including
adsorption, chemical oxidation, biological and catalytic oxidation. During the
past decade, great interest has been focused on a promising technology
based on the oxidation of the hazardous and refractory organic compounds,
by the use of advanced oxidation processes. Various combinations of
hydrogen peroxide, ozone and ultraviolet light are used to generate hydroxyl
radicals.
Focus of the current research is to synthesis the lanthanide
complexes of Schiff base ligands and to study their applications as
antimicrobial agents and in catalysis.
1.1 SCHIFF BASE
Schiff bases are condensation products of primary amines with
carbonyl compounds and they were first reported by Hugo Schiff in 1864.
The common structural feature of these compounds is the azomethine group
with a general formula RN=CH-R1, where R and R1 are alkyl, aryl, cyclo alkyl
or heterocyclic groups which may be variously substituted. These
compounds are also known as anils, imines or azomethines [14 -17].
R NH2 + R' C
O
H R N CH R' + H2O
Primary amine Aldehyde Schiff base By product
Scheme 1.1 Process of condensation of aldehyde and primary amine
Schiff bases that contain aryl substituents are substantially more
stable than alkyl substituents. Schiff bases of aliphatic aldehydes are
relatively unstable and readily polymerizable, while those of aromatic
aldehydes have effective conjugation and stability.
4
The formation of a Schiff base from an aldehydes or ketones is a
reversible reaction and generally takes place under acid or base catalysis, or
upon heating [18].
C
O
H R'+ NH2R CH R'
OH
NHR
CH R'
NR
+ H2O
Aldehyde Primary amine Carbinolamine Imine By product
Scheme 1.2 Process of formation of Schiff base with carbinolamine intermediate
The formation is generally driven to the completion by separation
of the product or removal of water or both. Many Schiff bases can be
hydrolysed back to their aldehydes or ketones and amines by aqueous acid
or base [19].
The mechanism of Schiff base formation is another variation on
the theme of neucleophilic addition to the carbonyl group. In this case, the
neucleophile is the amine. In the first part of the mechanism, the amine
reacts with the aldehyde or ketone to give an unstable addition compound
called carbinolamine. The carbinolamine loses water by either acid or base
catalysed pathways. Since the carbinolamine is an alcohol, it undergoes acid
catalysed dehydration.
Typically the dehydration of the carbinolamine is the rate-
determining step of Schiff base formation and that is why the reaction is
catalysed by acids. Yet the acid concentration cannot be too high because
amines are basic compounds. If the amine is protonated and becomes non-
neucleophilic, equilibrium is pulled to the left and carbinolamine formation
cannot occur. Therefore, many Schiff bases synthesis are best carried out at
mildly acidic pH [20].
5
The dehydration of carbinolamines is also catalysed by base. This
reaction is somewhat analogous to the E2 elimination of alkyl halides except
that it is not a concerted reaction. It proceeds in two steps through an anionic
intermediate. The Schiff base formation is really a sequence of two types of
reactions, i.e. addition followed by elimination.
Because of the relative easiness of preparation, synthetic flexibility
and the special property of C=N group, Schiff bases are generally excellent
chelating agents, especially when a functional group like –OH or –SH is
present close to the azomethine group so as to form a five or six membered
ring with the metal ion. Several studies showed that the presence of a lone
pair of electrons in a sp2 hybridised orbital of nitrogen atom of the
azomethine group is of considerable chemical and biological importance
[21].
The electron-donating groups, such as azomethines can trap
metal ions with large radii and high coordination numbers. In such a case,
the two or more metal atoms are located in one cavity in close proximity to
each other and which in turn can be characterised by unusual magnetic
properties and catalytic activity [22]. Versatility of Schiff base ligands,
biological, analytical and industrial applications of their complexes make
further investigations in this area highly desirable.
1.1.1 Amino Acid Schiff Base
Schiff base complexes of amino acids have gained importance
because of their physiological and pharmacological activities. The
complexes of amino acid Schiff bases are considered to constitute new kinds
of potential antimicrobial and anticancer reagents due to the presence of
azomethine functional group [23].
Several structural studies have been carried out on Schiff base
complexes of transition and rare earth metals derived from salicylaldehyde
6
and amino acids, in view of the fact that, these complexes can be used as
non-enzymatic model analogous to the key intermediates in many metabolic
reactions of amino acids such as transamination, decarboxylation, and -
elimination and racemisation [24]. Further, the reactive functional group
associated with the amino acid side chain enhances the bridging nature of
the ligand with the central metal ion playing a vital role in metabolic activities.
The Schiff base derived amino acid have been considered to be
suitable candidate, which allow easy artificial linkage of various functional
groups with N-terminal to generate a variety of multidentate metal
complexes. The coordination behaviour of aminoacid – salicylaldehyde
derived ligands with diverse metal ions has been well explored [25].
Synthetic metallo nucleases, showing photo-induced nuclease
activity are of importance in photodynamic therapy of cancer. Hence, protein
binding and photo induced protein cleavage activity of metal complexes of
Schiff base ligands derived from amino acids have been well documented.
These are used as new generation metal based anticancer drugs to control
tumor metastases [26].
1.2 RARE EARTH METAL CHEMISTRY
1.2.1 General Characteristics
The lanthanides exhibit a number of features in their chemistry
that differentiate them from the d-block metals. The reactivity of the elements
is greater than that of the transition metals, because they exhibit a very wide
range of coordination numbers, generally 6–12 [27]. Their coordination
geometries are determined by ligand steric factors rather than crystal field
effects.
The lanthanides form labile ‘ionic’ complexes that undergo facile
exchange of ligand. The 4f orbitals in the Ln3+ ion do not participate directly
in bonding, being well shielded by the 5s2 and 5p6 orbitas. Their
7
spectroscopic and magnetic properties are thus largely uninfluenced by the
ligand [28]. Lanthanides have small crystal-field splitting and very sharp
electronic spectra in comparison with the d-block metals. They prefer anionic
ligands with donor atoms of rather high electronegativity (e.g. O, F).
They readily form hydrated complexes, on account of the high
hydration energy of the small Ln3+ ion and this can cause uncertainty in
assigning coordination numbers. Insoluble hydroxides precipitate at neutral
pH unless complexing agents are present. The chemistry is largely that of
one (3+) oxidation state, certainly in aqueous solution. They do not form
Ln=O or Ln N multiple bonds of the type known for many transition metals
and certain actinides [29]. Unlike the transition metals, they do not form
stable carbonyls and have virtually no chemistry in the zero oxidation state.
1.2.2 Magnetic Properties
With the exception of La3+ and Lu3+, the Ln3+ ions all contain
unpaired electrons and are paramagnetic. Their magnetic properties are
determined entirely by the ground state, as the excited states are so well
separated from the ground state, owing to spin–orbit coupling and are thus
thermally inaccessible [30]. The ground state for a given lanthanide ion is
unaffected by the ligands bound to it and thus crystal field splittings are weak
because of the shielding of the 4f electrons by the filled 5s and 5p orbitals.
Since the magnetic moment of the Ln3+ ions is essentially independent of
environment, one cannot distinguish between coordination geometries as is
sometimes possible for transition metals, in the case of octahedral and
tetrahedral Co2+ complexes.
1.2.3 Coordination Chemistry
Compared with transition metals, lanthanide elements have two
distinct characteristics in terms of their coordination number [31]:
8
i) Large coordination numbers. For example, the
coordination number of 3d transition metals is generally four
or six. However, the most common coordination number of
lanthanide complexes is eight or nine. This number is close
to the sum of the 6s, 6p, and 5d orbitals. Another fact
responsible for the large coordination number of lanthanide
complexes is the large ionic radius of the lanthanide
elements. The ionic radius of Fe3+ and Co3+ are 55 and 54
pm, respectively for the coordination number six. However,
the ionic radius of La3+, Gd3+, and Lu3+ are 103.2, 93.8, and
86.1 pm, respectively for the same coordination number.
ii) Variable coordination numbers. The coordinating
stabilisation energy (about 4.18 kJ·mol 1) of lanthanide ions
is much smaller than the crystal field stabilisation energy of
transition metals (typically 418 kJ·mol 1). Therefore, the
coordinating bonds of lanthanide complexes are not
directional and the coordination number varies from 3 to 12.
1.2.4 Photophysical Properties
The ground state spectral terms of lanthanide elements in the
periodic table can be sorted into two categories and these are divided by
gadolinium: the first category consists of elements before gadolinium, which
includes lanthanum, cerium, praseodymium, neodymium, promethium,
samarium, europium, and gadolinium, while the second category contains
the elements after gadolinium, which includes gadolinium, terbium,
dysprosium, holmium, erbium, thulium, ytterbium, and lutetium [32].
Because the 4f shells of lanthanide elements are unfilled, different
arrangements of 4f electrons generate different energy levels. The 4f
electron transitions, between the various energy levels, could generate
numerous absorption and emission spectra.
9
1.3 DONORS
Binding of metallo elements with polydentate ligands to form ring
structure, where the metal atom is part of the ring, is called chelation. In
chelates, metal is firmly held by a number of ligand atoms usually nitrogen,
oxygen or sulphur through coordinate covalent bonds.
Ligands that contain significantly different chemical functions such
as hard and soft donors find increasing use in chemistry because of their
selectivity introduced in the metal-ligand interactions and their possible
dynamic behavior [33].
Schiff bases are generally bi, tri or tetra dentate ligands capable of
forming very stable complexes with rare earth metals. Monodentate Schiff
bases are not known to form stable complexes, probably due to the
insufficient basic strength of the imino nitrogen of the C=N group. Bi or
tridentate Schiff base ligands are able to coordinate with many different
metal ions through both azomethine group and OH/SH group [34], and to
stabilize them in various oxidation states, enabling the use of Schiff base
metal complexes for a large variety of useful organic transformations.
The presence of hard N- and soft S-donor atoms in the backbone
of Schiff base ligands, enable them to react readily with both transition and
main group metal ions yielding stable metal complexes, some of which have
been shown to exhibit interesting physico-chemical properties and significant
biological activities [35]. There has been much interest in hard / soft mixed
donor ligands for use in catalysis [36].
The rare earth metal complexes having N and O donor Schiff
bases possess unusual configuration, structural liability and are sensitive to
molecular environment because of the versatility of their steric and electronic
properties, which can be modified by choosing the appropriate amine
10
precursors and ring substituents. They have shown an exponential increase
in their activity as inorganic catalyst for various organic transformations.
1.4 SCHIFF BASE – RARE EARTH METAL COMPLEXES
The luminescent properties of lanthanides have attracted much
attention for their wide applications in light emitting diodes, liquid crystal,
fluoro immune assays, biophysics, Laser technology and optical
telecommunication systems [37]. The luminescent intensities of the
lanthanide metal complexes are strongly dependent on (i) the efficiency of
the organic ligand to absorb UV light, (ii) the efficiency of energy transfer
from the ligand to metal, and (iii) the efficiency of lanthanide metal
luminescence.
Recently, the design and construction of lanthanide-based
complexes have sparked increasing interest not only on account of the
intriguing variety of architectures and topologies in supramolecular chemistry
and crystal engineering, but also the special photo/electroluminescence,
photocatalytic, and magnetic characteristics [38].
Schiff-base ligands with N, O donor sets have often been used
since the Schiff-base ligands may assemble coordination architectures
directed by the lanthanide (III) ions, while the lanthanide ions can promote
Schiff-base condensation and can give access to complexes. Owing to the
stabilisation of Schiff bases by coordination with lanthanide ions, it is
possible to study applications of the complexes. Complexes of Schiff base
and lanthanide are extensively used as catalysts for RNA hydrolysis, agents
in cancer radiotherapy, contrast agents for NMR imaging and luminescent
probes in visible and near IR domain [39].
11
1.5 BIOLOGICAL IMPORTANCE
Schiff bases were reported to possess antibacterial, antifungal and
antitumor activities. Several researchers have studied the synthesis,
characterisation and structure-activity relationship of Schiff bases.
The rare earth complexes of hydroxycoumarin derivatives are also
subjects of increasing interest in bioinorganic and coordination chemistry.
Lanthanides (III) complexes show antitumor activity and some interesting
lanthanide (III) complexes of coumarin derivatives have been reported [40].
Lanthanides and lanthanide compounds have attracted a great
deal of interest in recent years because they have applications in medicinal
inorganic chemistry and in materials science. In medicine, lanthanide
complexes are exploited as contrast agents for magnetic resonance imaging
(MRI) and are gaining importance in other diagnostic procedures and also as
radio therapeutic drugs [41].
1.5.1 Antimicrobial Activities
The presence of both hard nitrogen or oxygen and soft sulphur
donor atoms in the backbones, makes the ligands readily coordinate with a
wide range of transition metal ions yielding stable and intensely coloured
metal complexes, some of which have been shown to exhibit interesting
physical and chemical properties and potentially useful biological activities
[42].
In recent years, there have been several reports about the studies
on the preparation, characterisation, and antimicrobial properties of rare
earths combine with antibacterial materials. These studies all indicate that
rare earths can increase antibacterial properties. It has been established that
the antibacterial materials containing rare earths can release many free
hydroxylic radicals, which can kill bacteria efficiently [43].
12
Cleiton da Silva et al [44] have reported the synthesis and
antimicrobial activity of a series of Schiff bases derived from the
condensation of 5-chloro-salicylaldehyde and primary amines and found that
they were most active against the standard bacterial species. They have
also reported the efficiency of the Schiff bases to inhibit the growth of fungi
of clinical interest, such as Aspergillus fumigatus, Aspergillus flavus,
Trichophyton mentagrophytes and Penicillium marneffei.
Halli et al have reported a series of Co(II), Ni(II), Cu(II), Cd(II),
Zn(II) and Hg(II) complexes of neutral bidentate Schiff base with azomethine
nitrogen and carbonyl oxygen donor atoms. All compounds showed varying
antioxidant activities while Ni(II), Zn(II), and Hg(II) complexes have shown
good antioxidant activity compared to the Schiff base ligand. Further, the
DPPH (2,2-diphenyl-1-picrylhydrazyl) scavenging capacity of the
synthesised compounds dependents on the concentration [45].
1.6 CATALYTIC ACTIVITIES
Oxidation reaction is so important that it continues to be an area
attracting intense interest among academic and industrial chemists. An ideal
oxidation system would employ inexpensive, readily abundant, terminal and
environment friendly oxidants like H2O2, molecular oxygen and so on,
instead of the noxious traditional oxidants such KMnO4, K2Cr2O7, OsO4 etc.,
[46, 47].
The utilisation of peroxides as surrogates of dioxygen has been
extensively investigated for the oxidation of various organic substrates,
including amines, sulfides, alkanes, alkenes or alcohols [48]. The alkali metal
added to the supported Lanthanum catalysts caused selective promotion of
the catalytic activity for the partial oxidation of benzyl alcohol [49].
Oxidation of amines to their corresponding oxygen containing
derivatives has attracted much attention during the past few decades.
13
Azobenzene, azoxybenzene, nitrobenzene and nitrosobenzene have been
formed in the oxidation of aniline by organic and inorganic oxidants. The
product composition in the oxygenation of amines depends on the oxidant,
catalyst, quaternary ammonium salts and reaction conditions employed [50].
C. F. Chang et al (2009) have reported their results on the
oxidation of amines by aqueous hydrogen peroxide under the influence of
Si-Co as catalyst, in which quantised amount of catalyst, oxidant and
reaction time was observed for carrying out the catalytic reaction [51]. Hence
the rare earth metal complexes have received attention as promising
oxidation catalysts in the selective oxygenation of aromatic and aliphatic
amines, in term of lesser quantum of catalyst and load time.
1.7 METALLO – ELEMENTS UNDER INVESTIGATION
1.7.1 Praseodymium
Praseodymium is a chemical element that has the symbol Pr and
atomic number 59. Praseodymium is a soft, silvery, malleable and ductile
metal in the lanthanide group. It is too reactive to be found in native form,
and when artificially prepared, it slowly develops a green oxide coating.
Compounds of praseodymium occur in oxidation states +2, +3
and/or +4. Praseodymium (IV) is a strong oxidant, instantly oxidizing water to
elemental oxygen (O2), or hydrochloric acid to elemental chlorine. Thus, in
aqueous solution, only the +3 oxidation state is encountered. Praseodymium
(III) salts are yellow-green and, in solution, present a fairly simple absorption
spectrum in the visible region, with a band in the yellow-orange at 589–
590 nm (which coincides with the sodium emission doublet), and three
bands in the blue/violet region, at 444, 468 and 482 nm approximately.
Praseodymium is paramagnetic at any temperature above 1K [52].
These positions vary slightly with the counter-ion. Praseodymium oxide, as
obtained by the ignition of salts such as the oxalate or carbonate in air, is
14
essentially black in colour with a tint of brown or green and contains +3 and
+4 praseodymium in a somewhat variable ratio, depending upon the
conditions of formation. Its formula is conventionally rendered as Pr6O11.
Praseodymium oxide in solid solution with ceria, or with ceria-zirconia, have
been used as oxidation catalysts [53].
1.7.2 Gadolinium
Gadolinium is a chemical element with symbol Gd and atomic
number 64. It is a silvery-white, malleable and ductile rare-earth metal. It is
found in nature only in combined (salt) form. Gadolinium is paramagnetic at
room temperature, with a ferromagnetic curie point of 20 °C [54].
Gadolinium combines with most elements to form Gd (III)
derivatives. Nitrogen, carbon, sulfur, phosphorus, boron, selenium, silicon
and arsenic at elevated temperatures, forming binary compound [55].
Unlike other rare earth elements, metallic gadolinium is relatively
stable in dry air. However, it tarnishes quickly in moist air, forming a loosely
adhering gadolinium (III) oxide (Gd2O3), which spalls off, exposing more
surfaces to oxidation
Gadolinium has no known native biological role, but its compounds
are used as research tools in biomedicine. Gd3+ compounds are components
of MRI contrast agents. It is used in various ion channel electrophysiology
experiments to block sodium leak channels and stretch activated ion
channels.
1.7.3 Samarium
Samarium is a chemical element with symbol Sm and atomic
number 62. It is a moderately hard silvery metal that readily oxidizes in air.
Being a typical member of the lanthanide series, samarium usually assumes
the oxidation state +3. Compounds of samarium (II) are also known, most
15
notably the monoxide SmO, mono chalcogenides SmS, SmSe and SmTe, as
well as samarium (II) iodide. The last compound is a common reducing
agent in chemical synthesis. Samarium has no significant biological role and
is only slightly toxic.
Important application of samarium and its compounds is as
catalyst and chemical reagent. Samarium catalysts assist decomposition of
plastics, dechlorination of pollutants such as polychlorinated biphenyls
(PCBs), as well as the dehydration and dehydrogenation of ethanol [56].
Samarium metal has no biological role in human body. Its salts
stimulate metabolism, but it is unclear whether this is the effect of samarium
or other lanthanides present with it. The total amount of samarium in adults
is about 50 micrograms, mostly in liver and kidneys and with about 8
micrograms per liter being dissolved in the blood. Samarium is not absorbed
by plants to a measurable concentration and therefore is normally not a part
of human diet. However, a few plants and vegetables may contain up to 1
part per million of samarium. Insoluble salts of samarium are non-toxic and
the soluble ones are only slightly toxic [57].
1.7.4 Terbium
Terbium is a chemical element with the symbol Tb and atomic
number 65. It is a silvery-white rare earth metal that is malleable, ductile and
soft enough to be cut with a knife. Terbium is never found in nature as a free
element, but it is contained in many minerals, including cerite, gadolinite,
monazite, xenotime and euxenite. The most common valence state of
terbium is +3, as in Tb2O3. The +4 state is known in TbO2 and TbF4 [58].
Terbium burns readily to form a mixed terbium (III, IV) oxide.
Terbium oxide is used in green phosphors in fluorescent lamps
and colour TV tubes. Sodium terbium borate is used in solid state devices.
The brilliant fluorescence allows terbium to be used as a probe in
16
biochemistry, where it somewhat resembles calcium in its behavior. Terbium
"green" phosphors (which fluorescence a brilliant lemon-yellow) are
combined with divalent europium blue phosphors and trivalent europium red
phosphors to provide the "trichromatic" lighting technology which is by far the
largest consumer of the world's terbium supply. Trichromatic lighting
provides much higher light output for a given amount of electrical energy
than the incandescent lighting [59].
1.7.5 Erbium
Erbium is a chemical element in the lanthanide series, with the
symbol Er and atomic number 68. A silvery-white solid metal when artificially
isolated, natural erbium is always found in chemical combination with other
elements on Earth [60].
Erbium's everyday uses are varied. It is commonly used as a
photographic filter and because of its resilience it is useful as a metallurgical
additive. A large variety of medical applications (i.e. dermatology, dentistry)
utilize erbium ion's 2940 nm emission, which is highly absorbed in water
(absorption coefficient about 12000/cm). Such shallow tissue deposition of
laser energy is necessary for laser surgery, and the efficient production of
steam for laser enamel ablation in dentistry.
Erbium does not have a biological role, but erbium salts can
stimulate metabolism. Human consume 1 milligram of erbium a year on
average [61]. The highest concentration of erbium in human is in the bones,
but there is also erbium in the human kidneys and liver.
1.7.6 Ytterbium
Ytterbium is a chemical element with symbol Yb and atomic
number 70. It is the fourteenth and penultimate element in the lanthanide
series, or last element in the f-block, which is the basis of the relative stability
of the +2 oxidation state. However, like the other lanthanides, the most
17
common oxidation state is +3, seen in its oxide, halides and other
compounds. In aqueous solution, like compounds of other late lanthanides,
soluble ytterbium compounds form complexes with nine water molecules.
Because of its closed-shell electron configuration, its density and melting
and boiling points differ from those of the other lanthanides.
The ytterbium +3 ion is used as a doping material in active laser
media, specifically in solid state lasers and double clad fiber lasers.
Ytterbium lasers are highly efficient, have long lifetimes and can generate
short pulses; ytterbium can also easily be incorporated into the material used
to make the laser [62]. Ytterbium lasers commonly radiate in the 1.06–
1.12 µm band being optically pumped at wavelength 900 nm–1 µm,
dependently on the host and application. The small quantum defect makes
ytterbium a prospective dopant for efficient lasers and power scaling [63].
Ytterbium can also be used as a dopant to help improve the grain
refinement, strength and other mechanical properties of stainless steel.
Some ytterbium alloys have rarely been used in dentistry [64].
18
2. LITERATURE OVERVIEW
2.1 INTRODUCTION
Nowadays, the research field dealing with Schiff base coordination
chemistry has expanded enormously. The importance of Schiff base
complexes for bioinorganic chemistry, biomedical applications,
supramolecular chemistry, catalysis and material science, separation and
encapsulation processes, and formation of compounds with unusual
properties and structures has been well recognised and reviewed. In this
chapter the various fields where the Schiff base complexes finds applications
and several aspects explored by the researchers has been reviewed in
detail.
2.2 ANTIMICROBIAL PROPERTIES
Schiff bases have been reported to show a variety of biological
actions by virtue of the azomethine linkage, which is responsible for various
antibacterial, antifungal, herbicidal and clinical activities. They form an
interesting class of ligands that has enjoyed popular use in the coordination
chemistry of transition, inner transition and main group elements.
Biological and pharmaceutical activities of Schiff base derived
from 2-thiophene carboxaldehyde and aminobenzoic acid have been studied
in comparison to Cu, Fe, Zn, Ni and Co complexes by Safaa et al (2011)
[65]. These compounds were screened for the antimicrobial activity against
bacterial species and fungal species. E. coli was inhibited by Fe, Cu and Zn
complexes and Candida species was inhibited with low inhibition zone.
19
Taha et al (2011) [66] reported the synthesis of Ln (III) complexes
of the Schiff base ligand bis-(salicyladehyde)-1,3-propylenediimine and
screened them for the antibacterial activity. The results obtained reflected
that the ligand exhibited a good activity against Pseudomonas aeruginosa
and Shigella dysenteriae and do not show any activity against Proteus
vulgaris. Most of the tested Ln (III) complexes possessed a high
antibacterial activity against the Gram-negative bacteria tested.
Jadhav et al (2011) [67] explored the antimicrobial activity of the
Schiff base ligands synthesised from dehydroacetic acid, o-phenylene
diamine and fluoro benzaldehyde and its metal complexes of Cu(II), Ni(II),
Co(II), Fe(III) and Mn(II). The results of investigation indicated that all the
ligands and their metal complexes arrested the growth of Aspergillus niger
and Trichoderma. Metal complexes showed considerable increase in fungi
toxicity compared to their ligands. The in vitro antibacterial activity against
bacteria such as Staphylococcus aureus and Escherichia coli, by paper disc
plate method, show that the inhibition by metal complexes was higher than
that of the free ligands and corresponding metal salts against the same
organism under identical experimental conditions.
A series of La(III), Th(IV) and VO(IV) complexes with Schiff bases
derived from 8-formyl-7-hydroxy-4-methylcoumarin and o-phenylenediamine
/ ethylenediamine have been synthesised and screened for their in vitro
antimicrobial activity by Kulkarni et al (2009) [40]. Antibacterial study
revealed that, Schiff bases and some metal complexes were found to be
highly active against Escherichia coli, Pseudomonas aeruginosa and
Salmonella typhi. In case of antifungal studies, both Schiff bases and some
of their complexes were found to be highly active against Aspergillus niger,
Aspergillus flavus and Cladosporium fungi.
The antimicrobial activity of nine Ln (III) complexes of the Schiff
base ligand derived by the condensation of 2-hydroxy-1 naphthaldehyde
with 1,6-hexanediamine, was explored by Ajlouni et al (2012) [22]. All the
20
nine Ln (III) complexes and the Schiff base ligand was studied against
Pseudomonas aeruginosa, Klebsiella and Escherichia coli bacteria. It was
observed from the result that most of the synthesised complexes of the
tested series possessed good antibacterial activity against bacteria and the
microbial activity of the complexes in most cases is higher than that of the
corresponding ligand.
The anti-oxidant potential of Schiff base ligand and its lanthanide
complexes, [Ln(H2L)(NO3)2 . 2H2O]NO3, ((Ln = La, Pr, Nd, Sm, Eu, Gd, Tb,
Dy and Er) (H2L = Schiff base ligand)) was determined by its scavenging
ability on the stable 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical by
Ajlouni et al (2012) [68]. Ln (III) complexes are significantly more efficient in
quenching DPPH radical than the free ligand. Ligand interacts with the
positively charged Ln (III). The electron density is drawn from the oxygen
that makes the O–H bond more polarised; as a result, the H atom has a
greater tendency to ionize than those in the free ligand. Due to the above
reasons the lanthanide complexes show stronger antioxidant activities than
the ligand alone.
Teng-Jin et al (2014) [69] synthesised two multidentate Schiff
bases by reacting S-4 picolyldithiocarbazate with 4-carboxybenzaldehyde
(Cb4PDTC) and pyridine-2-carboxaldehyde (Pc4PDTC) and their transition
metal Ni(II), Cu(II), Zn(II) and Cd(II)) complexes. Moreover, their anti-
microbial, cytotoxic and antioxidant activities were evaluated. The result
which showed that only copper (II) and cadmium (II) complexes are active
against four types of fungi and bacteria
The antioxidant activities of four Ag(I), Cd(II) and Cu(II) complexes
[Ag2L2](ClO4)2, [CdL(NO3)2], [Cd2L2Cl4] and [Cu2L2 (ClO4)3](ClO4) with the
Schiff base ligand derived from 1-(pyrazin-2-yl) ethanone and 1,2-
ethanediamine were described by Omer et al (2014) [70]. The metal
complexes showed better antioxidant activities than the ligand. Among these
complexes, [Cu2L2 (ClO4)3] (ClO4) complex showed a higher activity than the
21
other complexes. This was attributed to the chelation of the organic
molecules with the metal ions to generate a strong effect on scavenging
radicals in the biological system. The antioxidant activity of the ligand and its
complexes showed a guiding role for the design and synthesis of potential
antioxidants and therapeutic agents for some diseases.
Wider investigations were carried out by Ceyhan et al (2011) [71]
on biological activities of the Schiff base ligands (HL1 and HL2 obtained from
2,6-di-tert-butyl-4-hydroxy aniline, and two carbonyl compounds 2,6-di-
formyl-4-isopropyl phenol and 2,6-di-formyl-4-tert-butyl phenol) and their
metal complexes against the bacteria and yeast. The organisms used were
C. xerosis, B. brevis, B.megaterium, B. cereus, M. smegmatis, S. aureus, M.
luteus and E. faecal (as Gram-positive bacteria) and P. aeruginosa, K.
pneumoniae, E. coli, Y. enterocolitica, K. fragilis, S. cerevisiae, and C.
albicans (as Gram-negative bacteria). The diffusion agar technique has been
used to evaluate the antibacterial activity of the synthesised complexes. The
results of the bactericidal screening showed that the Schiff base ligand HL1
has no activity on B. megaterium, M. luteus, S. cerevisiae, and K. fragilis, it
shows activity against the other microorganisms. The ligand HL2 does not
show any activity against M. smegmatis, M. luteus, E. faecalis, E. coli,
S. cerevisiae, and C. albicans, but, it has moderate activity against the other
microorganisms.
The antimicrobial properties of the novel transition metal Schiff
base complexes derived from 5-bromosalicylaldehyde and 1,2-bis(4-chloro-
2-aminophenoxy)ethane has been well explored by Salih et al (2014) [72].
The Schiff and its all metal complexes showed weak antibacterial activities
against E. coli, while Ligand (L), Cu(II), Ni(II), Co(II), Zn(II), Ti(III), V(III) and
Fe(III) complexes showed weak antibacterial activities against B. subtilis
except Mn(II). On the other hand, Ni(II) complex exhibited strong
antibacterial activity against M. luteus, Zn(II) and Mn(II) showed weak
antibacterial activities against M. luteus. The ligand and it’s all metal
complexes did not exhibit antibacterial activities against P. aeruginosa.
22
Kavitha et al [73] reported the antimicrobial properties for a series
of Co(II) complexes of 3-formyl chromone Schiff bases the ligands either
exhibited no activity or having low to moderate activity against bacteria and
fungi strains. But their Co (II) complexes showed moderate to good activity
compared to the standard antibiotics. Among all the Co(II)complexes,
[Co(L2)2].3H2O (L2=2-((4-oxo-4H-chromen-3 yl)methylneamino) benzoicacid)
complex showed effective activity against all bacteria and fungi strains.
However [Co(L4)2].3H2O (L4=3-((2-mercaptophenylimino)methyl)-4H-
chromen-4-one)does not show activity against P.vulgaris and C.albicans. In
comparison, the activity of all the strains was increased by ligands when
coordinated with Co (II) ion.
2.3 LUMINESCENT PROPERTIES
Organo lanthanide complexes attract considerable interest, not
only because of their structures, but also potential applications of their
luminescent properties. The luminescence of a complex depends not only on
the metal ion but also on the coordination environment, e.g., a metal-
centered, ligand sensitised luminescence may occur when a suitable ligand
efficiently absorbs the excitation energy followed by energy transfer to the
metal center.
Taha et al (2011) [66] synthesised and characterised the
tetradentate Schiff base ligand L (L = bis-(salicyladehyde)-1,3-
propylenediimine) and its Ln (III) complexes. The Tb and Dy complexes
exhibited characteristic luminescence of Tb and Dy ions whereas the Nd, La,
Gd, Er, Sm and Pr complexes showed only the fluorescence characteristic of
the ligand. This indicated that the ligand L was a good organic chelator to
absorb and transfer energy to Tb and Dy ions. They explained that the
energy gap between the lowest triplet state energy level of the ligand and
the lowest excited state level of Tb (III) favour to the energy transfer process
for Tb.
23
Figure 2.1 Emission spectrum of the complex [TbL(NO3)2(H2O)2](NO3)
Pengfei Yan et al (2007) [74] synthesised six new 1D lanthanide
Schiff base coordination polymers and characterised them by elemental
analysis and spectroscopic analysis. Fluorescent spectroscopic analysis
indicated that ligand tunes the luminescent properties of the lanthanide ions.
The triplet state energy level of the Schiff base ligand matched well with the
lowest excited state (4G5/2) level of Sm3+ ion. Hence they observed that the
lanthanide schiff-base complexes are promising luminescent materials. The
studied the design of analogous polymers using various Schiff bases and
explored the accessibility of the Lewis acid lanthanide metal sites in the
complexes.
Pawan et al (2011) [75] has reported the mesogenic Schiff-base,
N,N-di-(4-decyloxysalicylidene)- l,6-diaminohexane, coordinates to Ln (III)
as a neutral bi-dentate species to yield seven-coordinate complexes with La,
Pr, Nd, Sm, Eu, Gd, Tb, Dy and Ho, the polyhedron being possibly distorted
mono-capped octahedron. The zwitterion-species of the neutral bi-dentate
ligand, coordinated to the Ln (III) metal ion through two phenolate oxygens.
The fluorescence studies indicate that the ligand appeared to be a suitable
organic chelator for energy transfer to Tb (III) ion.
24
Figure 2.2 The fluorescence spectra of (a) Tb (III) and (b) Sm (III) complexes
Tian-Lin et al (2007) [76] reported the synthesis of a new Schiff
base ligand with tripodal structure, N,N,N-tri-(3-indolemethanal)
triaminotriethylamine and its complex with terbium. The author revealed that
the Schiff base ligand could form stable complex with terbium ion and was
coordinated to Schiff base nitrogen atoms and the bridgehead nitrogen atom
of the ligand. The terbium complex with ligand can emit intrinsic spectrum of
the ion under excitation of ultraviolet light. The results indicated that H+ could
strongly enhance the luminescence of terbium complex with ligand in
aqueous solutions. The results demonstrate that the nitrogen atom of indole
is important for the fluorescence enhancement of the switch. The
mechanism of the fluorescence enhancement by protonation of the indole
nitrogen atom is due to the suppressed photoinduced electron transfer
(PIET) fluorescence quenching when adding acid.
Jean-Claude et al (2007) [77] has explored the wide choice of
luminescence properties displayed by lanthanide ions, as well as the well-
mastered introduction of these ions into a wealth of different molecular and
extended structures such as coordination polymers and microporous
materials, which is a fantastic playground for scientists and engineers. This
also revealed that the lanthanides will be the key elements in helping
scientists to meet all the future technological challenges, including solving
25
the energy problem. This will also boost the capability to monitor biological
processes essential to life and help physicians curing major diseases such
as cancer.
2.4 CATALYTIC PROPERTIES
Organic pollutants in industrial wastes predominantly contain
amines. Research has been widely carried out to oxidise these amines into
nontoxic products. Schiff base ligands and its transition and rare earth metal
complexes are used as catalyst for this oxidation studies. Researchers have
been aiming to oxidise the amines to the desired products and also enhance
the life cycle of the catalyst under optimum conditions.
A new approach for polymerisation of aniline has been reported by Nabid et al (2007) [78] by using transition-metal tetrasulfonated phthalocyanine as catalysts. This approach provided a distinct advantage over similar reactions employing native enzymes due to higher stability and lower price of the catalysts. The polymerisation was accomplished in an aqueous buffer at pH 2. The results indicate that application of Fe complexes in polymerisation of aniline is better than Mn and Co as catalysts. Also they have shown that the metallophthalocyanines are better catalysts than metalloporphyrin.
Alizadeh et al (2005) [50] showed that the oxidation of aniline by 35% hydrogen peroxide, catalysed by H3PW12O40 family (under two-phase conditions at room temperature or under reflux) provided a simple and general procedure for the preparation of nitrosoaniline, which was difficult to prepare selectively by conventional methods. The results clearly demonstrated that this oxidation system was more efficient in the selective oxidation of aniline with hydrogen peroxide.
The oxidations of primary aromatic amines were investigated by Wenchao Lu et al (2008) [79]. Cuprous chloride-air system can catalyze the oxidation of primary aromatic amines to azo derivatives, anils and quinone
26
anils. They have reported that the experimental procedure is simple and the products could be easily isolated in high yields.
Scheme 2.1 Catalytic Oxidation of aniline using hydrogen peroxide
Scheme 2.2 Catalytic Oxidation of 4-methoxyaniline
The catalytic activities of the lanthanum (La) catalysts supported
on the zeolite and SiO2 and the alkali metal-added counterparts (alkali
metal/La/support) were studied by Masaya et al (2004) [49] using the gas-
phase catalytic oxidation of benzyl alcohol. The addition of alkali metal to the
La/NaZSM-5 and La/SiO2 catalysts caused an increase in the oxidation
activity, particularly the partial oxidation activity of benzyl alcohol. The added
alkali metal was indicated to play an important role in activating the reactant
through the adsorption of benzyl alcohol, in addition to inhibiting the
deposition of carbonaceous materials on the catalyst.
Chang et al (2009) [51] have given the procedure in their work
which offers several advantages for the preparation of azoxybenzenes from
the corresponding aniline such as low loading of catalyst, mild conditions,
high yields and clean reactions, which make it a useful and attractive
27
methodology for organic synthesis. The simple workup procedure is also
beneficial to this method. Although the preparation of the catalyst was
nontrivial, it offers information for the future design of new catalysts.
Scheme 2.3 Oxidation of anilines with hydrogen peroxide over Si-Co
Through the literature review it has been observed that the Schiff
bases show a variety of biological actions by virtue of the azomethine
linkage, which is responsible for various antibacterial, antifungal and
antioxidant properties. Upon complexation, these properties found to
enhance due to the coordination with the central metal ions. In addition, it
has been reported that the Schiff base complexes of transition, rare earth
metal ions have played a significant role in various reactions to enhance
their yield and product selectivity. The convenient route of synthesis and
thermal stability of Schiff base ligands have contributed significantly for their
possible applications in catalysis as metal complexes. Catalytic activity of
Schiff base complexes show significant variations with structure and type of
Schiff base ligands used. These studies have clearly demonstrated that the
Schiff base complexes of rare earth metals are versatile and efficient
catalysts for reaction of commercial importance and suitable to catalyze
various reactions under mild conditions.
Keeping all these facts in mind and the efficacy of the Schiff base
metal complexes, new type of Schiff base ligands using aminoacid
derivatives and rare earth Schiff base complexes are synthesized and they
are screened for various applications like antibacterial, antifungal,
luminescent and catalytic properties.
28
2.5 AIMS AND OBJECTIVES
The major objectives of the current study are:
i) to prepare new Schiff bases having N, O donor ligands using
the derivatives of aminoacids viz., serine, threonine and
leucine respectively with 5-bromo salicylaldehyde.
ii) to synthesise complexes with the above ligands using rare
earth metals like Pr, Sm, Gd, Tb, Er and Yb.
iii) to characterise the various Schiff base ligands and rare earth
metal complexes using spectral / analytical techniques like
FTIR, NMR, UV, mass and TGA/DTA.
iv) to study the fluorescence effect of Ln (III) Schiff base
complexes derived from serine, threonine and leucine.
v) to study the applicability towards the antimicrobial activity of
the rare earth metal Schiff base complexes derived from
serine, threonine and leucine.
vi) to study the catalytic effect of rare earth metal Schiff base
complexes derived from leucine, in the oxidation of aniline
and substituted anilines.
2.6 OUTLINE OF THE THESIS
The content of the current thesis has been divided into ten
chapters.
Chapter one: This chapter throws light on the fundamental
concepts and brief introduction of the present work.
Chapter two: This chapter reviews the literature concerning
various Schiff bases derived from amino acid, importance of Schiff bases,
29
their characterisation and rare earth metal Schiff base and their applications
in various fields.
Chapter three: A detailed description of all the reagents and
materials used, procedures for physical measurements has been discussed
in this chapter. Also, the procedures for the preparation of Schiff bases in
addition to the synthesis of their corresponding rare earth metal complexes,
procedures for antimicrobial, antioxidant and the catalytic activities of the
synthesised compounds has been discussed.
Chapter four: This chapter illustrates the preparation and
characterisation of the rare earth metal Schiff base complexes of type
[Ln(L1)(NO3)2(H2O)].NO3.Where, Ln = Pr (III), Sm (III), Gd (III), Tb (III), Er
(III) and Yb (III) and L1 = Sodium 2-(5-bromo-2-hydroxybenzylideneamino)-
3-hydroxypropanoate, derived from L-serine and 5-bromosalicylaldehyde.
Fluorescence characteristics of the above said complexes have been
studied and the complexes are screened for their antimicrobial activities.
Chapter five: The synthesis of various rare earth metal
complexes of the Schiff base ligand L2 derived from threonine and 5-
bromosalicylaldehyde, L2 = Sodium 2-(5-bromo-2-hydroxybenzylidene
amino)-3-hydroxybutanoate and the spectral characterisation of the newly
synthesised complexes have been expressed in this chapter, along with their
fluorescence, antimicrobial activities.
Chapter six: This chapter describes the synthesis of new
lanthanide complexes of Pr (III), Sm (III), Gd (III), Tb (III), Er (III) and Yb
(III) with the Schiff base, Sodium 2-(5-bromo-2-hydroxybenzylideneamino)-
4-methylpentanoate, derived from leucine and 5-bromosalicylaldehyde.
Their fluorescence and antimicrobial nature have also been studied.
Chapter Seven: This chapter describes the catalytic nature of the
synthesised lanthanide complexes, Pr (III), Sm (III), Gd (III), Tb (III), Er (III)
30
and Yb (III) with the Schiff base, derived from leucine towards the oxidation
of anilines and substituted anilines with H2O2 as oxidant.
Chapter Eight: This is a concluding chapter which focuses on the
summary of the present work. Various tridentate Schiff base ligands L1, L2,
L3 and their Ln (III) complexes were synthesised and characterised by
elemental analysis, TGA/DTA, spectral analysis like 1H NMR, UV, FT-IR and
Mass Spectrometry. The fluorescence studies of the synthesised complexes
indicate that the ligand L is a good organic chelator to absorb energy and
transfer it to Ln (III) ions. The biological studies of the complexes show that
most of the synthesised complexes possess a good biological activity
against pathogens tested than the corresponding free Schiff base ligand.
The Ln (III) complexes of the Schiff base ligand L3 possess good catalytic
ability for oxidation of aniline under mild conditions and [Gd(L3)(NO3)2
(H2O)]NO3 complex was chosen as standard to check the generality and
efficiency of oxidation of various substituted anilines.
Chapter Nine: The future prospect of the current investigation has
been presented in this chapter.
Chapter Ten: The list of references used throughout the thesis
has been given in this chapter.
31
3. EXPERIMENTAL METHODS AND TECHNIQUES
The details of the general experimental techniques adopted,
analytical procedures and materials employed along with details like
preparation of ligands, preparation of metal complexes, solvent purification
are described in this chapter.
3.1 MATERIALS EMPLOYED
The following chemicals were used at various stages of this work:
The sources of the chemicals are given within parenthesis. 5-bromo
salicylaldehyde, L-Leucine (Sigma-Aldrich), L-Serine (Sigma-Aldrich),
L-Threonine (Sigma-Aldrich), Praseodymium (III) nitrate hexahydrate (Rare
Earths), Samarium (III) nitrate hexahydrate (Rare Earths), Gadolinium
(III) nitrate hexahydrate (Rare Earths), Erbium (III) nitrate hexahydrate
(Rare Earths), Terbium (III) nitrate hexahydrate (Rare Earths), Ytterbium
(III) nitrate hexahydrate (Rare Earths), Sodiumhydroxide pellets (SRL),
Phenylamine (Sigma-Aldrich), p-Tolylamine (Sigma-Aldrich), 4-Chloro-
phenylamine (Sigma-Aldrich), 4-Nitro-phenylamine (Sigma-Aldrich),
4-Methoxy-phenylamine (Sigma-Aldrich), m-phenylenediamine (Sigma-
Aldrich), 3-Methoxy-phenylamine (Sigma-Aldrich), 3-Chloro-phenylamine
(Sigma-Aldrich), m-Tolylamine (Sigma-Aldrich), 2-Chloro-phenylamine
(Sigma-Aldrich), 2-Methoxy-phenylamine (Sigma-Aldrich), Amino-benzoic
acid (Sigma-Aldrich), 30 % H2O2 (SRL).
3.2 SOLVENTS
Common solvents like ethanol, methanol, acetone, acetonitrile,
chloroform, dichloromethane, hexane, petroleum ether, DMSO, DMF(HPLC
Grade), and CDCl3 used at various stages of this work were purified
32
according to the standard procedures described either in Weissberger series
(Weissberger et al 1970) or in qualitative analysis by Vogel (Vogel 1978).
3.3 EXPERIMENTAL METHODS
3.3.1 Synthesis of Schiff Base Ligand [L1]
The sodium salt of the Schiff base ligand L1 was synthesised as
per the following literature procedure [80]. To an aqueous solution of
L-Serine (0.002 mol) in 10 mL water containing NaOH (0.002 mol),
5-bromosalicyaldehyde (0.002 mol) in 10 mL ethanol was added drop wise
with constant stirring and heated under reflux for 3-5 h on a mantle at 50oC.
Then, the reaction mixture was cooled to room temperature. Fine shining
yellow precipitate of the sodium salt of the Schiff base ligand L1 (sodium 2-
(5-bromo-2-hydroxybenzylideneamino)-3-hydroxypropanoate) formed was
filtered off, washed with ethanol-water mixture and stored in a vacuum
desiccator over anhydrous calcium chloride.
H2NOH
OOH
serine
+HO
OBr
5-bromosalicylaldehyde
OHN
Br
OOH
ONaEtOH/NaOH
Reflux - 3h
L1sodium 2-(5-bromo-2-hydroxybenzylideneamino)-3-
hydroxypropanoate
Scheme 3.1 Synthesis of Schiff base ligand [L1]
3.3.2 Synthesis of [Ln(L1)(NO3)2(H2O)].NO3 Complexes
The rare earth Schiff base complexes were synthesised as per the
following general literature procedure [80]. A 0.002 mol of a Schiff base
ligand L1 was dissolved in 10 mL of ethanol. To this solution, a solution of
0.002 mol Ln(NO3)3.xH2O in 10 mL water, was added drop wise with
33
constant stirring and finally heated under reflux for 3 – 5 h on a hot plate at
50oC. The reaction mixture was cooled to room temperature. A fine yellow
precipitate of the solid complexes formed was filtered off, washed with
ethanol-water mixture and stored in a vacuum desiccator over anhydrous
calcium chloride.
The following Ln (III) complexes were prepared using the similar
procedure and its physical properties are tabulated in Table 3.1.
[Pr(L1)(NO3)2(H2O)] NO3,
[Sm(L1)(NO3)2(H2O)] NO3,
[Gd(L1)(NO3)2(H2O)] NO3,
[Tb(L1)(NO3)2(H2O)] NO3,
[Er(L1)(NO3)2(H2O)] NO3,
[Yb(L1)(NO3)2(H2O)] NO3.
CH
O
N CO
LnO
NO3
NO3
H2O NO3
OH
OHN
Br
OOH
ONa
L1
BrLn(NO3)3.xH2OReflux3-5 h
+EtOH / H2O mixture
Scheme 3.2 Synthesis of rare earth metal Schiff base [L1] complexes.
34
Table 3.1 Physical properties and the percentage yield of the Schiff base ligand [L1] and its Ln (III) complexes
Compound Molecular Formula Colour Yield (%)
L1 C10H9O4NBrNa Bright Yellow 79
[Pr(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrPr Yellow 86
[Sm(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrSm Yellow 84
[Gd(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrGd Pale Yellow 96
[Tb(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrTb Yellow 92
[Er(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrEr Yellow 74
[Yb(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrYb Yellow 81
3.3.3 Synthesis of Schiff Base Ligand [L2]
The sodium salt of the Schiff base ligand L2 was synthesised as
per the following literature procedure [81]. To an aqueous solution of
threonine (0.002 mol) in 10 mL water containing NaOH (0.002 mol),
5-bromosalicyaldehyde (0.002 mol) in 10 mL ethanol was added drop wise
with constant stirring and heated under reflux for 3-5 h. on a mantle at 50oC.
Then, the reaction mixture was cooled to room temperature. Fine shining
yellow precipitate of the sodium salt of the Schiff base ligand (sodium 2-(5-
bromo-2-hydroxybenzylideneamino)-3-hydroxybutanoate) formed was
filtered, washed with ethanol-water mixture and stored in a vacuum
desiccator over anhydrous calciumchloride.
35
NH2
OH
OHO
Threonine
+HO
OBr
5-bromosalicylaldehyde
OHN
Br
OOH
ONaEtOH/NaOH
Reflux - 3h
L2sodium 2-(5-bromo-2-hydroxybenzylideneamino)-3-
hydroxybutanoate
Scheme 3.3 Synthesis of Schiff base ligand [L2]
3.3.4 Synthesis of [Ln(L2)(NO3)2(H2O)].NO3 Complex
The rare earth Schiff base complexes were synthesised as per the
following general literature procedure [81]. A 0.002 mol of a Schiff base
ligand L2 was dissolved in 10 mL of ethanol. To this solution, a solution of
0.002 mol Pr(NO3)3.xH2O in 10 mL water, was added drop wise with
constant stirring and finally heated under reflux for 3 – 5 h. on a hot plate at
50oC. The reaction mixture was cooled to room temperature. A fine yellow
precipitate of the solid complex formed was filtered, washed with ethanol-
water mixture and stored in a vacuum desiccator over anhydrous calcium
chloride.
The following Ln (III) complexes were prepared using the similar
procedure and its physical properties are tabulated in Table 3.2.
[Pr(L2)(NO3)2(H2O)] NO3,
[Sm(L2)(NO3)2(H2O)] NO3,
[Gd(L2)(NO3)2(H2O)] NO3,
[Tb(L2)(NO3)2(H2O)] NO3,
[Er(L2)(NO3)2(H2O)] NO3,
[Yb(L2)(NO3)2(H2O)] NO3.
36
OHN
Br
OOH
ONa
L2
Ln(NO3)3.xH2OReflux3-5 h
NO3
+EtOH / H2O mixture
CH
O
N CO
LnO
NO3
NO3
H2O
OH
Br
Scheme 3.4 Synthesis of rare earth metal Schiff base [L2] complexes.
Table 3.2 Physical properties and the percentage yield of the Schiff base ligand [L2] and its Ln (III) complexes
Compound Molecular Formula Colour Yield (%)
L2 C11H11O4NBrNa Bright Yellow 81
[Pr( L2)(NO3)2(H2O)]NO3 C11H12O11N3BrPr Yellow 93
[Sm(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrSm Yellow 87
[Gd(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrGd Yellow 86
[Tb(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrTb Pale Yellow 94
[Er(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrEr Yellow 88
[Yb(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrYb Pale Yellow 79
3.3.5 Synthesis of Schiff Base Ligand [L3]
The sodium salt of the Schiff base ligand was synthesised as per
the following literature procedure [82]. To an aqueous solution of Leucine
(0.002 mol) in 10 mL water containing NaOH (0.002 mol), 5-
bromosalicyaldehyde (0.002 mol) in 10 mL ethanol was added drop wise
with constant stirring and heated under reflux for 3-5 h. on a mantle at 50oC.
Then, the reaction mixture was cooled to room temperature. Fine shining
yellow precipitate of the sodium salt of the Schiff base ligand (sodium 2-(5-
bromo-2-hydroxybenzylideneamino)-4-methylpentanoate) formed was
37
filtered off, washed with ethanol-water mixture and stored in a vacuum
desiccator over anhydrous calcium chloride.
NH2
O
HO
Leucine
+HO
OBr
5-bromosalicylaldehyde
OHN
Br
O
ONaEtOH/NaOH
Reflux - 3h
L3
sodium 2-(5-bromo-2-hydroxybenzylideneamino)-4-methylpentanoate
Scheme 3.5 Synthesis of Schiff base ligand [L3]
3.3.6 Synthesis of [Ln(L3)(NO3)2(H2O)] NO3 Complex
The rare earth Schiff base complex was synthesised as per the
following general literature procedure [82]. A 0.002 mol of a Schiff base
ligand L3 was dissolved in 10 mL of ethanol. To this solution, a solution of
0.002 mol Ln(NO3)3.xH2O in 10 mL water, was added drop wise with
constant stirring and finally heated under reflux for 3 – 5 h. on a hot plate at
50oC. The reaction mixture was cooled to room temperature. A fine yellow
precipitate of the solid complex formed was filtered off, washed with ethanol-
water mixture and stored in a vacuum desiccator over anhydrous calcium
chloride.
The following Ln (III) complexes were prepared using the similar
procedure and its physical properties are tabulated in Table 3.3.
[Pr(L3)(NO3)2(H2O)] NO3,
[Sm(L3)(NO3)2(H2O)] NO3,
[Gd(L3)(NO3)2(H2O)] NO3,
[Tb(L3)(NO3)2(H2O)] NO3,
[Er(L3)(NO3)2(H2O)] NO3,
[Yb(L3)(NO3)2(H2O)] NO3.
38
NO3OHN
Br
O
ONa
L3
Ln(NO3)3.xH2O
Reflux3-5 h
+EtOH / H2O mixture
CH
O
N C
O
Ln
O
NO3
NO3
H2OBr
Scheme 3.6 Synthesis of rare earth metal Schiff base [L3] complexes
Table 3.3 Physical properties and the percentage yield of the Schiff base ligand [L3] and its Ln (III) complexes
Compound Molecular Formula Colour Yield (%)
L3 C13H16O3NBrNa Bright Yellow 86
[Pr( L3)(NO3)2(H2O)]NO3 C13H16O10N3BrPr Yellow 96
[Sm(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrSm Yellow 94
[Gd(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrGd Yellow 96
[Tb(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrTb Yellow 95
[Er(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrEr Yellow 91
[Yb(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrYb Yellow 89
3.3.7 In vitro Antibacterial Study
The synthesised Schiff base ligand L1 and their corresponding
Ln (III) complexes were screened for antibacterial activity against the gram
negative and gram positive pathogens namely, Escherichia coli, Proteus,
Pseudomonas aeruginosa, Staphylococcus aureus, L2, L3 and their
corresponding Ln (III) complexes against the pathogens namely Escherichia
coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus
agalactiae by the reported method [83]. The stock solution (1 mg mL-1) of
the test chemical was prepared in DMF solution. The stock solution was
39
further diluted with sterilised distilled water to different dilutions in µg mL-1.
The test chemicals of different dilutions were added to sterile blank
antimicrobial susceptibility discs. The bacteria were subcultured in agar
medium and the discs were kept onto the same. The petridishes were
incubated for 24 h at 37oC. The Standard antibacterial drug (ciprofloxacin/
Amikacin) was also screened under similar conditions for comparison.
Activity was determined by measuring the zones of growth inhibition
surrounding the discs. Growth inhibition was compared with the standard
drug. In order to clarify the effect of solvent (DMF) on the biological
screening, DMF alone was added to separate discs and used as control, and
it showed no activity against bacterial strains.
3.3.8 In vitro Antifungal Study
The synthesised Schiff base ligand L1, L2, L3 and their
corresponding Ln (III) complexes were screened for in vitro antifungal
activity according to the disc diffusion method. The assay was determined
against the fungal species Candida and Aspergillus by the reported method
[84, 85]. The stock solution (1 mg mL-1) of the test chemical was prepared in
DMF solution. The stock solution was further diluted with sterilised distilled
water to different dilutions in µg mL-1. The test chemicals of different dilutions
were added to sterile blank antimicrobial susceptibility discs. The fungi were
sub cultured in potato dextrose agar (PDA) and the discs were kept onto the
same. The petridishes were incubated for 72 h at 28°C. The standard
antimicrobial drug Ketoconazole was also screened under similar conditions
for comparison. The results were recorded by measuring the zones of
growth inhibition surrounding the discs. The mean value obtained from three
independent replicates was used to calculate the zone of growth inhibition of
each sample. In order to clarify the effect of solvent (DMF) on the
antimicrobial screening, DMF alone was added to separate discs and used
as control, and it show no activity against the fungal strains.
40
3.3.9 Catalytic Oxidation of Aniline
To a stirred solution of the catalyst (0.015 mmol) and 30 % of
H2O2 (10 mmol) in CH2Cl2 (7 mL), aniline (8 mmol) was added and the
reaction mixture was stirred at room temperature for the required time.
Progress of the reaction was monitored by TLC at regular intervals and
continued for mentioned reaction time. After removal of the solvent, the
residue was purified by Silica gel flash chromatography to afford
azobenzene. All the azobenzene thus obtained were identified by
comparing 1H NMR data with values reported in the literature and those of
the authentic samples. The desired 3,3’-azotoluene was obtained (Yield:
66 %), for which, 1H NMR (CDCl3, 200 MHz): (ppm) = 2.44 (s, 6H), 7.27–
7.73 (m, 14H). 13C NMR (CDCl3, 100 MHz): (ppm) = 20.9, 119.7, 123.4,
128.7, 131.4, 138.0, 152.4.
Scheme 3.7 Catalytic oxidation of aniline
3.4 ANALYTICAL METHODS
3.4.1 Microanalysis
Carbon, hydrogen and nitrogen contents of the newly prepared
ligands and complexes were analysed at CDRI, Lucknow and IIT, Madras.
3.4.2 Molecular Weight Determination
Molecular weight determination was done by Rast micro method
by determining the freezing point depression of a solvent. Diphenyl (71oC)
CH2Cl2(2 ml), r.t.
NH2
Phenylamine
GdL1(NO3)2H2O].NO3/H2O2 N N
Diphenyl-diazene
[GdL1 (NO3) 2H2O]NO3/H2O2
CH2Cl2 (2mL), 30oC
41
was used as the solvent which was calibrated using naphthalene. About 10
mg of the complex was introduced to 100 mg of diphenyl to determine its
melting point depression. The molecular weight was determined by
employing the equation,
3f
f
K wM 10T W
(3.1)
Where Kf = cryoscopic constant of the solvent employed, w = weight of
the solute, Tf = freezing point depression and W = weight of the
solvent taken.
3.5 INSTRUMENTAL METHODS
3.5.1 Infrared Spectra
The infrared spectra of all the complexes and the ligands were
recorded on a Perkin-Elmer 577 (4000-400 cm-1) double beam infrared
spectrophotometer or Perkin-Elmer 783 spectrophotometer or on a JASCO
FT / IR 5300 model spectrophotometer.
KBr pellet method was used here, which involves the mixing of
powdered KBr with the solid sample and pressing the mixture under high
pressure. The KBr pellet thus obtained was inserted into the holder in the
spectrometer and the spectrum was obtained.
3.5.2 Electronic Spectra
Electronic spectra were recorded in DMF (HPLC Grade) solution
on a Shimadzu UV-Vis. 160 spectrophotometer in the range 200-800 nm.
The concentration of the samples prepared was (1.0 10-6 M) and the
spectrum was recorded at room temperature.
42
3.5.3 NMR Spectra
Proton magnetic resonance spectral measurements were made on
a Brucker 300 MHz (or) Perkin-Elmer R32, 90 MHz (or) Joel, GSX 400, 400
MHz spectrometer in deuterated organic solvent DMSO with
tetramethylsilane (TMS) as the internal standard. Frequencies were
measured by the side band technique and area was determined
planimetrically.
43
4. SCHIFF BASE DERIVED FROM SERINE AND ITS LANTHANIDE (III) COMPLEXES
4.1 INTRODUCTION
An enhanced global change has given a pressing need to develop
an alternate synthetic approach for biologically and synthetically important
compounds. Schiff base ligands and their metal complexes have been
shown to exhibit a variety of application including biological, clinical,
analytical and industrial in addition to their important roles in catalysis and
organic synthesis [86-90] and hence continue to occupy as a vital ligands in
metal coordination chemistry [91-93], even almost a century since their
discovery. Since, chemistry of lanthanides is a promising research area
stimulated by a wide variety of applications, coordination chemistry of
lanthanides and its complexes have aroused much interest [94]. Schiff
bases can coordinate to many lanthanide systems, because of their
excellent coordination nature to the rare earth ions and the ability of
sensitizing the properties of lanthanide ions [95, 96]. An interesting
coordination chemistry of lanthanide Schiff base complexes and their role in
chemical, medical and industrial processes are enough to recognize them as
worthwhile for the synthesis of new complexes. Therefore, an attempt has
been made to describe synthesis, characterisation and biological evaluation
of some lanthanide (III) Schiff base complexes containing N, O donor atoms.
A novel tridentate Schiff base ligand [L1] (Figure 4.1) and its six
lanthanide (III) complexes were synthesised (Chapter 3). The coordination
behaviour of lanthanide(III) ions with Schiff base ligand [L1] have been
studied using 1HNMR , elemental analysis, Thermal studies, Mass, FT-IR
and UV-Vis., data. Moreover, Fluorescence behaviour and antimicrobial
44
efficiency of these complexes against different microorganisms have also
been studied.
OHN
Br
OOH
ONa
L1
sodium 2-(5-bromo-2-hydroxybenzylideneamino)-3-hydroxypropanoate
Figure 4.1 Sodium salt of the Schiff base ligand [L1]
4.2 RESULTS AND DISCUSSION
In the present investigation, the Schiff base ligand [L1] and its six
new lanthanide metal complexes were synthesised and characterised by
different analytical techniques. The ligand [L1] was synthesised by the one
step condensation of L-serine with 5-bromosalicyaldehyde and characterised
by UV-Vis, FT-IR, 1H NMR, Mass and TG Analysis. All the Ln (III)
complexes (Ln= Pr, Sm, Gd, Tb, Er and Yb) were synthesised as per the
scheme given in Scheme 4.1, in which Ln(NO3)3.xH2O was used as the
source of metal and they correspond to the formula [LnL1(NO3)2(H2O)] NO3.
All the complexes were non-hygroscopic powders and stable in air, soluble
in DMSO and DMF, sparingly soluble in methanol, ethanol, acetonitrile and
ethylacetate.
45
H2NOH
OOH
serine
+ HO
OBr
5-bromosalicylaldehyde
OHN
Br
OOH
ONaEtOH/NaOH
Reflux - 3h
L1
sodium 2-(5-bromo-2-hydroxybenzylideneamino)-3-hydroxypropanoate
Reflux 3-5h
Ln(NO3)3.xH2O
CH
O
N CO
LnO
NO3
NO3
H2O NO3
OH
Br
Ln(III) complexes
Scheme 4.1 Synthesis of Schiff base ligand [L1] and Ln (III) Schiff
base complex [Ln = Pr (III), Sm (III), Gd (III), Tb (III), Er (III) and Yb (III)]
4.2.1 Elemental Analysis
Table 4.1 shows the list of the elemental analysis of the Schiff
base ligand [L1] and synthesised Ln (III) Schiff base complexes which are in
good agreement with the calculated values.
46
Table 4.1 Elemental Analysis of the ligand [L1] and Ln (III) Schiff base complexes
Compound Molecular Formula
Molecular weight
Cal.(Exp.)%
C H N
L1 C10H9O4NBrNa 310 38.73(38.67) 2.93(3.23) 4.52(4.73)
[Pr(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrPr 569.01 21.11(21.45) 1.77(1.56) 7.38(7.53)
[Sm(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrSm 578.46 20.76(21.06) 1.74(1.92) 7.26(7.59)
[Gd(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrGd 585.35 20.52(20.76) 1.72(1.53) 7.18(7.42)
[Tb(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrTb 587.03 20.46(20.22) 1.72(1.31) 7.16(7.32)
[Er(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrEr 595.36 20.17(20.45) 1.96(1.38) 7.06(7.23)
[Yb(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrYb 601.14 19.98(19.57) 1.68(1.36) 6.99(6.55)
4.2.2 Mass Spectra
A mass spectrum of the newly synthesised Schiff base ligand
confirms the proposed formula by detecting the molecular fragments. Mass
spectrometry chemical ionisation of the ligand and the lanthanide complexes
(Figures 4.1 and 4.9) show abundant molecular ions at various m/z values.
The mass spectrum of the ligand shows molecular ions [C10H9O4BrNNa]+. at
m/z = 310 and important fragments at m/z = 256 [C9H6O3BrN]+, 185
[C7H5BrO]+ , 125 [C3H4O3NNa]+ and 79 [Br]+. Some isotopic peaks of the
compounds are also found around these peaks [97].
The mass spectrum of the Pr (III) complex shows molecular ions
[C10H10O11N3BrPr]+. at m/z = 569 and important fragments at m/z = 425
[C10H8O4NBrPr]+, 184 [C7H4BrO]+ , 102 [C3H4O3N]+ and 79 [Br]+.
The mass spectrum of the Sm (III) complex shows molecular ions
[C10H10O11N3BrSm]+. at m/z = 578 and important fragments at m/z = 459
[C10H8O4NBrSm]+, 184 [C7H4BrO]+ , 102 [C3H4O3N]+ and 79 [Br]+.
47
The mass spectrum of the Gd (III) complex shows molecular ions
[C10H10O11N3BrGd]+. at m/z = 585 and important fragments at m/z = 442
[C10H8O4NBrGd]+, 184 [C7H4BrO]+ , 102 [C3H4O3N]+ and 79 [Br]+.
The mass spectrum of the Tb (III) complex shows molecular ions
[C10H10O11N3BrTb]+. at m/z = 587 and important fragments at m/z = 445
[C10H8O4NBrTb]+, 184 [C7H4BrO]+ , 102 [C3H4O3N]+ and 79 [Br]+.
The mass spectrum of the Er (III) complex shows molecular ions
[C10H10O11N3BrEr]+. at m/z = 595 and important fragments at m/z = 453
[C10H8O4NBrEr]+, 184 [C7H4BrO]+ , 102 [C3H4O3N]+ and 79 [Br]+.
The mass spectrum of the Yb (III) complex shows molecular ions
[C10H10O11N3BrYb]+. at m/z = 601 and important fragments at m/z = 459
[C10H8O4NBrYb]+, 184 [C7H4BrO]+ , 102 [C3H4O3N]+ and 79 [Br]+.
Figure 4.2 Mass Spectrum of the Schiff base ligand [L1]
m/z
%
48
Figure 4.3 Mass Spectrum of the [Pr(L1)(NO3)2(H2O)]NO3 complex
m/z
%
49
Figure 4.4 Mass Spectrum of the [Sm(L1)(NO3)2(H2O)]NO3 complex
m/z
%
50
Figure 4.5 Mass Spectrum of the [Gd(L1)(NO3)2(H2O)]NO3 complex
m/z
%
51
Figure 4.6 Mass Spectrum of the [Tb(L1)(NO3)2(H2O)]NO3 complex
m/z
%
52
Figure 4.7 Mass Spectrum of the [Er(L1)(NO3)2(H2O)]NO3 complex
m/z
%
53
Figure 4.8 Mass Spectrum of the [Yb(L1)(NO3)2(H2O)]NO3 complex
m/z
%
54
Figure 4.9 HR-MS of the [Pr(L1)(NO3)2(H2O)]NO3 complex
55
4.2.3 Molar Conductance
Molar conductivity data for all the Ln (III) Schiff base complexes in
DMF solution at room temperature are observed to be in the range of
110-121 Scm2mol-1 and are given in Table 4.2. This suggests 1:1
electrolytes and the two nitrate are coordinated to the Ln (III) ion [98].
Table 4.2 Molar conductance of the ligand [L1] and Ln (III) Schiff base complexes in DMF
Compound
Molecular Formula m
(S cm2 mol 1)
L1 C10H9O4NBrNa -
[Pr(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrPr 121.02
[Sm(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrSm 119.52
[Gd(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrGd 117.82
[Tb(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrTb 116.24
[Er(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrEr 112.63
[Yb(L1)(NO3)2(H2O)]NO3 C10H10O11N3BrYb 110.02
4.2.4 Thermo Gravimetric Analysis
Thermogravimetric and differential thermogravimetic analysis were
carried out for the Schiff base ligand [L1] and its corresponding Ln (III)
complexes within the temperature range from ambient temperature to 900oC
under N2 flow. The correlation between the different decomposition steps of
Ln (III) complexes with corresponding weight losses are discussed in terms
of proposed formula of the Ln (III) complexes. The water content was
determined by the thermogravimetric analysis (TGA). The TGA results
showed that the ligand [L1] (Figure 4.10) is thermally stable in the
temperature range 25 – 223oC. The decomposition starts at 223oC and gets
completed at 3000C with one decomposition step.
56
The thermal behaviour studies of all the complexes are almost
same. The thermogram of Ln (III) Schiff base complexes are depicted in
Figure 4.11 – 4.16. In the thermogram of all Ln (III) complexes, the
coordinated water molecules decomposes around 103 - 106oC with a weight
loss about 3%, lattice nitrate and coordinated nitrate molecules decomposed
in the region 140 - 145oC and 340 - 342oC with a weight loss about 10.4%
and 20.6% respectively.
The Gd (III) complex decomposed significantly around 415oC due
to loss of organic moiety with the weight loss about 34.2%. Finally, these
processes were followed by the last step, in which, oxidation Gd (III) occurs
to give corresponding oxide as residue [99].
The Pr (III) Schiff base complex was stable up to 342°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 342–520°C with DTG peak at 415°C
corresponds to loss of organic moiety.
The Sm (III) Schiff base complex was stable up to 343°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 342–498°C with DTG peak at 422°C
corresponds to loss of organic moiety.
The Yb (III) Schiff base complex was stable up to 340°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 342–520°C with DTG peak at 415°C
corresponds to loss of organic moiety.
The Tb (III) Schiff base complex was stable up to 346°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 346–530°C with DTG peak at 425°C
corresponds to loss of organic moiety.
57
Figure 4.10 (a) TG and (b) DTA curves of Schiff base ligand [L1]
a
b
58
Figure 4.11 TG/DTA curves of the [Pr(L1)(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
59
Figure 4.12 TG/DTA curves of the [Sm(L1)(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
60
Figure 4.13 TG/DTA curves of the [Gd(L1)(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
61
Figure 4.14 TG/DTA curves of the [Tb(L1)(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
62
Figure 4.15 TG/DTA curves of the [Er(L1)(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
63
Figure 4.16 TG/DTA curves of the [Yb(L1)(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
64
The Er (III) Schiff base complex was stable up to 342°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 342–510°C with DTG peak at 432°C
corresponds to loss of organic moiety.
4.2.5 1H NMR SPECTRA
The 1H NMR Spectra of Schiff base ligand [L1] (Figure 4.17) in
DMSO-d6 shows signal of triplets at 4.09 ppm and doublet at 4.12 are
due to , methine and methylene hydrogen atom respectively [100]. The
multiplets in 6.65-7.62 ppm region are assigned to the protons of
benzylidene ring groups. The broad singlet at 3.32 ppm and 2.0 ppm is
due to the aromatic hydroxyl and allylic hydroxyl group respectively [101].
The strong singlet at 8.11 ppm is assigned for the azomethine roton [102].
This is in accordance with what the following IR data have revealed.
65
Figure 4.17 1H NMR spectrum of the Schiff base ligand [L1]
66
4.2.6 IR Spectra
The IR band assignments are given in Table 4.3 and spectra in
Figure 4.18 – 4.24. The IR spectra of Ln (III) complexes displays the ligand
characteristic bands with the appropriate shifts due to complex formation and
the IR spectra of all the complexes displays similarity. The IR band at 1678
cm-1 of the free Schiff base ligand is due to the presence of azomethine
group. Upon complexation, these bands are shifted to lower wave number by
20 cm-1 indicating [95] a stronger double bond character of the imine band
and a coordination of the azomethine nitrogen atom to the Ln (III) ion
[103,104]. This coordination is further supported by the appearance of
medium intensity band around 474 cm-1 assigned to Ln-N vibration.
IR spectrum of the free Schiff base ligand exhibits a broad band at
3100 and 3400cm-1, which is attributed to the stretching frequencies of
aromatic hydroxyl substituent and allylic hydroxyl substituent. The
disappearance of aromatic hydroxyl group after complexation denotes the
coordination through phenolic –OH with the central metal ion [105]. The
characteristic band around 3365cm-1 remains in the spectra of the
complexes shows the non-coordination of allylic –OH to the central metal
ion.
The coordination of Ln (III) ion with the phenolic -OH is further
supported by the appearance of a medium intensity band around 536 cm-1
assigned to Ln-O vibration [95]. The absorption bands of coordinated nitrates
were observed at about 1465( 1), 1159( 2), 829( 3), 1323( 4). In addition,
the separation of two highest frequency band ( 1- 4) is approximately 140
cm-1 and accordingly the coordinated NO3- ion in the complexes is a
bidentate ligand [106-108]. The band at 1383 cm-1 in the spectrum of the
complexes indicates that the existence of free nitrate group in the
coordination sphere [109].
67
Table 4.3 Infrared spectral data for the ligand [L1] and the Ln (III) complexes
Compounds R-OH C=N
NO3-
asym (COO
-) sym (COO
-) Ln-O Ln-N
1 2 3 4 0
L 3323 1678 - - - - - - - - -
[PrL(NO3)2(H2O)]NO3 3392 1631 1454 1158 829 1323 1383 1525 1381 540 474
[SmL(NO3)2(H2O)]NO3 3385 1648 1466 1159 827 1323 1383 1525 1390 534 473
[GdL(NO3)2(H2O)]NO3 3395 1652 1466 1159 829 1325 1383 1515 1390 540 474
[ErL(NO3)2(H2O)]NO3 3392 1658 1465 1158 826 1323 1383 1510 1390 540 474
[TbL(NO3)2(H2O)]NO3 3380 1649 1466 1157 825 1325 1383 1520 1384 536 473
[YbL(NO3)2(H2O)]NO3 3365 1654 1465 1159 829 1323 1383 1525 1384 536 474
68
Figure 4.18 IR spectrum of the Schiff base ligand [L1]
69
Figure 4.19 IR spectrum of the [Pr(L1)(NO3)2H2O]NO3 complex
70
Figure 4.20 IR spectrum of the [Sm(L1)(NO3)2H2O]NO3 complex
71
Figure 4.21 IR spectrum of the [Gd(L1)(NO3)2H2O]NO3 complex
72
Figure 4.22 IR spectrum of the [Tb(L1)(NO3)2H2O]NO3 complex
73
Figure 4.23 IR spectrum of the [Er(L1)(NO3)2H2O]NO3 complex
74
Figure 4.24 IR spectrum of the [Yb(L1)(NO3)2H2O]NO3 complex
75
The complexes show strong band in the region 1510 -1525 cm-1
and a weaker band in the region 1381 - 1390 cm-1 assigned to asymmetric
and symmetric stretching frequencies of COO- group respectively. The
frequency difference between the asymmetric and symmetric stretching
frequencies comes around 215 cm-1, which suggests the monodentate
coordination of the carboxyl group of amino acid with the Ln (III) ion [110].
The existence of medium intensity band around 1625 cm-1 is due to the
symmetric and the asymmetric O–H stretching vibrations of inner-sphere
water molecule [111].
4.2.7 Electronic Spectroscopy
The UV-visible absorption spectra of the Schiff base ligand [L1]
and its Ln (III) complexes (Figures 4.25 – 4.31) were carried out in DMF at
room temperature. The values of the absorption wavelength and its band
assignments are listed in Table 4.4 and comparative spectrum is shown in
Figure 4.32. The absorption of the ligand [L1] is characterised by three main
absorption bands at 232, 261 and 385 nm. The band appearing at lower
energy is attributed to n * transition of conjugation between the lone pair
of electrons of p orbital of N atom in azomethine group and conjugated
bond of the benzene ring [112]. The bands appearing at higher energy are
attributed to * of the benzene ring and * transition of the
azomethine group [113,114].
The UV-visible absorption spectra of all the Ln (III) Schiff base
complexes show similarities, which indicates similarity in their structures and
generally show the characteristic bands of the free ligands with some
changes both in frequencies and intensities. Upon complexation, the
absorption bands of the complexes are slightly shifted to shorter wavelength
(Blue shift) compared to those of the free ligand. These modifications of the
shifts and intensity of the absorption bands indicates the coordination of the
ligand to the metal ion. In general, the lanthanide ions do not appreciably
76
contribute to the spectra of their complexes, since f-f transitions are Laporte-
forbidden and very weak in nature [115].
The Sm (III) and Gd (III) complexes have high absorbance when
compared to other complexes. This is due to the difference in their molar
absorptivity of the complexes that cause the spectrum to become more
intense which is referred to as hyperchromic shift and the decrease in
absorbance is referred to as a hypochromic shift. There is a variety of factors
that can cause these changes. One of the factors is found in a process
known as solvatochromism. It can also be due to the solvent polarizability
as well. Basically it is the change in the colour of a material, as a function of
the dielectric properties of the solvent.
Figure 4.25 UV spectra of the Schiff base ligand [L1] in DMF solution
(1.0 10-6 M) at room temperature
Wavelength (nm)
Abs
orba
nce
77
Figure 4.26 UV-visible spectrum of the[Pr(L1)(NO3)2H2O]NO3complex
in DMF solution (1.0 10-6 M) at room temperature
Figure 4.27 UV-visible spectrum of the [Sm(L1)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Wavelength (nm)
Abs
orba
nce
Wavelength (nm)
Abs
orba
nce
78
Figure 4.28 UV-visible spectrum of the [GdL1)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Figure 4.29 UV-visible spectrum of the [Tb(L1)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Wavelength (nm)
Abs
orba
nce
Wavelength (nm)
Abs
orba
nce
79
Figure 4.30 UV-visible spectrum of the [Er(L1)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Figure 4.31 UV-visible spectrum of the [Yb(L1)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Wavelength (nm)
Abs
orba
nce
Wavelength (nm)
Abs
orba
nce
80
Figure 4.32 Comparative UV spectra of the Schiff base ligand [L1] and Ln (III) Schiff base complexes in DMF solution
(1.0 10-6 M) at room temperature
81
Table 4.4 UV-Vis Spectral Data max. (nm) for the ligand [L1] and the complexes
Compound max (nm) Band assignment
L1 232,261 385
* *
[Pr(L1)(NO3)2(H2O)]NO3 221,248 323
* *
[Sm(L1)(NO3)2(H2O)]NO3 226,244 346
* *
[Gd(L1)(NO3)2(H2O)]NO3 214,243 376
* *
[Tb(L1)(NO3)2(H2O)]NO3 224,244 343
* *
[Er(L1)(NO3)2(H2O)]NO3 226,246 352
* *
[Yb(L1)(NO3)2(H2O)]NO3 222,243 352
* *
4.2.8 Fluorescence Studies
The rare earth elements still have a unique and important impact
on our lives. The unfilled 4f electronic structure of the rare earth elements
makes them have special properties in luminescence, magnetism and
electronics, which could be used to develop many new materials for various
applications such as phosphors, magnetic materials, hydrogen storage
materials and catalysts.
The emission spectra of the Schiff base ligand and its Ln (III)
complexes are shown in Figure 4.8. The emission spectrum were recorded
upon excitation at 360 nm and the free ligand [L1] exhibits broad
fluorescence band around 425 nm attributed to * transition [116,117].
82
The emission spectrum of Sm (III) displays five luminescence bands
corresponding to the * transition at 440 nm, 4G5/2 6H3/2 at 485 nm, 4G5/2 6H5/2 at 565 nm,4G5/2 6H7/2 at 598 nm, 4G5/2
6H9/2 at 644 nm
respectively. The intensity sequence of the peaks is I4G5/2 6H9/2 I4G5/2 6H7/2
I4G5/2 6H5/2 I4G5/2 6H3/2 [118].
For Er (III) complex, the emission spectrum excited at 300 nm
shows four luminescence bands corresponding to * at 440 nm, 4S3/2 4I15/2 at 486 nm , 4S3/2 4I13/2 at 613 nm, 4S3/2 4I11/2 at 647 nm
transitions, respectively.
For Tb (III) complex, the emission spectrum excited at 300 nm
shows five luminescence bands. * broad band at 433nm. Further,
sharp luminescence bands corresponding to 5D4 7F6 at 480 nm, 5D4 7F6 at 545 nm, 5D4 7F6 at 586 nm,
5D4 7F6 at 625 nm transition
respectively. The appearance of small band at 840 nm denotes the
secondary derivatives of the rare earth Schiff base complexes. These
results indicate that the ligand L1 is a good chelating organic chromophore
and can be used to absorb and transfer energy to the Ln (III) ions.
The Gd (III), Pr (III) and Yb (III) complexes, shows a broad
emission band around 438-456 nm, which is assigned to * transition.
The fluorescence intensity of these complexes are less while compare with
other complexes, this may be attributed to the complexation occurs with
ligands evident from lesser binding constant values.
83
Figure 4.33 Emission spectra of Sm (III) Er (III) and Tb (III) Schiff
base complexes in DMF solution (1.0 10-6 M) at room
temperature. Emission spectrum is obtained with
exc. = 360 nm
4.2.9 Antibacterial Studies
The Schiff-base ligand [L1] and its Ln (III) complexes reported
here were evaluated for antibacterial activity against Escherichia coli,
Proteus, Staphylococcus aureus and Pseudomonas aeruginosa and the
percentage inhibition detail of the same for maximum concentration
(100 µg mL-1) are tabulated in Table 4.5. The Schiff base ligand [L1] is
biologically active and its activity arise from the presence of imine group
which imports in elucidating the mechanism of transformation reaction in
biological systems. However, its Ln (III) complexes showed remarkable
antibacterial activity as a result of chelation of metal with organic ligand
synergistically increasing its effect [119].
From the results obtained, the antibacterial activity of Ln (III) Schiff
base complexes is found to be higher than that of a free Schiff base ligand,
84
against the same microorganism under identical experimental conditions.
This is similar to earlier observations [120].
Remarkable enhancement in activity was found for Sm (III) Schiff
base complex against the species Escherichia coli. For the species Proteus
Sm (III) Schiff base complex showed higher activity than the other Ln (III)
complexes. In a similar manner the percentage inhibition was higher for
Er (III) complex against both Staphylococcus aureus and Pseudomonas
aeruginosa pathogens. The percentage inhibition for the Schiff base ligand
and all the Ln (III) complexes have been depicted in Figure 4.35 - 4.38.
This increased activity of the Ln (III) complexes upon chelation is
attributed to Tweedy’s chelation theory, according to which, the chelation
reduces the polarity of the metal atom mainly because of the positive charge
of the metal partially shared with donor atoms present on the ligand and
there is electron delocalisation over the whole chelate ring [121]. This, in
turn, increases the lipophilic character of the metal chelate and favors its
permeation through the lipid layers of the bacterial membranes [109].
Generally, it is suggested that the chelated complexes deactivate
various cellular enzymes, which play a vital role in various metabolic
pathways of these microorganisms. Other factors such as solubility,
conductivity and dipole moment, affected by the presence of metal ions, may
also increase the biological activity of the metal complexes compared to the
ligand.
85
Table 4.5 Antibacterial results of the Schiff base ligand [L1] and their Ln (III) complexes for maximum concentration (100 µg mL-1)
Compound % inhibition against bacteria
E. coli Proteus P. aeruginosa S. aureus
L1 70.43 50.61 44.93 55.32
[Pr(L1)(NO3)2(H2O)]NO3 85.46 60.23 46.42 72.45
[Sm(L1)(NO3)2(H2O)]NO3 85.92 70.16 56.43 82.53
[Gd(L1)(NO3)2(H2O)]NO3 84.57 75.73 60.82 72.82
[Tb(L1)(NO3)2(H2O)]NO3 82.92 53.72 47.24 75.69
[Er(L1)(NO3)2(H2O)]NO3 71.95 44.32 74.21 68.32
[Yb(L1)(NO3)2(H2O)]NO3 70.94 58.41 49.34 65.46
DMF - - - -
Ciproflaxacin 100 100 100 100
86
(a) Escherichia coli (b) Staphylococcus aureus
(c) Pseudomonas aeruginosa
C – Control; 1 – 25 µg mL-1 ; 2 – 50 µg mL-1 ;
3 - 75 µg mL-1 ; 4 – 100 µg mL-1
Figure 4.34 Zone of inhibition of (a) Sm(III) (b) Sm(III) (c) Er(III) complexes of Schiff base Ligand [L1] for bacterial species
87
Figure 4.35 Percentage Inhibition of Schiff base ligand [L1] and their Ln (III) Schiff base complexes against Escherichia coli
Figure 4.36 Percentage Inhibition of Schiff base ligand [L1] and their Ln (III) Schiff base complexes against Proteus
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Escherichia coli
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Proteus
% in
hibi
tion
% in
hibi
tion
88
Figure 4.37 Percentage Inhibition of Schiff base ligand [L1] and their Ln (III) Schiff base complexes against Pseudomonas aeruginosa
Figure 4.38 Percentage Inhibition of Schiff base ligand [L1] and their Ln (III) Schiff base complexes against Staphylococcus aureus
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Pseudomonas aeruginosa
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Staphylococcus aureus
% in
hibi
tion
% in
hibi
tion
89
4.2.10 Antifungal Studies
The antifungal activity of the Schiff-base ligand [L1] and its Ln (III)
complexes reported here were evaluated for Candida and Aspergillus
species and the percentage inhibition detail of the same for maximum
concentration (100 µg mL-1) are tabulated in Table 4.6. The comparative
antifungal activity have been depicted in Figure 4.40 and 4.41. The Schiff
base ligand [L1] and all the Ln (III) complexes show high antifungal activity
against the reported species. However the Ln (III) complexes showed
remarkable antibacterial activity than the Schiff base ligand. This is probably
due to the greater lipophilic nature of the complexes [119].
It was observed that the antifungal activity of few complexes were
very near to the standard antifungal agent Ketokonazole. Compared to all
other Ln (III) complexes the Yb (III) complex shows very high activity
against the species Candida. In the case of Aspergillus species, the Sm (III)
complex has higher activity among other Ln (III) complexes.
It was evident from the data that this activity significantly increased
on coordination. This enhancement in the activity may be rationalised on the
basis that their structures mainly possess an additional C=N bond. It has
been suggested that the Schiff base with nitrogen and oxygen donor
systems inhibit enzyme activity, since the enzymes which require these
groups of their activity appear to be especially more susceptible to
deactivation by metal ions on coordination.
Moreover, coordination reduces the polarity of the metal ion mainly
because of the partial sharing of its positive charge with the donor groups
[120] within the chelate ring system formed during coordination. The activity
of the complexes can be related to the strength of the metal–ligand bond,
besides other factors such as size of the cation, receptor sites, diffusion and
a combined effect of the metal and the ligands for inactivation of the
biomolecules.
90
Table 4.6 Antifungal results of the Schiff base ligand [L1] and their Ln (III) complexes for maximum concentration (100 µg mL-1)
Compound % inhibition against fungi
Candida Aspergillus
L1 65.45 60.29
[Pr(L1)(NO3)2(H2O)]NO3 67.87 75.25
[Sm(L1)(NO3)2(H2O)]NO3 89.35 90.47
[Gd(L1)(NO3)2(H2O)]NO3 95.25 72.49
[Tb(L1)(NO3)2(H2O)]NO3 94.76 89.91
[Er(L1)(NO3)2(H2O)]NO3 93.86 95.12
[Yb(L1)(NO3)2(H2O)]NO3 97.83 89.75
DMF - -
Ketokonazole 100 100
91
(a) Candida (b) Aspergillus
C – Control; 1 – 25 µg mL-1 ; 2 – 50 µg mL-1
3 - 75 µg mL-1 ; 4 – 100 µg mL-1
Figure 4.39 Zone of inhibition of Tb (III) complex of Schiff base Ligand [L1] for fungal species
92
Figure 4.40 Percentage Inhibition of Schiff base ligand [L1] and their Ln (III) Schiff base complexes against Candida
Figure 4.41 Percentage Inhibition of Schiff base ligand [L1] and their Ln (III) Schiff base complexes against Aspergillus
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Candida
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Aspergillus
% in
hibi
tion
% in
hibi
tion
93
4.3 CONCLUSION
The results of the spectral studies of the synthesised tridentate
Schiff base ligand L1 and its Ln (III) complexes under investigation
supported the suggested structures. Thermal study reveals that these
complexes are stable up to 340°C. The fluorescence data reveals that the
Sm (III), Tb (III) and Er (III) complexes exhibit characteristic luminescence
of Sm (III), Tb (III) and Er (III) ions, which indicates that the ligand L1 is a
good organic chelator to absorb and transfer energy to Sm (III), Tb (III) and
Er (III) ions. The antibacterial activity results show that most of the
synthesised complexes possess a good antimicrobial activity against the
pathogens tested than the corresponding free Schiff base ligand.
94
5. SCHIFF BASE DERIVED FROM THREONINE AND ITS LANTHANIDE (III) COMPLEXES
5.1 INTRODUCTION
Lanthanide complexes attract considerable interest in bioinorganic
and coordination chemistry Schiff base complexes derived from amino acids
are important due to their ability to possess unusual configurations and
biological importance [122,123]. Lanthanide Schiff base complexes have
some advantages for luminescence research because of their special
structures [124]. Exhibiting outstanding optical properties and a broad
spectrum of biological activities, rare-earth metal complexes of Schiff-base
type ligands derived from amino acids attract great interest of researchers in
recent years [125,126]. In general, lanthanide complexes display varying
cytotoxic effects [127,128].
Such properties of this type of complexes encouraged us [129]
further to synthesize, characterize and study the fluorescence and biological
activity of the Pr (III), Sm (III), Gd (III), Er (III), Tb (III) and Yb (III)
complexes of the Schiff base ligand [L2] (Figure 5.1). All the synthesised
compounds are screened in vitro for their antibacterial and antifungal
activities using disc diffusion assay. Human pathogenic bacteria Escherichia
coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus
agalactiae and fungi Candida, Aspergillus are evaluated based on their
toxicity to different concentrations of Ln (III) Schiff base complexes.
95
OHN
Br
OOH
ONa
L2sodium 2-(5-bromo-2-hydroxybenzylideneamino)-3-
hydroxybutanoate
Figure 5.1 Sodium salt of the Schiff base ligand L2
5.2 RESULTS AND DISCUSSION
In the present investigation, the Schiff base ligand [L2] and its six
new lanthanide metal complexes were synthesised and characterised by
different analytical techniques. The ligand [L2] was synthesised by one step
condensation of L-threonine with 5-bromosalicyaldehyde and characterised
by UV-Vis, FT-IR, 1H NMR, Mass and TG analysis. All the Ln (III)
complexes were synthesised as per the scheme given in Scheme 5.1, in
which Ln(NO3)3.xH2O was used as the source of metal and they correspond
to the formula [Ln(L2)(NO3)2(H2O)].NO3. All the complexes were stable in air
and non-hygroscopic powders, soluble in DMSO and DMF, sparingly soluble
in methanol, ethanol, acetonitrile and ethylacetate.
L2
96
NH2
OH
OHO
Threonine
+ HO
OBr
5-bromosalicylaldehyde
OHN
Br
OOH
ONaEtOH/NaOH
Reflux - 3h
L2sodium 2-(5-bromo-2-hydroxybenzylideneamino)-3-
hydroxybutanoate
Ln(NO3)3.xH2OReflux3-5 h
NO3CH
O
N CO
LnO
NO3
NO3
H2O
OH
Br
Ln (III) Complexes
Scheme 5.1 Synthesis of Schiff base ligand [L2] and Ln (III) Schiff base complexes [Ln = Pr (III), Sm (III), Gd (III), Tb (III), Er (III) and Yb (III)]
5.2.1 Elemental Analysis
Table 5.1 shows the list of the elemental analysis of the Schiff
base ligand [L2] and synthesised Ln (III) Schiff base complexes which are in
good agreement with the calculated values based on the proposed
molecular formula.
97
Table 5.1 Elemental Analysis of the ligand [L2] and Ln (III) Schiff base complexes
Compound Molecular Formula Molecular weight Cal.(Exp.)%
C H N
L2 C11H11O4NBrNa 324.1 40.72(40.76) 3.39(3.42) 4.31(4.32)
[Pr(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrPr 583.04 24.03(24.06) 2.67(2.69) 7.01(7.01)
[Sm(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrSm 592.49 22.27(22.30) 2.02(2.04) 7.08(7.09)
[Gd(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrGd 599.38 22.02(22.04) 2.00(2.02) 7.00(7.01)
[Tb(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrTb 601.06 21.96(21.98) 1.99(2.01) 6.98(6.99)
[Er(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrEr 609.39 21.66(21.68) 1.96(1.98) 6.89(6.90)
[Yb(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrYb 615.17 21.45(21.48) 1.95(1.97) 6.82(6.83)
98
5.2.2 Mass Spectra
A mass spectrum of the newly synthesised Schiff base ligand
confirms the proposed formula by detecting the molecular fragments. Mass
spectrometry chemical ionisation of the ligand and the lanthanide complexes
as shown in Figures 5.2 – 5.9, show abundant molecular ions at various m/z
values. The mass spectrum of the ligand shows molecular ions
[C11H11O4BrNNa]+. at m/z = 323 and important fragments at m/z = 245
[C11H11O3NNa]+, 185 [C7H5BrO]+, 141 [C4H6O3NNa]+ and 79 [Br]+. Some
isotopic peaks of the compounds are also found around these peaks [97].
The mass spectrum of the Pr (III) complex shows molecular ions
[C11H12O11N3BrPr]+. at m/z = 599 and important fragments at m/z = 441
[C11H10O4NBrPr]+, 184 [C7H4BrO]+ , 116 [C4H6O3N]+ and 79 [Br]+.
The mass spectrum of the Sm (III) complex shows molecular ions
[C11H12O11N3BrSm]+. at m/z = 592 and important fragments at m/z = 450
[C11H10O4NBrSm]+, 184 [C7H4BrO]+ , 116 [C4H6O3N]+ and 79 [Br]+.
The mass spectrum of the Gd (III) complex shows molecular ions
[C11H12O11N3BrGd]+. at m/z = 599 and important fragments at m/z = 457
[C11H10O4NBrGd]+, 184 [C7H4BrO]+ , 116 [C4H6O3N]+ and 79 [Br]+.
The mass spectrum of the Er (III) complex shows molecular ions
[C11H12O11N3BrEr]+. at m/z = 609 and important fragments at m/z = 467
[C11H10O4NBrEr]+, 184 [C7H4BrO]+ , 116 [C4H6O3N]+ and 79 [Br]+.
The mass spectrum of the Tb (III) complex shows molecular ions
[C11H12O11N3BrTb]+. at m/z = 601 and important fragments at m/z = 459
[C11H10O4NBrTb]+, 184 [C7H4BrO]+ , 116 [C4H6O3N]+ and 79 [Br]+.
The mass spectrum of the Yb (III) complex shows molecular ions
[C11H12O11N3BrYb]+. at m/z = 615 and important fragments at m/z = 473
[C11H10O4NBrYb]+, 184 [C7H4BrO]+ , 116 [C4H6O3N]+ and 79 [Br]+.
99
Figure 5.2 Mass Spectrum of the Schiff base ligand [L2]
%
m/z
100
Figure 5.3 Mass Spectrum of the [Pr(L2)(NO3)2(H2O)]NO3 complex
%
m/z
101
Figure 5.4 Mass Spectrum of the [Sm(L2)(NO3)2(H2O)]NO3 complex
%
m/z
102
Figure 5.5 Mass Spectrum of the [Gd(L2)(NO3)2(H2O)]NO3 complex
%
m/z
103
Figure 5.6 Mass Spectrum of the [Tb(L2)(NO3)2(H2O)]NO3 complex
%
m/z
104
Figure 5.7 Mass Spectrum of the [Er(L2)(NO3)2(H2O)]NO3 complex
%
m/z
105
Figure 5.8 Mass Spectrum of the [Yb(L2)(NO3)2(H2O)]NO3 complex
%
m/z
106
Figure 5.9 HR-MS of the [Pr(L2)(NO3)2(H2O)]NO3 complex
107
5.2.3 Molar Conductance
Molar conductivity data for all the Ln (III) Schiff base complexes in
DMF solution at room temperature are observed to be in the range of 112-
123 Scm2mol-1 are tabulated in Table 5.2. This suggests 1:1 electrolytes and
the two nitrate are coordinated to the Ln (III) ion [98].
Table 5.2 Molar conductance of the ligand [L1] and Ln (III) Schiff base complexes
Compound Molecular Formula m
(S cm2 mol 1)
L2 C11H11O4NBrNa -
[Pr(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrPr 123.03
[Sm(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrSm 121.32
[Gd(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrGd 119.62
[Tb(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrTb 115.42
[Er(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrEr 113.35
[Yb(L2)(NO3)2(H2O)]NO3 C11H12O11N3BrYb 112.12
5.2.4 Thermo Gravimetric Analysis
Thermogravimetric and differential thermogravimetic analysis were
carried out for the Schiff base ligand [L2] and its corresponding Ln (III)
complexes within the temperature range from ambient temperature to 800°C
under N2 flow. The correlation between the different decomposition steps of
Ln (III) complexes with corresponding weight losses are discussed in terms
of proposed formula of Ln (III) complexes. The TGA results show that the
ligand [L2] (Figure 5.10 - 5.16) is thermally stable in the temperature range
25 – 275°C. The decomposition starts at 275°C and gets completed at 330°C
with one decomposition step.
The thermal behavior studies of all the complexes are almost
same. Hence, the Ln (III) complex has been discussed. In the thermogram
108
of all Ln (III) complex, the coordinated water molecules decomposes around
104oC with a weight loss of about 2.7%, lattice nitrate and coordinated
nitrate molecules decomposed in the region 154°C and 373°C with a weight
loss of about 9.4% and 18.5% respectively.
The Gd (III) complex decomposes significantly around 445°C due
to the loss of organic moiety with the weight loss of about 45.8%. Finally,
these processes are followed by the last step, in which, oxidation Gd (III)
occurs to give the corresponding oxide as residue [99]. The Pr (III) Schiff
base complex was stable up to 378°C and its decomposition started at this
temperature. The complexes underwent decomposition in the range 378–
570 °C with DTG peak at 450°C corresponds to loss of organic moiety.
The Sm (III) Schiff base complex was stable up to 356°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 356–520°C with DTG peak at 429°C
corresponds to loss of organic moiety.
The Yb (III) Schiff base complex was stable up to 364°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 364–550°C with DTG peak at 410°C
corresponds to loss of organic moiety.
The Tb (III) Schiff base complex was stable up to 380°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 380–550°C with DTG peak at 432°C
corresponds to loss of organic moiety.
The Er (III) Schiff base complex was stable up to 390°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 390–500°C with DTG peak at 448°C
corresponds to loss of organic moiety.
109
Figure 5.10 TG/DTA curves of the Schiff base ligand [L2] (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
110
Figure. 5.11 TG/DTA curves of the [PrL2(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
111
Figure. 5.12 TG/DTA curves of the [SmL2(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
112
Figure. 5.13 TG/DTA curves of the [GdL2(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
113
Figure 5.14 TG/DTA curves of the [TbL2(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
114
Figure 5.15 TG/DTA curves of the [ErL2(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
115
Figure 5.16 TG/DTA curves of the [YbL2(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
116
5.2.5 1H NMR Spectra
The 1H NMR Spectra of Schiff base ligand in DMSO-d6 has been
depicted in Figure 5.17. It shows that the signal of doublets at 4.04 ppm
and 4.0 ppm are due to methine and methylene hydrogen atom respectively
[100]. The multiplets in 6.93-7.34 ppm region are assigned to the protons
of aromatic benzylidene ring groups. The broad singlet at 5.0 ppm and
2.0 ppm is due to the aromatic hydroxyl and allylic hydroxyl group
respectively [101]. The strong singlet at 8.13 ppm is assigned for the
azomethine proton [102]. This is in accordance with what the following IR
data has revealed.
117
Figure 5.17 1H NMR spectra of the Schiff base ligand [L2]
118
5.2.6 IR Spectra
The IR band assignments are given in Table 5.3 and spectra in
Figures 5.18 – 5.24. The IR spectra of Ln (III) complexes displays the ligand
characteristic bands with appropriate shifts due to the complex formation,
and the IR spectra of all the complexes display similarity. The IR band at
1694 cm-1 of the free Schiff base ligand is due to the presence of
azomethine group. Upon complexation, these bands are shifted to lower
wave number by 20-40 cm-1 indicating [95] a stronger double bond character
of the imine band and a coordination of the azomethine nitrogen atom to the
Ln (III) ion [103,104]. This coordination is further supported by the
appearance of medium intensity band around 470 cm-1 assigned to Ln-N
vibration.
IR spectrum of the free Schiff base ligand exhibits a broad band at
3050 and 3250 cm-1, which is attributed to the stretching frequencies of
aromatic hydroxyl substituent and allylic hydroxyl substituent. The
disappearance of aromatic hydroxyl group after complexation denotes the
coordination through phenolic –OH with the central metal ion [105]. The
characteristic band around 3239 cm-1 remains in the spectra of the
complexes and shows the non-coordination of allylic –OH to the central
metal ion.
The coordination of Ln (III) ion with the phenolic -OH is further
supported by the appearance of a medium intensity band around 535 cm-1
assigned to Ln-O vibration [95]. The absorption bands of coordinated nitrates
were observed at about 1466( 1), 1163( 2), 828( 3), 1375( 4). In addition,
the separation of two highest frequency bands ( 1- 4) is approximately 90
cm-1 and accordingly the coordinated NO3- ion in the complexes is a
bidentate ligand [106-108]. The band at 1395 cm-1 in the spectrum of the
complexes indicates that the existence of free nitrate group in the
coordination sphere [109]. The complexes show strong band in the region
1540-1565 cm-1 and a weak band in the region 1275 - 1370 cm-1 assigned to
119
asymmetric and symmetric stretching frequencies of COO- group
respectively. The frequency difference between the asymmetric and
symmetric stretching frequencies comes around 170 cm-1, which suggests
the monodentate coordination of the carboxyl group of amino acid with the
Ln (III) ion [110]. The existence of medium intensity band around 1610 cm-1
is due to the symmetric and the asymmetric O–H stretching vibrations of
inner-sphere water molecule [111].
120
Table 5.3 Infrared spectral data for the ligand [L2] and the Ln (III) complexes
Compounds R-OH C=N NO3
- asym(COO
-) sym(COO
-) Ln-O Ln-N
1 2 3 4 0
L 3250 1694 - - - - - - - - -
[PrL(NO3)2(H2O)]NO3 3242 1651 1458 1160 829 1373 1388 1555 1281 540 474
[SmL(NO3)2(H2O)]NO3 3228 1668 1466 1159 827 1363 1385 1549 1280 534 473
[GdL(NO3)2(H2O)]NO3 3225 1652 1466 1159 829 1365 1383 1515 1390 540 474
[ErL(NO3)2(H2O)]NO3 3235 1658 1467 1160 829 1355 1383 1510 1390 540 472
[TbL(NO3)2(H2O)]NO3 3240 1659 1466 1157 825 1360 1383 1520 1382 536 471
[YbL(NO3)2(H2O)]NO3 3239 1675 1466 1163 828 1375 1395 1564 1275 535 470
121
Figure 5.18 IR spectrum of the Schiff base ligand [L2]
122
Figure 5.19 IR spectrum of the [Pr(L2)(NO3)2H2O]NO3 complex
123
Figure 5.20 IR spectrum of the [Sm(L2)(NO3)2H2O]NO3 complex
124
Figure 5.21 IR spectrum of the [Gd(L2)(NO3)2H2O]NO3 complex
125
Figure 5.22 IR spectrum of the [Tb(L2)(NO3)2H2O]NO3 complex
126
Figure 5.23 IR spectrum of the [Er(L2)(NO3)2H2O]NO3 complex
127
Figure 5.24 IR spectrum of the [Yb(L2)(NO3)2H2O]NO3 complex
128
5.2.7 Electronic Spectroscopy
The UV-Vis. absorption spectra for the freshly prepared solutions
of the Schiff base ligand [L2] and its Ln (III) complexes (Figures 5.25 – 5.31)
in DMF are recorded at room temperature. The values of the absorption
wavelength and its band assignments are listed in Table 5.4 and
comparative spectrum is shown in Figures 5.32. The absorption of the
ligand [L2] is characterised by three main absorption bands at 237, 271 and
376 nm. The band appearing at lower energy is attributed to n *
transition of conjugation between the lone pair of electrons of p orbital of N
atom in azomethine group and conjugated bond of the benzene ring [112].
The bands appearing at higher energy are attributed to * of the
benzene ring and * transition of the azomethine group [113,114].
The UV-visible absorption spectra of all the Ln (III) Schiff base
complexes show similarities, which indicate similarity in their structures and
generally show the characteristic bands of the free ligands with some
changes both in frequencies and intensities. Upon complexation, the
absorption bands of the complexes are slightly shifted to shorter wavelength
(Blue shift) compared to those of the free ligand. These modifications of the
shifts and intensity of the absorption bands indicate the coordination of the
ligand to the metal ion. In general, the lanthanide ions do not appreciably
contribute to the spectra of their complexes, since f-f transitions are Laporte-
forbidden and very weak in nature [115].
The difference in absorbance among the lanthanide (III) metal
complexes is attributed to their difference in molar absorptivity. The increase
in absorption is referred to as hyperchromic shift and the decrease in
absorption is referred to as hypochromic shift. These shifts are caused due
to the factor known as solvatochromism. This leads to the change in colour
of the complexes as a function of the dielectric properties of the solvent. It
was observed that the Sm (III) and Gd (III) complexes have high
129
absorbance when compared to other complexes. The reasons of which may
also be due to the solvent polarizability factor.
Figure 5.25 UV-visible spectrum of the Schiff base ligand [L2] in DMF
solution (1.0 10-6 M) at room temperature.
Figure 5.26 UV-visible spectrum of the [Pr(L2)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Abs
orba
nce
Wavelength (nm)
Abs
orba
nce
Wavelength (nm)
130
Figure 5.27 UV-visible spectrum of the [Sm(L2)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Figure 5.28 UV-visible spectrum of the [Gd(L2)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Abs
orba
nce
Wavelength (nm)
Abs
orba
nce
Wavelength (nm)
131
Figure 5.29 UV-visible spectrum of the [Tb(L2)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Figure 5.30 UV-visible spectrum of the [Er(L2)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room temperature
Abs
orba
nce
Wavelength (nm)
Abs
orba
nce
Wavelength (nm)
132
Figure 5.31 UV-visible spectrum of the [Yb(L2)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Figure 5.32 Comparative UV-visible spectra of the Schiff base ligand
L2 and its Ln (III) complexes in DMF solution (1.0 10-6
M) at room temperature
Abs
orba
nce
Wavelength (nm)
Abs
orba
nce
Wavelength (nm)
133
Table 5.4 UV-visible Spectral Data max. (nm) for the ligand [L2] and the complexes
Compound max (nm) Band assignment
L2 237,271 376
* *
[Pr(L2)(NO3)2(H2O)]NO3 219,246
353 * *
[Sm(L2)(NO3)2(H2O)]NO3 226,241
367 * *
[Gd(L2)(NO3)2(H2O)]NO3 219,243
358 * *
[Tb(L2)(NO3)2(H2O)]NO3 226,253
339 * *
[Er(L2)(NO3)2(H2O)]NO3 228,252
362 * *
[Yb(L2)(NO3)2(H2O)]NO3 221,249
335 * *
134
5.2.8 Fluorescence Studies
The emission spectra of the ligand [L2] and its Ln (III) complexes
(1.0 10 5M in DMF solution) are recorded at the room temperature.
The emission spectrum of the free ligand exhibits broad
fluorescence band centered at 430 nm attributed to * transitions
[116,117]. Inspection of emission spectra ( exc.= 360 nm) shown in
Figure 5.33. indicate that [Sm(L2)(NO3)2(H2O)].NO3, [Er(L2)(NO3)2(H2O)]NO3
and [Tb(L2)(NO3)2(H2O)].NO3 complexes exhibit the characteristic emission
spectra of the Sm (III), Er (III) and Tb (III) ions, respectively. This indicates
that the Schiff base ligand is a good chelating organic chromophore and can
be used to absorb and transfer energy to the Ln (III)ions.
The sensitised emission spectrum of the [Sm(L2)(NO3)2
(H2O)].NO3complex displays three luminescence bands at 560, 610and 640
nm corresponding to the 4G5/26H5/2,4G5/2
6H7/2 and 4G5/26H9/2 transitions
respectively.
For the Tb (III) complex, the emission spectrum excited at 300 nm
shows three luminescence bands at 501, 535, and 599 nm corresponding to
the 5D47F6, 5D4
7F5 and 5D47F4 transitions respectively.
For Er (III) complex, the emission spectrum shows three
luminescence bands at 490, 520 and 650 nm corresponding to the blue
emission 4F9/26H15/2, 4F9/2
6H13/2 and 4F9/26H11/2 transitions respectively.
The above three Schiff base complexes was sensitised by its
chelating organic ligand, which was acting as photosensitiser. The emission
of Ln (III) ions can be mainly observed by sensitisation process upon the
excitation of the chelating Schiff base organic moiety, since the organic
chromophores have large molar absorption coefficients of several orders as
compared with those of Ln (III) ions.
135
Figure 5.33 Emission spectra of Sm (III), Er (III) and Tb (III) Schiff
base complexes in DMF solution (1.0 10-6 M) at room
temperature. Emission spectrum is obtained with
exc. = 360 nm.
136
5.2.9 Antibacterial Studies
The Schiff-base ligand [L2] and its Ln (III) complexes reported
here were evaluated for antibacterial activity against Escherichia coli,
Streptococcus agalactiae, Staphylococcus aureus, and Pseudomonas
aeruginosa and the percentage inhibition detail of the same for different
concentrations (60,40 and 20µg mL-1) are tabulated in Table 5.5. The Schiff
base ligand [L2] is biologically active and its activity arise from the presence
of imine group which imports in elucidating the mechanism of transformation
reaction in biological systems. However its Ln (III) complexes showed
remarkable antibacterial activity as a result of chelation of metal with organic
ligand synergistically increasing its effect [119].
From the results obtained, the antibacterial activity of Ln (III) Schiff
base complexes is found to be higher than that of a free Schiff base ligand,
against the same microorganism under identical experimental conditions.
This is similar to earlier observations [120].
Remarkable enhancement in activity was found for Gd (III) Schiff
base complex against the species Escherichia coli. For the species
Streptococcus agalactiae Sm (III) and Pr (III) Schiff base complex showed
higher activity than the other Ln (III) complexes. In a similar manner the
percentage inhibition was higher for Er (III) complex against both
Staphylococcus aureus, and Pseudomonas aeruginosa pathogens. The
percentage inhibition for the Schiff base ligand and all the Ln (III) complexes
have been depicted in Figure 5.35 - 5.38.
This increased activity of the Ln (III) complxes upon chelation is
attributed to Tweedy’s chelation theory, according to which, the chelation
reduces the polarity of the metal atom mainly because of the positive charge
of the metal partially shared with donor atoms present on the ligand and
there is electron delocalisation over the whole chelate ring [121]. This, in
137
turn, increases the lipophilic character of the metal chelate and favors its
permeation through the lipid layers of the bacterial membranes [109].
Generally, it is suggested that the chelated complexes deactivate
various cellular enzymes, which play a vital role in various metabolic
pathways of these microorganisms. Other factors such as solubility,
conductivity and dipole moment, affected by the presence of metal ions, may
also increase the biological activity of the metal complexes compared to the
ligand.
Table 5.5 Antibacterial results of the Schiff base ligand [L2] and their Ln (III) complexes for maximum concentration (60 µg mL-1)
Compound % inhibition against bacteria
E. coli S.agalactiae P. aeruginosa S. aureus
L2 51.15 64.70 73.48 76.47
[Pr(L2)(NO3)2(H2O)]NO3 56.43 70.58 58.42 76.47
[Sm(L2)(NO3)2(H2O)]NO3 64.70 70.58 72.58 82.35
[Gd(L2)(NO3)2(H2O)]NO3 70.58 64.70 94.11 82.35
[Tb(L2)(NO3)2(H2O)]NO3 59.28 62.83 81.73 80.25
[Er(L2)(NO3)2(H2O)]NO3 59.46 72.85 60.12 85.56
[Yb(L2)(NO3)2(H2O)]NO3 65.06 72.87 74.46 82.45
DMF - - - -
Amikacin 100 100 100 100
138
(a) Escherichia coli (b) Pseudomonas aeruginosa
(c) Streptococcus agalactiae (d) Staphylococcus aureus
C – Control; 1 - 20 µg mL-1 ; 2 – 40 µg mL-1 ; 3 – 60 µg mL-1
Figure 5.34 Zone of inhibition of (a) Gd (III) (b) Gd (III) (c) Yb (III)
(d) Er (III) complex of Schiff base Ligand [L2] for bacterial species
139
Figure 5.35 Percentage Inhibition of Schiff base ligand [L2] and their Ln (III) Schiff base complexes against Escherichia coli
Figure 5.36 Percentage Inhibition of Schiff base ligand [L2] and their Ln (III) Schiff base complexes against Streptococcus agalactiae
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Escherichia coli
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Streptococcus agalactiae
% in
hibi
tion
% in
hibi
tion
140
Figure 5.37 Percentage Inhibition of Schiff base ligand [L2] and their Ln (III) Schiff base complexes against Pseudomonas aeruginosa
Figure 5.38 Percentage Inhibition of Schiff base ligand [L2] and their Ln (III) Schiff base complexes against Staphylococcus aureus
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Pseudomonas aeruginosa
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Staphylococcus aureus
% in
hibi
tion
% in
hibi
tion
141
5.2.10 Antifungal Studies
The antifungal activity of the schiff-base ligand [L2] and its Ln (III)
complexes reported here were evaluated for Candida and Aspergillus
species and the percentage inhibition detail of the same for different
concentrations (60,40 and 20 µg mL-1) are tabulated in Table 5.6. The
comparative antifungal activity have been depicted in Figure 5.40 and 5.41.
The Schiff base ligand [L2] and all the Ln (III) complexes show high
antifungal activity against the reported species. However the Ln (III)
complexes showed remarkable antibacterial activity than the Schiff base
ligand. This is probably due to the greater lipophilic nature of the complexes
[119].
It was observed that the antifungal activity of few complexes were
very near to the standard antifungal agent Ketokonazole. Compared to all
other Ln (III) complexes the Sm (III) complex shows very high activity
against the Candida species. In the case of Aspergillus species also the
Sm (III) complex has high activity of all the Ln (III) complexes.
It was evident from the data that this activity significantly increased
on coordination. This enhancement in the activity may be rationalised on the
basis that their structures mainly possess an additional C=N bond. It has
been suggested that the Schiff base with nitrogen and oxygen donor
systems inhibit enzyme activity, since the enzymes which require these
groups for their activity appear to be especially more susceptible to
deactivation by metal ions on coordination.
Moreover, coordination reduces the polarity of the metal ion mainly
because of the partial sharing of its positive charge with the donor groups
[120] within the chelate ring system formed during coordination. The activity
of these complexes can be related to the strength of the metal–ligand bond,
besides other factors such as size of the cation, receptor sites, diffusion and
142
a combined effect of the metal and the ligands for inactivation of the
biomolecules.
Table 5.6 Antifungal results of the Schiff base ligand [L2] and their Ln (III) complexes for maximum concentration (60 µg mL-1)
Compound % inhibition against fungi
Candida Aspergillus
L2 62.14 52.18
[Pr(L2)(NO3)2(H2O)]NO3 64.70 65.49
[Sm(L2)(NO3)2(H2O)]NO3 98.92 94.11
[Gd(L2)(NO3)2(H2O)]NO3 100 70.58
[Tb(L2)(NO3)2(H2O)]NO3 96.42 85.24
[Er(L2)(NO3)2(H2O)]NO3 97.54 93.74
[Yb(L2)(NO3)2(H2O)]NO3 98.45 92.62
DMF - -
Ketokonazole 100 100
143
(a) Candida (b) Aspergillus
C – Control; 1- 20 µg mL-1 ; 2 – 30 µg mL-1 ; 3 – 60 µg mL-1
Figure 5.39 Zone of inhibition of (a) Gd(III) (b) Sm(III) complex of Schiff base Ligand [L2] for fungal species
144
Figure 5.40 Percentage Inhibition of Schiff base ligand [L2] and their Ln (III) Schiff base complexes against Candida
Figure 5.41 Percentage Inhibition of Schiff base ligand [L2] and their Ln (III) Schiff base complexes against Aspergillus
0
10
20
30
40
50
60
70
80
90
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Candida
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Aspergillus
% in
hibi
tion
% in
hibi
tion
145
5.3 CONCLUSION
The chapter presented includes the synthesis of the Ln (III)
complexes of the tridentate Schiff base ligand L2 formed by the
condensation of L-Threonine and 5-bromosalicyaldehyde. The structures
of the Schiff base ligand L2 and the lanthanide metal complexes have been
confirmed by various spectral studies like 1H NMR, UV, FT-IR and Mass
Spectrometry. The results of investigation support the suggested structures.
The coordination number eight is suggested for the metal ion in these
lanthanide(III) complexes. The fluorescence data reveals that the Sm (III),
Tb (III) and Er (III) complexes exhibit characteristic luminescence of
Sm (III), Tb (III) and Er (III) ions. The synthesised complexes exhibit
enhanced antimicrobial activity than the corresponding free Schiff base
ligand. All the newly synthesised compounds possess higher antifungal
properties than the antibacterial property.
146
6. SCHIFF BASE DERIVED FROM LEUCINE AND ITS LANTHANIDE (III) COMPLEXES
6.1 INTRODUCTION
Schiff base ligands have gained paramount importance due to
their versatility like straight forward synthesis, electron donor property and
multidentate nature, which results in very high binding constants for d- and
f-block metals [130, 131]. The condensation between –NH2 group of the
amino acids and carbonyl group of the aldehydes or ketones needs a
special condition due to Zwitter ionic effect of aminoacids. It has been
observed that pH plays a vital role in the process of condensation [132, 133].
The trivalent lanthanide ion, complexes with strongly chelating species
containing highly electronegative donor atoms, forms stable complexes
[134]. Lanthanide and lanthanide complexes have attracted a great deal of
interest in recent years because they have applications as antioxidants
[135], in medicinal inorganic chemistry [136, 137], catalysis [138],
luminescence chemical probes and sensors [139] and pharmacological
activities [140, 141]. Further the lanthanide complexes were found to exhibit
extremely sharp emission [142].
As a result of the above facts, and in view of the diversified
roles of lanthanide Schiff base metal complexes, in continuation of our work
[129, 143], we have synthesised and studied the physicochemical properties
of lanthanide(III) complexes derived from Schiff base ligand [L3] (Figure
6.1) with N, O donor atoms. The structures of the isolated complexes have
been established using spectral techniques like UV-visible, FT-IR, 1H NMR
and Mass Spectrometry. The fluorescence study and investigation of
antimicrobial activity of rare earth metal Schiff base complexes were made.
147
OHN
Br
O
ONa
L3
sodium 2-(5-bromo-2-hydroxybenzylideneamino)-4-methylpentanoate
Figure 6.1 Sodium salt of the Schiff base ligand L3
6.2 RESULTS AND DISCUSSION
In the present investigation, the Schiff base ligand [L3] and its six
new lanthanide metal complexes were synthesised and characterised by
different analytical techniques. Scheme 6.1 summarizes the multi-step
procedure leading to the target complexes. The ligand was synthesised by
the one step condensation of leucine and 5 bromosalicylaldehyde
and characterised by UV-Vis, FT-IR, 1H NMR, Mass and TG Analysis.
All the Ln (III) complexes were synthesised by the multistep
procedure in which Ln(NO3)3.xH2O was used as the source of metal and
they correspond to the formula [Ln(L3)(NO3)2(H2O)].NO3. All the complexes
were stable in air and non-hygroscopic powders, soluble in DMSO, DCM
and DMF, sparingly soluble in methanol, ethanol, acetonitrile and
ethylacetate.
148
NH2
O
HO
Leucine
+ HO
OBr
5-bromosalicylaldehyde
OHN
Br
O
ONaEtOH/NaOH
Reflux - 3h
L3
sodium 2-(5-bromo-2-hydroxybenzylideneamino)-4-methylpentanoate
Reflux 3-5h
Ln(NO3)3.xH2O
NO3CH
O
N C
O
Ln
O
NO3
NO3
H2OBr
Ln(III) complexes
Scheme 6.1 Synthesis of Schiff base ligand [L3] and Ln (III) Schiff
base Complexes [Ln = Pr (III), Sm (III), Gd (III), Tb (III), Er (III) and Yb (III)]
6.2.1 Elemental Analysis
Table 6.1 shows the list of the elemental analysis of the Schiff
base ligand and synthesised Ln (III) Schiff base complexes which are in
good agreement with the calculated values.
149
Table 6.1 Elemental Analysis of the ligand [L3] and Ln (III) Schiff base complexes
Compound Molecular Formula Molecular weight Cal.(Exp.)%
C H N
L3 C13H16O3NBrNa 336 46.45(46.65) 4.50(4.49) 4.17(4.15)
[Pr( L3)(NO3)2(H2O)]NO3 C13H16O10N3BrPr 596 26.16(26.18) 2.85(2.85) 7.03(7.04)
[Sm(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrSm 605 25.75(25.76) 2.78(2.80) 6.93(6.93)
[Gd(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrGd 612 25.48(25.47) 2.76(2.77) 6.84(6.85)
[Tb(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrTb 613 25.40(25.40) 2.74(2.76) 6.85(6.84)
[Er(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrEr 621 25.05(25.06) 2.74(2.73) 6.73(6.74)
[Yb(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrYb 628 24.81(24.83) 2.69(2.70) 6.65(6.68)
150
6.2.2 Mass Spectra
A mass spectrum of the newly synthesised Schiff base ligand [L3] confirms the proposed formula by detecting the molecular fragments. Mass spectrometry chemical ionisation of the ligand [L3] (Figure 6.2- 6.9) shows m/z at 336. The HRMS of the complexes (Figure 6.2) show the molecular ions [M]+. at various m/z values. Some isotopic peaks are also found around the fragment peaks [144].
The mass spectrum of the Pr (III) complex shows molecular ions
[C13H16O10N3BrPr]+. at m/z = 595 and important fragments at m/z = 453
[C13H14O3NBrPr]+, 184 [C7H4BrO]+ , 128[C6H10O2N]+ and 79 [Br]+.
The mass spectrum of the Sm (III) complex shows molecular ions
[C13H16O10N3BrSm]+. at m/z = 604 and important fragments at m/z = 462
[C13H14O3NBrSm]+, 184 [C7H4BrO]+ , 128[C6H10O2N]+ and 79 [Br]+.
The mass spectrum of the Gd (III) complex shows molecular ions
[C13H16O10N3BrGd]+. at m/z = 611 and important fragments at m/z = 469
[C13H14O3NBrGd]+, 184 [C7H4BrO]+ , 128[C6H10O2N]+ and 79 [Br]+.
The mass spectrum of the Tb (III) complex shows molecular ions
[C13H16O10N3BrTb]+. at m/z = 612 and important fragments at m/z = 471
[C13H14O3NBrTb]+, 184 [C7H4BrO]+ , 128[C6H10O2N]+ and 79 [Br]+.
The mass spectrum of the Er (III) complex shows molecular ions
[C13H16O10N3BrEr]+. at m/z = 620 and important fragments at m/z = 479
[C13H14O3NBrEr]+, 184 [C7H4BrO]+ , 128[C6H10O2N]+ and 79 [Br]+.
The mass spectrum of the Yb (III) complex shows molecular ions
[C13H16O10N3BrYb]+. at m/z = 627 and important fragments at m/z = 485
[C13H14O3NBrYb]+, 184 [C7H4BrO]+ , 128[C6H10O2N]+ and 79 [Br]+.
151
Figure 6.2 Mass Spectrum of the Schiff base ligand [L3]
%
m/z
152
Figure 6.3 Mass Spectrum of the [Pr(L3)(NO3)2(H2O)]NO3 complex
%
m/z
153
Figure 6.4 Mass Spectrum of the [Sm(L3)(NO3)2(H2O)]NO3 complex
%
m/z
154
Figure 6.5 Mass Spectrum of the [Gd(L3)(NO3)2(H2O)]NO3 complex
%
m/z
155
Figure 6.6 Mass Spectrum of the [Tb(L3)(NO3)2(H2O)]NO3 complex
%
m/z
156
Figure 6.7 Mass Spectrum of the [Er(L3)(NO3)2(H2O)]NO3 complex
%
m/z
157
Figure 6.8 Mass Spectrum of the [Yb(L3)(NO3)2(H2O)]NO3 complex
%
m/z
158
Figure 6.9 HR-MS of the [Pr(L3)(NO3)2(H2O)]NO3 complex
159
6.2.3 Molar Conductance
Molar conductivity data for all the Ln (III) Schiff base complexes in
DMF solution at room temperature are observed to be in the range of
110-125 Scm2mol-1 are tabulated in Table 6.2. This suggests 1:1 electrolytes
and the two nitrate are coordinated to the Ln (III) ion [98].
Table 6.2 Molar conductance of the ligand [L3] and Ln (III) Schiff base complexes
Compound Molecular Formula m
(S cm2 mol 1)
L3 C13H16O3NBrNa -
[Pr( L3)(NO3)2(H2O)]NO3 C13H16O10N3BrPr 112
[Sm(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrSm 116
[Gd(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrGd 110
[Tb(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrTb 125
[Er(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrEr 122
[Yb(L3)(NO3)2(H2O)]NO3 C13H16O10N3BrYb 119
6.2.4 Thermo Gravimetric Analysis
The presence of water molecules and the thermal behaviour of the
Schiff base ligand and the complexes were investigated by thermal analysis.
Thermogravimetric curves, TGA and DTA for the ligand Figure 6.10 and
[Ln(L3)(NO3)2(H2O)]NO3complexes have been obtained in nitrogen
atmosphere between 0-800°C. Figures 6.11-6.16 represents the TGA and
DTA curves for Ln (III) Schiff base complexes.
160
The thermogram of all the Ln (III) Schiff base complexes shows
that the appearance of small endothermic peak on DTA curve around 100°C
corresponds to the loss of the water molecule [145]. The corresponding
weight loss on TGA curve is 2.7% due to the release of water molecule. A
further increase of temperature up to 200°C, leads to the elimination of
HNO3 molecule, 28.31%.
The enhancement of temperature up to 400°C in Pr (III) complex,
leads to the decomposition of organic moiety with the weight loss of 40.23 %
[146]. The final residue of 28.76 %corresponds to the Pr2O3 [163]. The
thermal behaviour of the other lanthanide complexes is similar to
[Pr(L3)(NO3)2(H2O)]NO3which indicates that the complexes undergo two
major steep degradation steps. In the first stage, the coordinated water
molecules are eliminated followed by the elimination of nitric acid, the
second stage decomposition corresponding to the elimination of the Schiff
base ligand and beyond 640oC the TGA curve show no change, possibly
due to the complexes being decomposed to its corresponding Ln2O3 [147].
The Gd (III) Schiff base complex was stable up to 196°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 196 - 530°C with DTG peak at 426°C
corresponds to loss of organic moiety.
The Sm (III) Schiff base complex was stable up to 201°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 201 - 540°C with DTG peak at 540°C
corresponds to loss of organic moiety.
The Yb (III) Schiff base complex was stable up to 198°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 201 - 510°C with DTG peak at 420°C
corresponds to loss of organic moiety.
161
Figure 6.10 TG/DTA curves of the Schiff base ligand [L3] (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
162
Figure. 6.11 TG/DTA curves of the [PrL3(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
163
Figure. 6.12 TG/DTA curves of the [SmL3(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
164
Figure. 6.13 TG/DTA curves of the [GdL3(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
165
Figure. 6.14 TG/DTA curves of the [TbL3(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
166
Figure. 6.15 TG/DTA curves of the [ErL3(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
167
Figure. 6.16 TG/DTA curves of the [YbL3(NO3)2H2O]NO3 complex; (a) TG – thermogravimetric analysis curve; (b) DTA – differential thermal analysis curve
a
b
168
The Tb (III) Schiff base complex was stable up to 196°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 196 - 498°C with DTG peak at 436°C
corresponds to loss of organic moiety.
The Er (III) Schiff base complex was stable up to 203°C and its
decomposition started at this temperature. The complexes underwent
decomposition in the range 203 - 520°C with DTG peak at 440°C
corresponds to loss of organic moiety.
6.2.5 1H NMR Spectra
The 1H NMR Spectra of Schiff base ligand in DMSO-d6 is shown
in Figure 6.17, which shows signal of multiplets at 0.84-0.88 ppm
equivalent to the 6H of two methyl groups. Singlet at 1.69 ppm
corresponds to the methine protons associated with two methyl groups.
Multiplets at 2.43-2.56 ppm are due to , methylene hydrogen atom
associated with a azomethine group [148]. The multiplets in 6.59-7.49
ppm region are assigned to the protons of the benzylidene ring groups
[149]. The singlet at 3.32 ppm is due to the water impurity of the
deuterated DMSO, and the strong singlet at 8.34 ppm is assigned to
the azomethine proton [150]. This is in accordance with the IR data.
169
Figure 6.17 1H NMR spectra of the Schiff base ligand [L3]
170
6.2.6 IR Spectra
The IR spectral data for the Schiff base ligand and Ln (III)
complexes, are listed in Table 6.3 and the comparative spectrum of the
Schiff base ligand and the complex is shown in Figures 6.18 – 6.24. In order
to study the binding mode of the Schiff base ligand to the metal ion in the
complexes, the IR Spectrum of the free Schiff base ligand was compared
with the spectra of the complexes. The change in profile of stretching
frequencies in the complexes, while compared with those observed for the
isolated ligand confirms the coordination of the ligand with the central metal
ion. The IR spectral shifts of different complexes are similar, indicating
similar structures of the Ln (III) complexes.
The IR spectrum of the ligand shows a strong absorption band
around 1665 cm-1, which may be attributed to the azomethine group and it
was found that this absorption frequency shifted to 1640 cm-1 in the spectra
of the complex indicates a stronger double bond character of the imine bond
and a coordination of the azomethine nitrogen atom to the Ln (III) ion
[151,152]. This coordination is further confirmed through the appearance of
a medium intensity band around 420 cm-1 assigned to an Ln-N vibration.
The IR spectrum of the free Schiff base ligand exhibits a broad band around
3400 cm-1, which is attributed to the stretching frequency of the aromatic
hydroxyl substituent group, perturbed by intramolecular hydrogen bonding
[O-H…N] between phenolic hydrogen and azomethine nitrogen atoms
[153,154]. Further, the appearance of the –OH band around 3490 cm-1 in
the spectra of the complexes with an increase in intensity indicates that the
hydroxyl oxygen is coordinated to the Ln (III) ion without proton
displacement [94].
The appearance of band near 1260 cm-1 in the free Schiff base
ligand is associated with the Ar-O band of the phenolic hydroxyl substituent
[155]. The shift in the stretching frequency of Ar-O band around 1270 cm-1
in the spectra of the Ln (III) complexes suggest the coordination of Ln (III)
171
ion occurs through the oxygen atom of the hydroxyl benzene of the Schiff
base ligand [156]. The complexes show a strong band in the region 1500 -
1525 cm-1 and a weaker band in the region 1380 - 1400 cm-1 assigned to
asymmetric and symmetric stretching frequencies of COO- group
respectively. The frequency difference between the asymmetric and
symmetric stretching frequencies comes around 215 cm-1, which
suggests the monodentate coordination of the carboxyl group of amino
acid with the Ln (III) ion [157]. This is further confirmed through the
appearance of a medium intensity band around 540 cm-1, which may be
assigned to Ln-O vibration [158]. The infrared spectra of the Ln (III)
complexes displays several intense band at 1470 cm-1 ( 1), 1028 cm-1
( 2), 825 cm-1 ( 3) and 1290 cm-1 ( 4), which represents the
coordinated nitrate ions with the central metal ion. The difference in
frequency separation is approximately 180 cm-1, which suggests that the
mode of coordination of NO3- ion with the central metal ion is bidentate in
nature [159,160]. The IR band at 1383 cm-1 in the spectrum of the complex
indicates the existence of the free nitrate group in the coordination
sphere. The existence of medium intensity band around 1615 cm-1 is
due to the symmetric and the asymmetric O–H stretching vibrations of
inner-sphere water molecule [161]. The presence of coordinated water is
also established and supported by TG/DTA analysis of these complexes.
172
Table 6.3 Infrared spectral data for the Schiff base ligand [L3] and the Ln (III) complexes
Compounds OH C=N Ar-O NO3
- asym(COO
-) sym(COO
-) Ln-O Ln-N
1 2 3 4 0
L3 3400 1665 1260 - - - - - - - - -
[Pr( L3)(NO3)2(H2O)]NO3 3490 1640 1268 1470 1028 825 1290 1383 1505 1380 540 420
[Sm(L3)(NO3)2(H2O)]NO3 3485 1642 1270 1471 1029 827 1292 1383 1515 1390 548 421
[Gd(L3)(NO3)2(H2O)]NO3 3495 1640 1270 1470 1029 825 1290 1383 1505 1380 545 420
[Tb(L3)(NO3)2(H2O)]NO3 3492 1638 1268 1471 1028 826 1292 1383 1500 1380 540 422
[Er(L3)(NO3)2(H2O)]NO3 3480 1641 1270 1470 1028 825 1292 1383 1510 1390 546 420
[Yb(L3)(NO3)2(H2O)]NO3 3498 1640 1270 1470 1029 826 1292 1383 1525 1400 545 418
173
Figure 6.18 IR spectrum of the Schiff base ligand [L3]
Wavenumber (1/cm)
% T
174
Figure 6.19 IR spectrum of the [Pr(L3)(NO3)2H2O]NO3 complex
Wavenumber (1/cm)
% T
175
Figure 6.20 IR spectrum of the [Sm(L3)(NO3)2H2O]NO3 complex
Wavenumber (1/cm)
% T
176
Figure 6.21 IR spectrum of the [Gd(L3)(NO3)2H2O]NO3 complex
Wavenumber (1/cm)
% T
177
Figure 6.22 IR spectrum of the [Tb(L3)(NO3)2H2O]NO3 complex
Wavenumber (1/cm)
% T
178
Figure 6.23 IR spectrum of the [Er(L3)(NO3)2H2O]NO3 complex
Wavenumber (1/cm)
% T
179
Figure 6.24 IR spectrum of the [Yb(L3)(NO3)2H2O]NO3 complex
Wavenumber (1/cm)
% T
180
6.2.7 Electronic Spectroscopy
The UV-visible absorption spectra for the Schiff base ligand
and the Ln (III) complexes were carried out in DMF at room temperature.
The numerical values of the maximum absorption wavelength ( max) are
listed in Table 6.4 and shown in Figures 6.25 – 6.32. The absorption of the
ligand is characterised by four main absorption bands in the regions 200-500
nm. The band at the max = 203 nm and at 241 nm is attributed to *
transition state [162, 163]. The band at the max = 334 nm corresponds to the
* transition state of the azomethine group and the max = 424 nm is
attributed to the n * transition state associated with the azomethine
group with an intra - molecular charge transfer [164].
The high extinction coefficient for absorption in the near UV-visible
range of Schiff base rare earth metal complexes, leads to the more effective
energy transfer from the ligand to the coordinated rare earth metal center.
This leads to the difference in spectral intensity of the Ln (III) complexes.
The UV-visible spectra of the complexes generally show the
characteristic bands of the free ligands with some changes both in
frequencies and intensities. These modifications of the shifts and the
intensity of the absorption bands confirmed the coordination of the ligand
to the metal ion. The UV-visible absorption spectra of all the Ln (III) Schiff
base complexes show a similarity, which indicates similarity in their
structures. In general, the lanthanide ions do not appreciably contribute to
the spectra of their complexes, since f-f transitions are Laporte-forbidden
and very weak in nature [165]. The absorption bands around 200, 330, 420
nm are slightly shifted to lower frequencies upon complexation. The
appearance of a new band around 270 nm, being absent in the ligand
gives further evidence for the complexation. The band at 273 nm is
attributed to the ligand metal charge transfer [166] and the one around 360
nm may assigned to the * transition state of the azomethine group
coupled with charge transfer from ligand to central metal ion [167].
181
Table 6.4 UV-Visible Spectral Data max. (nm) for the ligand [L3] and the complexes
Compound max (nm) 104(cm2 mol-1) Band assignment
L3 203,241,334, 424
5.05,4.52,3.28, 1.61
* *
[Pr( L3)(NO3)2(H2O)]NO3 200,229,364, 273 429
3.58,2.41,0.31, 0.47 0.05
* LMCT
*
[Sm(L3)(NO3)2(H2O)]NO3 202,242,359 280 442
3.17,0.79,0.15, 0.20 0.07
* LMCT
*
[Gd(L3)(NO3)2(H2O)]NO3 200,230,369, 276 428
3.40,1.36,0.0, 0.34 0.094
* LMCT
*
[Tb(L3)(NO3)2(H2O)]NO3 201,229,361, 273 433
4.09,3.30,0.52, 0.7 0.085
* LMCT
*
[Er(L3)(NO3)2(H2O)]NO3 203,229,364, 273 429
3.58,1.59,0.21, 0.34 0.05
* LMCT
*
[Yb(L3)(NO3)2(H2O)]NO3 200,222,339, 252 407
3.49,1.77,0.21, 0.83 0.071
* LMCT
*
182
Figure 6.25 UV-visible spectrum of the Schiff base ligand [L3] in DMF
solution (1.0 10-6 M) at room temperature
Figure 6.26 UV-visible spectrum of the [Pr(L3)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room temperature.
Abs
orba
nce
Wavelength (nm)
Abs
orba
nce
Wavelength (nm)
183
Figure 6.27 UV-visible spectrum of the [Sm(L3)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Figure 6.28 UV-visible spectrum of the [Gd(L3)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Abs
orba
nce
Wavelength (nm)
Abs
orba
nce
Wavelength (nm)
184
Figure 6.29 UV-visible spectrum of the [Tb(L3)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Figure 6.30 UV-visible spectrum of the [Er(L3)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature.
Abs
orba
nce
Wavelength (nm)
Abs
orba
nce
Wavelength (nm)
185
Figure 6.31 UV-visible spectrum of the [Yb(L3)(NO3)2H2O]NO3
complex in DMF solution (1.0 10-6 M) at room
temperature
Figure 6.32 Comparative UV-visible spectra of the Ln (III) complexes
in DMF solution (1.0 10-6 M) at room temperature
Abs
orba
nce
Wavelength (nm)
Abs
orba
nce
Wavelength (nm)
186
6.2.8 Fluorescence Studies
Photophysical studies of the ligand and its rare earth metal
complexes have been explored in this article. Figure 6.33 gives the
emission spectrum of the Samarium and Terbium Schiff base complexes in
DMF solution at room temperature. Fluorescence properties refer to any
process, which increases, decreases the fluorescence intensity or a shift of
the maximum absorption of a sample. These include excited state reaction,
molecular rearrangement, energy transfer, ground state complex formation
and quenching due to collision [146].
The emission spectra of the complexes were recorded upon the
excitation at 395 nm. The ligand present fluorescence band at 485 nm. The
fluorescence spectra of the complexes present bands that indicate the
formation of complexes and fluorescence property of the metallic ions. The
strongest emission was located around 485 nm for the free ligand, may be
attributed to * transition state, which shifts upon the complexation.
Due to the shielding of 4f orbitals from the environment by an outer shell of
5s and 5p orbitals, the f–f absorption bands are very narrow, which causes
the minimally perturbed spectral properties of the lanthanide ions by the
external field generated by the ligands [168]. An organic ligand is necessary
to improve the quantum yield of luminescent emission for the lanthanide
ions, since the absorption coefficients of the ligand are many orders of
magnitude larger than the intrinsically low molar absorption coefficients of
the trivalent lanthanide ions [169]. Besides, the direct coordination of an
organic ligand to a lanthanide ion can further improve the energy-transfer
rates by reducing the distance between the ligand and the lanthanide ion
[170, 171]. This energy excites the ligand to the excited singlet (S1) state,
followed by an energy migration via intersystem crossing from the S1 state to
a ligand triplet (T) state. The energy is then transferred from the triplet state
of the ligand to a resonance state of the coordinated lanthanide ion without
187
radiation, which in turn undergoes subsequent emission in the visible region
[172-175].
Inspection of emission spectra at exc. 395 nm exhibits the
characteristic emission spectra of Sm (III) and Tb (III) complexes. This
indicates the coordination nature of the ligand with rare earth metal (III) ions
for absorption and transfer of energy.
The sensitised emission spectra of Sm (III) Schiff base complexes
display two luminescence bands at 565 nm and 600 nm corresponding to
the 4G5/2 6H5/2 and 4G5/2 6H7/2 respectively and a shoulder at 642 nm
is due to 4G5/2 6H9/2.
The Tb (III) Schiff base complexes also display two fluorescence
bands around 556 nm and 590 nm, this may attributed to 5D4 7F5 and 5D4
7F4 respectively and a shoulder at 624 nm due to 5D4 7F3. This
indicates that the energy-transfer chain is successfully completed from the
excitation of the ligand to the emission of the coordinated Sm (III) and
Tb (III) central metal ions [162]. The appearance of small band at 840 nm
denotes the secondary derivatives of the rare earth Schiff base complexes.
188
Figure 6.33 Emission spectra of Sm (III) and Tb (III) Schiff base
complexes in DMF solution (1.0 10-6 M) at room
temperature. Emission spectra is obtained with
exc. = 395 nm
189
6.2.9 Antibacterial Studies
All the synthesised Ln (III) metal complexes and their parent Schiff
base ligand L3 were screened for their in vitro antibacterial activity against
Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus,
Streptococcus agalactiae. The percentage inhibition details of the same for
maximum concentration (100 µg mL-1) are tabulated in Table 6.5.
The antibacterial suggested that, the Schiff base L3 and its Ln (III)
metal complexes were found to be biologically active and some of the
Ln (III) metal complexes showed significantly enhanced antibacterial
activities. It is, however, known that, chelation tends to make the Schiff
bases to act as more powerful and potent bactereostatic agents [176,177],
thus inhibiting the growth of bacteria more than the parent Schiff bases.
Tb (III) Schiff base complex showed remarkable enhancement in
activity against the pathogens Escherichia coli, Streptococcus agalactiae,
and Pseudomonas aeruginosa. For the species Staphylococcus aureus
Gd (III) Schiff base complex showed higher activity than the other Ln (III)
complexes. The percentage inhibition for the Schiff base ligand L3 and all its
Ln (III) complexes have been depicted in Figure 6.35 - 6.38. From the result
obtained it is clear that the Tb (III) Schiff base complex acts as a better
antibacterial agent than the other Ln (III) complexes, which is evident from
the fact that, it shows greater activity against all the species under
investigation.
190
Table 6.5 Antibacterial results of the Schiff base ligand [L3] and their Ln (III) complexes for maximum concentration (100 µg mL-1)
Compound % inhibition against bacteria
E. coli S. agalactiae P. aeruginosa S. aureus
L3 53.76 63.24 75.79 75.46
[Pr(L3)(NO3)2(H2O)]NO3 58.35 69.45 59.54 73.76
[Sm(L3)(NO3)2(H2O)]NO3 59.79 71.73 70.61 81.94
[Gd(L3)(NO3)2(H2O)]NO3 64.26 63.61 88.64 83.18
[Tb(L3)(NO3)2(H2O)]NO3 65.92 72.49 94.79 79.76
[Er(L3)(NO3)2(H2O)]NO3 53.45 70.54 64.91 80.54
[Yb(L3)(NO3)2(H2O)]NO3 61.76 71.34 76.38 81.23
DMF - - - -
Amikacin 100 100 100 100
191
(a) Escherichia coli (b) Streptococcus agalactiae
(c) Staphylococcus aureus (d) Pseudomonas aeruginosa
C – Control ; 1 - 20 µg mL-1 ; 2 – 40 µg mL-1 ; 3 – 60 µg mL-1 ;
4 – 80 µg mL-1 ; 5 - 100 µg mL-1
Figure 6.34 Zone of inhibition of (a) Tb(III) (b) Tb(III) (c) Gd(III) (d) Tb(III) complexes of Schiff base Ligand [L3] for bacterial species
192
Figure 6.35 Percentage Inhibition of Schiff base ligand [L3] and their Ln (III) Schiff base complexes against Escherichia coli
Figure 6.36 Percentage Inhibition of Schiff base ligand [L3] and their Ln (III) Schiff base complexes against Streptococcus agalactiae
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Escherichia coli
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Streptococcus agalactiae
% in
hibi
tion
% in
hibi
tion
193
Figure 6.37 Percentage Inhibition of Schiff base ligand [L3] and their Ln (III) Schiff base complexes against Pseudomonas aeruginosa
Figure 6.38 Percentage Inhibition of Schiff base ligand [L3] and their Ln (III) Schiff base complexes against Staphylococcus aureus
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Pseudomonas aeruginosa
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Staphylococcus aureus
% in
hibi
tion
% in
hibi
tion
194
6.2.10 Antifungal Studies
Synthesised Ln (III) metal complexes and their Schiff base ligand
L3 were screened for their in vitro antifungal activity against Candida and
Aspergillus. The percentage inhibition detail of the same (Figure 6.40 - 6.41)
for maximum concentration (100 µg mL-1) are tabulated in Table 6.6.
Antifungal activity of synthesised Schiff base ligand L3 and some
of their complexes are almost nearer to the standard drug Ketokonazole. It
was evident from the data that this activity significantly increased on
coordination. This enhancement in the activity of the Schiff base may be
rationalised on the basis that the structure mainly possess C=N bond. It has
been suggested that the ligands with nitrogen and oxygen donor systems
inhibit enzyme activity, since the enzymes which require these groups for
their activity appear to be more susceptible for the deactivation by metal ions
on coordination [178,179].
From the observed data it was concluded that, the Schiff base
ligand L3 and its Ln (III) metal complexes are found to possess higher
antifungal activity than the antibacterial activity.
It was also observed that the antifungal activity of few complexes
were very near to the standard antifungal agent Ketokonazole. Compared to
all other Ln (III) complexes, Tb (III) complex shows greater activity against
the fungal species Candida and Aspergillus. Hence, the Tb (III) Schiff base
complex acts as the better antifungal agent.
195
Table 6.6 Antifungal results of the Schiff base ligand [L3] and their Ln (III) complexes for maximum concentration (100 µg mL-1)
Compound % inhibition against fungi
Candida Aspergillus
L3 63.42 54.37
[Pr(L3)(NO3)2(H2O)]NO3 62.49 63.81
[Sm(L3)(NO3)2(H2O)]NO3 89.07 87.25
[Gd(L3)(NO3)2(H2O)]NO3 97.18 73.15
[Tb(L3)(NO3)2(H2O)]NO3 99.04 95.23
[Er(L3)(NO3)2(H2O)]NO3 96.18 90.18
[Yb(L3)(NO3)2(H2O)]NO3 96.91 89.49
DMF - -
Ketokonazole 100 100
196
(a) Candida (b) Aspergillus
C – Control ; 1- 20 µg mL-1 ; 2 – 40 µg mL-1 ; 3 – 60 µg mL-1 ;
4 – 80 µg mL-1 ; 5 - 100 µg mL-1
Figure 6.39 Zone of inhibition of Tb(III) complex of Schiff base Ligand [L3] for fungal species
197
Figure 6.40 Percentage Inhibition of Schiff base ligand [L3] and their Ln (III) Schiff base complexes against Candida
Figure 6.41 Percentage Inhibition of Schiff base ligand [L3] and their Ln (III) Schiff base complexes against Aspergillus
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Candida
0102030405060708090
100
L Pr(III) Sm(III) Gd(III) Tb(III) Er(III) Yb(III)
Aspergillus
% in
hibi
tion
% in
hibi
tion
198
6.3 CONCLUSION
This chapter reports the synthesis and characterisation of the
tridentate Schiff base ligand L3, obtained by the condensation of L-
Leucine and 5-bromosalicyaldehyde and its Ln (III) complexes. The
analytical and spectral data reveal that the ligand coordinate to the central
Ln (III) ion by its phenolic oxygen, azomethine nitrogen and the carboxylic
oxygen with 1:1 stoichiometry and their coordination number is eight. The
samarium and terbium complexes exhibit interesting fluorescence properties.
The synthesised complexes show enhanced antimicrobial activity than the
corresponding free Schiff base ligand L3. All the synthesised Ln (III)Schiff
base complexes possess higher antifungal properties than the antibacterial
property. All the above facts reveal that these complexes can be
recommended for establishing a new line of search for antimicrobial agents.
199
7. CATALYTIC ACTIVITY OF LANTHANIDE (III) SCHIFF BASE COMPLEXES DERIVED FROM LEUCINE
7.1 INTRODUCTION
Catalytic oxidation has gained much interest among the academic
and industrial chemists [180]. Especially, oxidation of organic substrates by
inexpensive, readily abundant, terminal and environmental friendly oxidants
like aqueous H2O2, molecular oxygen are very attractive from the view point
of industrial technology and synthetic purposes [181]. Concerning the
green oxidant, hydrogen peroxide is one of the most powerful candidates
besides oxygen, because of its high atom efficiency, and water is expected
as the only by-product to be generated from the reaction [182,183].
Catalytic oxidation of amines to their corresponding oxygen
containing derivative has attracted much attention during the past few
decades [184]. Only few examples have been reported [185,186], among
which, it was found that transition-metal-catalysed oxidative reaction of
anilines to corresponding azobenzene is highly desirable under atmospheric
conditions [187].
Anilines are most widespread and principal contaminants of
industrial waste waters. These comprise an important class of environmental
contaminants and they are the building blocks for many textile dyes,
agrochemicals and other class of synthetic chemicals. The reaction
pathways of aromatic amines in natural systems are dominated by redox
reactions with soil and sediment constituents. Oxidation of such compounds
to harmless products is the important goal for basic research and industrial
applications [188]. Oxidation of anilines leads to the formation of
200
azobenzene [189], azoxybenzene [190,191], nitrobenzene [192] and
nitrosobenzene [193] by organic [194] and inorganic oxidants [189]. The
product composition in the oxygenation of amines depends on the oxidant,
catalyst and reaction condition employed. The oxidation of aniline leading to
the azo compound as a single product becomes a research interest for
chemists.
As a result of the above facts, and in view of the diversified roles
of lanthanide Schiff base metal complexes, in continuation of our work [129,
195], we have investigated the oxidation of aniline into their corresponding
azobenzene, using H2O2 as an oxygen source in the presence of rare earth
metal Schiff base complexes derived from leucine.
7.2 CATALYTIC OXIDATION OF ANILINE AND SUBSTITUTED ANILINES
The oxidation of aniline and its derivatives to the corresponding
azo compound have been carried out smoothly in an almost quantitative
yield using H2O2 as an oxidant and rare earth metal Schiff base complexes
as catalyst.
Table 7.1 gives the results of aniline oxidation into their
corresponding azobenzene as the product. All the reactions were carried
out at room temperature, by using 30 % H2O2 as an oxidant combined with
the catalytic amount of rare earth metal Schiff base complexes. The
azobenzene was produced in good yield at room temperature in CH2Cl2 with
the reaction time less than an hour.
Initially, the reaction was carried out without catalyst (Table 7.1,
entry 1) and enhanced amount of oxidant, it proceeds with the formation of
product with poor yield and greater reaction time. Then six types of catalyst
were tested (Table 7.1, entries 2-7), 70 – 90 % yields of azo benzene with
excellent conversions were obtained. To our surprise, among the various
201
catalyst used, the conversion of aniline to corresponding azobenzene in the
presence of [Gd(L3)(NO3)2(H2O)]NO3 with 10 mmol of H2O2, results 85 % of
yield within 15 minutes of reaction time at reflux (Table 7.1, entry 3).
Elevation of reaction temperature has no effect on the aniline oxidation with
the above Gd (III) Schiff base complex as a catalyst. The other tested
catalyst also gave moderate to good yield of oxidation product
(Table 6.5, entries 4-6). Although, the [Sm(L3)(NO3)2(H2O)]NO3 and
[Yb(L3)(NO3)2(H2O)]NO3 complexes gave the good yield of the product
(90 %), the reaction time (30 min. and 60 min. respectively) was the fact that
carries less importance in the purview of industrial and academics. The
effect of catalyst without oxidant (Table 7.1, entry 8) was also tested. No
starting material was converted into the product in the absence of H2O2.
After these testing, [Gd(L3)(NO3)2(H2O)]NO3 was chosen as the catalyst and
10 mL of H2O2 as an oxidant as the best reaction conditions.
To our delight 85 % of azobenzene was produced in CH2Cl2 with
total conversion of staring material and only 2 mol % of catalyst were utilised
for the oxidation purpose. With the best reaction condition (Table 7.1, entry
3) the experiment was carried out to check the generality and efficiency of
this methodology with the various kinds of substituted anilines are shown in
Table 7.2 Under the optimised conditions, aniline (entry 1) and various
substituted anilines were oxidised to its corresponding products in good to
excellent yields. The oxidative reaction of aromatic aniline with an electron
withdrawing substituted group such as nitro, acid and chloro group on the
phenyl ring proceeds with the yield of trace amount (entries 3, 4, 8 ,10 and
12) under the reaction conditions. This was suspected due to the low
electron density of phenyl ring. Further, among the various ortho, meta and
para substituted anilines, para substituted anilines results excellent yield of
the oxidative products (entries 2 and 5) while compared with meta
substituted aniline, which results good yield of the desired product (entries
6, 7 and 9) and ortho substituted aniline, which results a moderate yield of
202
the desired product (entry 11). The desired products were characterised by 1H NMR as shown in Figures 7.1 – 7.12.
In summary, a general rare earth metal Schiff base catalysed
oxidation of aniline and substituted aniline to the corresponding azo
compounds have been developed. The reaction proceeds at room
temperature and use H2O2 as the green oxidant, provides a simple and
general procedure for the preparation of azo derivatives that is difficult to
prepare by conventional methods. The result clearly demonstrates that this
oxidation system is more efficient in the oxidation of aniline to azobenzene
with H2O2 as an oxidant and [Gd(L3)(NO3)2(H2O)]NO3 complex as a catalyst.
Table 7.1 Oxidation of aniline catalysed by various Ln (III) complexes in CH2Cl2 at RT
Entry Catalyst Oxidant Yield (%)
Reaction Time (min.)
1 - Enhanced conc. H2O2
30 180
2 [Sm (L3) (NO3)2(H2O)]NO3 H2O2 90 30
3 [Gd (L3)(NO3)2(H2O)]NO3 H2O2 85 15
4 [Pr (L3)(NO3)2(H2O)]NO3 H2O2 70 25
5 [Eu (L3)(NO3)2(H2O)]NO3 H2O2 80 30
6 [Tb (L3) (NO3)2(H2O)]NO3 H2O2 75 25
7 [Yb (L3) (NO3)2(H2O)]NO3 H2O2 90 60
8 [Gd (L3) (NO3)2(H2O)]NO3 - - 240
203
Table 7.2 Oxidation of aniline and substituted anilines catalysed by Gd (III) complex in CH2Cl2 at RT
Entry Anilines Product Yield (%)
1
NH2
Phenylamine
N N
Diphenyl-diazene
85
2
NH2
CH3
p-Tolylamine
N N
H3C CH3
Di-p-tolyl-diazene
88
3
NH2
Cl4-Chloro-phenylamine
N N
Cl Cl
Bis-(4-chloro-phenyl)-diazene
30
4 NH2
O2N
4-Nitro-phenylamine
N N
O2N NO2
Bis-(4-nitro-phenyl)-diazene
12
5
OCH3
NH2
4-Methoxy-phenylamine
OCH3NNH3CO
Bis-(4-methoxy-phenyl)-diazene
88
6
m-phenylenediamine
NH2H2N
N NO2N NO2
Bis-(3-nitro-phenyl)-diazene
60
204
Table 7.2 (Continued)
Entry Anilines Product Yield (%)
7 OCH3
NH2
3-Methoxy-phenylamine
N
OCH3
Bis-(3-methoxy-phenyl)-diazene
H3CO
N
62
8 Cl
NH2
3-Chloro-phenylamine
NN
ClCl
Bis-(3-chloro-phenyl)-diazene
20
9 CH3
NH2
m-Tolylamine
N N
H3C CH3
Di-m-tolyl-diazene
66
10
NH2
Cl2-Chloro-phenylamine
N N
Cl Cl
Bis-(2-chloro-phenyl)-diazene
12
11
NH2
OCH3
2-Methoxy-phenylamine
N N
OMe MeO
Bis-(2-methoxy-phenyl)-diazene
25
12
NH2
Amino-benzoic acid
COOH
azodibenzoicacid
NN
OHO
OHO
12
205
Figure 7.1 1H NMR spectra of Diphenyl-diazene
ppm
206
Figure 7.2 1H NMR spectra of Di-p-tolyl-diazene
ppm
207
Figure 7.3 1H NMR spectra of Bis-(4-chloro-phenyl)-diazene
ppm
208
Figure 7.4 1H NMR spectra of Bis-(4-nitro-phenyl)-diazene
ppm
209
Figure 7.5 1H NMR spectra of Bis-(4-methoxy-phenyl)-diazene
ppm
210
Figure 7.6 1H NMR spectra of Bis-(3-nitro-phenyl)-diazene
ppm
211
Figure 7.7 1H NMR spectra of Bis-(3-methoxy-phenyl)-diazene
ppm
212
Figure 7.8 1H NMR spectra of Bis-(3-chloro-phenyl)-diazene
ppm
213
Figure 7.9 1H NMR spectra of Di-m-tolyl-diazene
ppm
214
Figure 7.10 1H NMR spectra of Bis-(2-chloro-phenyl)-diazene
ppm
215
Figure 7.11 1H NMR spectra of Bis-(2-methoxy-phenyl)-diazene
ppm
216
Figure 7.12 1H NMR spectra of Azodibenzoic acid
ppm
217
7.3 CONCLUSION
The Ln(III) Schiff base complexes have been applied as catalyst
for the oxidation of aniline and substituted aniline to the corresponding azo
compounds. Among them, the [Gd(L3)(NO3)2(H2O)]NO3 complex found to
possess good catalytic ability for oxidation of aniline under mild conditions
using the green oxidant H2O2 . It gave results 85 % of yield within 15 minutes
of reaction time.
218
8. SUMMARY AND CONCLUSION
8.1 Ln (III) SCHIFF BASE (L1) COMPLEXES
The tridentate Schiff base ligand L1 and its Ln (III) complexes of
the type [Ln(L1)(NO3)2(H2O)] NO3 were synthesised and characterised by
elemental analysis, TGA/DTA, spectral analysis like 1H NMR, UV, FT-IR and
Mass Spectrometry. The results of investigation support the suggested
structures of the lanthanide metal complexes. Thermal study reveals
thermal stability of complexes. Spectral study and thermal data showed that
two nitrate groups are bound in a bidentate manner to the central Ln (III)
ions in the coordination sphere while another nitrate is in the outer
coordination sphere in complexes. Hence, coordination number eight is
suggested for the metal ion in these lanthanide(III) nitrate complexes. The
fluorescence data reveals that the Sm (III), Tb (III) and Er (III) complexes
exhibit characteristic luminescence of Sm (III), Tb (III) and Er (III) ions,
which indicates that the ligand L1 is a good organic chelator to absorb and
transfer energy to Sm (III), Tb (III) and Er (III) ions. The antibacterial
activity results show that most of the synthesised complexes possess a good
antimicrobial activity against the pathogens tested than the corresponding
free Schiff base ligand.
8.2 Ln (III) SCHIFF BASE (L2) COMPLEXES
Ln (III) complexes of the general formula [LnL(NO3)2(H2O)] NO3
has been synthesised from the tridentate Schiff base ligand L2 formed by the
condensation of L-Threonine and 5-bromosalicyaldehyde. The bonding of
ligand to the metal ions has been confirmed by elemental analysis,
TGA/DTA, spectral analyses like 1H NMR, UV, FT-IR and Mass
219
Spectrometry. The results of investigation support the suggested structures
of the lanthanide metal complexes. Thermal study reveals the presence of
water molecules and thermal stability of the complexes. Spectral study and
thermal data show that two nitrate groups are bound in a bidentate manner
to the central Ln (III) ions in the coordination sphere, while another nitrate is
in the outer coordination sphere in complexes. Hence, coordination number
eight is suggested for the metal ion in these lanthanide(III) complexes. The
fluorescence data reveals that the Sm (III), Tb (III) and Er (III) complexes
exhibit characteristic luminescence of Sm (III), Tb (III) and Er (III) ions,
which indicate that the Schiff base ligand is a good organic chelator to
absorb and transfer energy to Ln (III) ions. The synthesised complexes
exhibited enhanced antimicrobial activity than the corresponding free Schiff
base ligand. All the newly synthesised compounds possess higher
antifungal properties than the antibacterial property.
8.3 Ln (III) SCHIFF BASE (L3) COMPLEXES
The rare earth metal complexes of the tridentate Schiff base
ligand L3, obtained by the condensation of L-Leucine and
5-bromosalicyaldehyde were characterised by elemental analysis,
TGA/DTA, spectral analysis like 1H NMR, UV, FT-IR, and Mass
Spectrometry. These analytical and spectral data reveal that the ligand
coordinate to the central Ln (III) ion by its phenolic oxygen, azomethine
nitrogen and the carboxylic oxygen with 1:1 stoichiometry and their
coordination number is eight. The samarium and terbium complexes present
interesting fluorescence properties. The synthesised complexes exhibited
enhanced antimicrobial activity than the corresponding free Schiff base
ligand L3. All the synthesised Ln (III) Schiff base complexes possess higher
antifungal properties than the antibacterial property.
220
8.4 CATALYTIC ACTIVITY OF Ln (III) SCHIFF BASE (L3) COMPLEXES
The Ln (III) Schiff base complexes of the ligand L3 have been
applied as catalyst for the oxidation of aniline and substituted aniline to the
corresponding azo compounds. The Ln (III) complexes possesses good
catalytic ability for oxidation of aniline under mild conditions using the green
oxidant H2O2 . The result clearly demonstrates that this oxidation system is
more efficient with [Gd(L3)(NO3)2(H2O)]NO3 complex as a catalyst. Hence,
this [Gd(L3)(NO3)2(H2O)]NO3 complex was utilised to check the generality
and efficiency of oxidation of various substituted anilines. This system
provides a simple and general procedure for the preparation of azo
derivatives, which are difficult to prepare by conventional methods.
221
9. SCOPE FOR FUTURE WORK
The following objectives are planned for future studies:
To obtain single crystal for all the Schiff base ligands and its
Ln (III) complexes and to explore the crystal structures.
To study the selective oxidation of aniline and substituted
anilines using the Ln (III) complexes derived from L1 and L2.
To investigate the reaction mechanism of oxidation of aniline.
To investigate methods for the recovery and reuse of catalyst
used for organic transformations.
To impregnate the synthesised Schiff base ligands and its
complexes into the ZnO nano particles and investigate further
their nature.
To explore the biological activities including antimicrobial,
antioxidant and anticancer efficiency of the above said nano
particles.
To investigate the luminescence property of the Ln (III) Schiff
base complexes embedded in the ZnO nano particle.
222
10. REFERENCES
1. Wilson M. “Microbial Inhabitants of Humans: Their Ecology and Role
in Health and Disease”, Cambridge, UK: Cambridge University
Press; 2005.
2. Aime S., Crich S.G., Gianolio E., Giovenzana G.B., Tei L. and
Terreno E., “High sensitivity lanthanide(III) based probes for MR-
medical imaging”, Coord. Chem. Rev., Vol.250, pp. 1562-1579,
2006.
3. Gassner A.L., Duhot C., Bunzli J.C.G. and Chauvin A.S.,
“Remarkable Tuning of the Photophysical Properties of Bifunctional
Lanthanide tris(Dipicolinates) and its Consequence on the Design of
Bioprobes”, Inorg. Chem., Vol.47, pp. 7802-7812, 2008.
4. Eliseeva S.V. and Bunzli J.C.G., “Lanthanide luminescence for
functional materials and bio-sciences”, Chem. Soc. Rev., Vol.39,
pp.189-227, 2010.
5. Hermann P., Kotek J., Kubicek V. and Lukes I., “Gadolinium(III)
complexes as MRI contrast agents: ligand design and properties of
the complexes”, Dalton Trans., Vol. 23, pp. 3027-3047, 2008.
6. Supkowski R.M., Bolender J.P., Smith W.D., Reynolds L.E.L. and
Horrocks W.D., “Lanthanide ions as redox probes of long-range
electron transfer in proteins”, Coord. Chem. Rev., Vol.186,
pp.307-319, 1999.
223
7. Martens S. and Mithofer A., “Flavones and Flavone synthases”,
Phytochemistry, Vol.66, pp.2399-2407, 2005.
8. Dixit N., Mishra L., Mustafi S.M., Chary K.V.R. and Houjou H.,
“Synthesis of a ruthenium(II) bipyridyl complex coordinated by a
functionalised Schiff base ligand: Characterisation, spectroscopic
and isothermal titration calorimetry measurements of M2+ binding and
sensing (M2+ = Ca2+, Mg2+)”, Spectrochim. Acta, Part A, Vol.73,
pp. 29-34, 2009.
9. Kureshy R.I., Khan N.H., Abdi S.H.R., Patel S.T. and Iyer P.J.,
“Chiral Ru(II) Schiff base complex-catalysed enantio selective
epoxidation of styrene derivatives using iodosyl benzene as oxidant.
II”, J. Mol. Catal. A: Chem., Vol.150, pp. 175-183, 1999.
10. Aoyama Y., Kujisawa J.T., Walanawe T., Toi A. and Ogashi H.,
“Catalytic reactions of metalloporphyrins. 1. Catalytic modification of
borane reduction of ketone with rhodium(III) porphyrin as catalyst”, J.
Am. Chem. Soc., Vol.108, pp. 943-947, 1986.
11. Kelly T.R., Whiting A. and Chandrakumar N.S., “A rationally
designed, chiral Lewis acid for the asymmetric induction of some
Diels-Alder reactions” J. Am. Chem. Soc., Vol.108, pp. 3510-3512,
1986.
12. Sengupta P., Ghosh S. and Mak T.C.W., “A new route for the
synthesis of bis(pyridine dicarboxylato)bis(triphenylphosphine)
complexes of ruthenium(II) and X-ray structural characterisation of
the biologically active trans-[Ru(PPh3)2(L1H)2] (L1H2=pyridine 2,3-
dicarboxylic acid)”, Polyhedron, Vol.20, pp. 975-980, 2001.
224
13. Ramasubramanian A.S., Ramachandra B.B. and Dileep R.,
“Thermal and Antibacterial Studies of Novel Lanthanide–Schiff Base
Complexes”, Synth. React. Inorg.Met.-Org., Nano-Met.Chem.,
Vol.42, pp. 548-553, 2012.
14. Cimerman Z., Miljanic S. andGalic N., “Schiff bases derived from
aminopyridines as spectrofluorimetric analytical reagents,”
CroaticaChemicaActa, Vol. 73, No.1, pp. 81-95, 2000.
15. Spichiger-Keller U., “Chemical Sesors and Biosensors for Medical
and Biological Applications”, Wiley-VCH, Weinheim, 1998.
16. Patel P. R., Thaker B. T. and Zele S., “Synthesis, Spectroscopic
Characterisation and Antimicrobial Activities of Some Rare Earth
Metal Complexes of Biologically Active Asymmetrical Tetradentate
Ligand” Indian J. Chem., Vol. 38 A, pp. 563-569, 1999.
17. Layer R.W., “The Chemistry of imines”, Chem. Rev., Washington,
DC, U.K., Vol. 63, pp. 489-510, 1963.
18. Cozzi P. G. “Metal–Salen Schiff base complexes in catalysis:
practical aspects”, Chem. Soc. Rev., Vol. 33, pp. 410-421, 2004.
19. Fessenden R. J. and Fessenden, J. S., “Organic Chemistry”, Sixth
Edition, Brooks/Cole Publishing Company, USA, pp. 563-564, 1998.
20. Streitwieser A., Heathcock C. H. and Kosower E. M., “Introduction to
Organic Chemistry”, Fourth Edition, Prentice Hall, New Jersey USA,
1998.
21. Kabak M., Elmali A. and Elerman Y., “Keto–enoltautomerism,
conformations and structure of N-(2-hydroxy-5-methylphenyl), 2-
hydroxybenzaldehydeimine” J. Mol. Struct., Vol. 477, pp.151-153,
1999.
225
22. Ajlouni A.M., Taha Z. A, Al Momani W., Hijazi A. K, Mohammad
Ebqa’ai, “Synthesis, characterisation, biological activities, and
luminescent properties of lanthanide complexes with N,N0-bis(2-
hydroxy-1-naphthylidene)-1,6-hexadiimine”, Inorg. Chim. Acta, Vol.
388, pp. 120–126, 2012.
23. Sattari D., Alipour E., Shriani S., Amighian J., “Metal complexes of N-
salicylideneamino acids” J. Inorg. Biochem., Vol. 45, pp. 115-122,
1992.
24. Sreenivasulu B., Vittal J. J., “Hydrogen-bonded copper(II)
and nickel(II) complexes and coordination polymeric structures
containing reduced Schiff base ligands”, Inorg. Chim. Acta, Vol. 362,
pp. 2735–2743, 2009.
25. Yun-Zhu Cao, Hai-Yan Zhao, Feng-Ying Bai, Yong-Heng Xing,
Dong-Ming Wei, Shu-Yun Niu, Zhan Shi, “Aminoacid-derivatised
oxidovanadium complexes: Synthesis, structure and bromination
reaction activity”, Inorg. Chim. Acta, Vol. 368, pp. 223–230, 2011.
26. Ameerunisha M.S., Saha S., Nethaji M. and Chakravarthy A.R.,
“Synthesis, crystal structures and protease activity of amino acid
Schiff base iron(III) complexes”, Ind. J. Chem., Vol. 48A,
pp. 473-479, 2009.
27. Ketelle B.H. and Boyd G.E., “The Exchange Adsorption of Ions from
Aqueous Solutions by Organic Zeolites. IV. The Separation of the
Yttrium Group Rare Earths” J. Am. Chem. Soc., Vol. 69,
pp. 2800-2812, 1947.
226
28. Spedding F.H., Fulmer E.I., Powell J.E. and Butler J.A., “The Separation of Rare Earths by Ion Exchange.1 IV. Further
Investigations Concerning Variables Involved in the Separation of Samarium, Neodymium and Praseodymium”, J. Am. Chem. Soc., Vol. 72, pp. 2349-2354, 1950.
29. Jensen W.B., “Positions of La and Lu in the Periodic Table”, J. Chem. Educ., Vol.59, pp. 634-636, 1982.
30. Karraker D.G., “Hypersensitive transitions of hydrated neodymium-(III)holmium-(III) and erbium-(III) ions”, Inorg. Chem., Vol. 7,
pp. 473-479, 1968.
31. Buono-core G.E., Li H., and Marciniak B., “Quenching of excited states by lanthanide ions and chelates in solution”, Coord. Chem.
Rev., Vol. 99, pp. 55–87, 1990.
32. Jingqing R. and Guangxian X., “INDO studies on the electronic structure and chemical bonding of a rare earth cluster compound, Gd10C4Cl18”, Lant. Act. Res., Vol. 2, pp. 67–78, 1987
33. Braunstein P., “Functional ligands and complexes for new structures,
homogeneous catalysts and nanomaterials”, J. Organomet. Chem., Vol. 689, pp. 3953-3967, 2004.
34. Maheswaran S. and Ramesh R., “Synthesis, Spectra, Dioxygen affinity and antifungal activity of Ru(III) Schiff base complexes”, J.
Inorg. BioChem., Vol. 96, pp. 457-462, 2003.
35. Akbar Ali M., Abu Bakar H. J. H., Mirza A. H., Smith S. J., Gahan L.
R. and Bernhardt P. V., “Preparation, spectroscopic characterisation and X-ray crystal and molecular structures of nickel(II), copper(II) and zinc(II) complexes of the Schiff base formed from isatin and S-
methyldithiocarbazate (Hisa-sme)”, Polyhedron, Vol. 27, pp. 71-79, 2008.
227
36. McGuinness D. D., Wasserscheid P., Morgan D. H. and Dixon J. T.,
“Ethylene Trimerisation with Mixed-Donor Ligand (N, P,S) Chromium
Complexes: Effect of Ligand Structure on Activity and Selectivity”,
Organometallics, Vol. 24, pp. 552-556, 2005.
37. Tahaa Z.A., Ajlounia A.M., Al-Hassanb K. A., Ahmed K. Hijazi, Ari B.
Faiqa, “Syntheses, characterisation, biological activity and
fluorescence properties of bis-(salicylaldehyde)-1,3-propylenediimine
Schiff base ligand and its lanthanide”, Spect. Chim. Acta Part A,
Vol. 81, pp. 317– 323, 2011.
38. Li Zhang, YufeiJi, XuebinXu ,ZhiliangLiuan, Jinkui Tang, “Synthesis,
structure and luminescence properties of a series of dinuclearLnIII
complexes (Ln=Gd, Tb,Dy,Ho,Er)”, J. Lumi., Vol. 132, pp. 1906–1909,
2012.
39. Lijuan Zhang, Fei Jiang, Yunshan Zhou, “Structures and
fluorescence of two new hetero-dinuclearlanthanide(III) complexes
derived from a Schiff-base ligand”, J. Coord. Chem., Vol. 62,
pp. 1476–1483, 2009.
40. Kulkarni A., Patil S.A., Badami P.S., “Synthesis, characterisation,
DNA cleavage and in vitro antimicrobial studies of La(III), Th(IV) and
VO(IV) complexes with Schiff bases of coumarin derivatives”, Europ.
J. Med. Chem., Vol. 44, pp. 2904–2912, 2009.
41. Salehzadeh S., Nouri S.M., Keypour H., Bagherzadeh M., “Synthesis
of gadolinium(III) and samarium(III) complexes of new potentially
heptadentate (N4O3) tripodal Schiff base ligands, and a theoretical
study”, Polyhedron, Vol. 24, pp. 1478–1486, 2005.
228
42. Omar M.M., Mohamed G.G., Ibrahim A.A., “Spectroscopic
characterisation of metal complexes of novel Schiff base. Synthesis,
thermal and biological activity studies”, Spect. Chimi. Acta Part A,
Vol. 73, pp. 358–369, 2009.
43. Zhang Bin, Lin Yan, Tang Xiaoning, XuYinhua and Xie Gang,
“Mechanism of antibacterial activity of silver and praseodymium-
loaded white carbon black”, J. Rare earths, Vol. 28, pp. 442-448,
2010.
44. Cleiton M. da Silva, Daniel L. da Silva, Luzia V. Modolo, Rosemeire
B. Alves, Maria A. de Resende, Cleide V.B. Martins and Angelo de
Fa´ tima, “Schiff bases: A short review of their antimicrobial
activities”, J. Adv. Res., Vol. 2, pp. 1–8, 2011.
45. Halli M.B. and Sumathi R.B., “Synthesis, physico-chemical
investigations and biological screening of metal (II) complexes with
Schiff base derived from naphthofuran-2-carbohydrazide and citral”,
Arab. J. Chem., Article in press, 2013.
46. Casuscelli S., Herrero E., Crivello M. and Perez C., “Application of
complex heteropolytungstates in limonene epoxidation by H2O2 in
biphasic medium”, Catal. Today, Vol. 107, pp. 230-234, 2005.
47. Mao J., Li N., Li H. and Hu X., “Novel Schiff base complexes as
catalysts in aerobic selective oxidation of -isophorone”, J.Mol.
Catal.A: Chem., Vol. 258, pp. 178-184, 2006.
48. Hosseini-Monfared H., Nather C., Winkler H. and Janiak C., “Highly
selective and ‘‘green’’ alcohol oxidations in water using aqueous 10%
H2O2 and iron-benzenetricarboxylate metal–organic gel”, Inorg.
Chim. Acta, Vol. 391 pp. 75–82, 2012.
229
49. Furukawa M., Nishikawa Y., Nishiyama S. and Tsuruya S., “Effect of
alkali metal added to supported La catalysts on the catalytic activity
in the gas-phase catalytic oxidation of benzyl alcohol”, J. Mol. Cat.
A: Chemical, Vol. 211 pp. 219–226, 2004.
50. Alizadeha M.H. andTayebee R., “Catalytic Oxidation of Aniline by
Aqueous Hydrogen Peroxide in the Presence of Some
Heteropolyoxometalates”, J. Braz. Chem. Soc., Vol. 16(1), pp.108-111,
2005.
51. Ching-Fu Chang and Shiuh-Tzung Liu, “Catalytic oxidation of anilines
into azoxybenzenes on mesoporoussilicas containing cobalt oxide”,
J. Mol. Cat. A: Chem., Vol. 299, pp. 121–126, 2009.
52. Jackson M., “Magnetism of Rare Earth”, The IRM quarterly Vol. 10,
No. 3, pp. 1-8, 2000.
53. Borchert Y., Sonstrom P., Wilhelm M., Borchert H. and Baumer M.,
"Nanostructured Praseodymium Oxide: Preparation, Structure, and
Catalytic Properties". J. Phy. Chem. C, Vol. 112, No. 8, pp. 3054-3063,
2008.
54. Lide D. R., “CRC Handbook of Chemistry and Physics”, Eighty sixth
Edition, Boca Raton (FL): CRC Press, ISBN 0-8493-0486-5,
pp. 4.122, 2005.
55. Cotton, “Advanced inorganic chemistry”, Sixth Edition, Wiley-India,
ISBN 81-265-1338-1, pp. 1128-1166, 2007.
56. Okazaki T., Suenaga K., Hirahara K., Bandow S., Iijima S. and
Shinohara H., "Electronic and geometric structures of
metallofullerene peapods", Physica B, 323, pp. 97-99, 2002,
230
57. Emsley, John, “Nature's Building Blocks: An A–Z Guide to the
Elements”, Oxford, England, UK: Oxford University Press,
ISBN 0-19-850340-7, pp. 371–374, 2001.
58. Gruen D.M., Koehler W.C., and Katz J.J., “Higher Oxides of the
Lanthanide Elements: Terbium Dioxide”, J. Ameri. Chem.
Soc.,Vol.73, No.4, pp. 1475–1479, 1951.
59. Patnaik, Pradyot, “Handbook of Inorganic Chemical Compounds”,
McGraw-Hill, pp. 920–992, 2003.
60. Georges A., Bersillon O., Blachot J. and Wapstra A.H., "The
NUBASE Evaluation of Nuclear and Decay Properties”, Nuc. Phy. A
(Atomic Mass Data Center), Vol. 729, pp. 3–128, 2003.
61. Sato V., Suenaga V., Okubo V., Okazaki T. and Iijima S., “Structures
of D5d-C80 and Ih-Er3NC80Fullerenes and Their Rotation Inside
Carbon Nanotubes Demonstrated by Aberration-Corrected Electron
Microscopy”, Nano Letters, Vol. 7, No.12, pp. 3704,2007.
62. Girard P., Namy J.L. and Kagan H. B., “Divalent lanthanide
derivatives in organic synthesis. 1. Mild preparation of samarium
iodide and ytterbium iodide and their use as reducing or coupling
agents”, J. Ameri. Chem. Soc., Vol. 102, No.8, pp. 2693-2724, 1980.
63. Grukh Dmitrii A., Bogatyrev V. A., Sysolyatin A.A., Paramonov
Vladimir M., Kurkov Andrei S. and Dianov Evgenii M., “Broadband
radiation source based on an ytterbium-doped fibre with fibre-length-
distributed pumping”, Quant. Electron., Vol. 34, No.3 pp. 247-248,
2004.
64. Emsley John, “Nature's building blocks: An A-Z guide to the
elements”, Oxford University Press, pp. 492–494, 2003.
231
65. Safaa Eldin H. Etaiwa, Dina M. Abd El-Aziza, Eman H. Abd El-Zaherb and Elham A. Ali, “Synthesis, spectral, antimicrobial and
antitumor assessment of Schiff base derived from 2-aminobenzothiazole and its transition metal complexes”, Spectrochim. Acta A., Vol.79, pp. 1331-1337, 2011.
66. Tahaa Z. A., AjlouniA. M., Al Momanib W. and Al-Ghzawia A. A., “Syntheses, characterisation, biological activities and photophysical properties of lanthanides complexes with a tetradentate Schiff base
ligand”, Spectrochim. Acta A., Vol.81, pp.570-577, 2011.
67. Jadhav S. M., Shelke V. A., Shankarwar S.G., MundeA. S. and ChondhekarT. K., “Synthesis, spectral, thermal, potentiometric and antimicrobial studies of transition metal complexes of tridentate
ligand”, J. Saudi. Chem. Soc., Vol.18, pp.27–34, 2011.
68. Ajlouni A. M., Tahaa Z. A., Al-HassanK. A. and AbuAnzeh A. M., “Synthesis, characterisation, luminescence properties and antioxidant activity of Ln (III) complexes with a new aryl amide
bridging ligand”, J. Lumines., Vol.132, pp. 1357-1363, 2012.
69. Khoo T.-J., Khaled M., Break B., Crouse K.A., Ibrahim M., Tahir
A.M., Ali A.R., Cowley D.J., Watkin M.T.H. and Tarafder, “Synthesis, characterisation and biological activity of two Schiff base ligands and their nickel(II), copper(II), zinc(II) and cadmium(II) complexes derived
from S-4-picolyldithiocarbazate and X-ray crystal structure of cadmium(II) complex derived from pyridine-2-carboxaldehyde”, Inorg. Chim. Acta, Vol.413, pp. 68–76, 2014.
70. Mohammed A.S., Omer, Jia-Cheng Liu, Wen-Ting Deng A, and
Neng-Zhi Jin, “Syntheses, crystal structures and antioxidant properties of four complexes derived from a new Schiff base ligand (N1E,N2E)-N1,N2-bis(1-(pyrazin-2-yl)ethylidene)ethane-1,2diamine”,
Polyhedron Vol.69, pp. 10–14, 2014.
232
71. Ceyhana G., Cumali C., ElikbUrus S., Demirtas I., Mahfuz Elmastas
and Tümer M., “Antioxidant, electrochemical, thermal, antimicrobial
and alkane oxidation properties of tridentate Schiff base ligands and
their metal complexes”, Spectrochim. Acta A, Vol.81, pp. 184-198,
2011.
72. Salih I., Baykara H., Oztomsuk A., Okumus V., Levent A., Seyitoglu
S.M. and Ozdemir S., Synthesis and characterisation of 1,2-bis(2-(5-
bromo-2 hydroxybenziliden amino)-4-chlorophenoxy)ethane and its
metal complexes: An experimental, theoretical, electrochemical,
antioxidant and antibacterial study”, Spectrochimica Acta Part A:
Molecular and Biomol. Spect., Vol.118, pp.632-642, 2014.
73. Kavitha P., Ramachary M., Singavarapu B.V.V.A. and Laxma Reddy
K., “Synthesis, characterisation, biological activity and DNA cleavage
study of tridentate Schiff bases and their Co(II)complexes”, J. Saudi
Chem. Soc., (Article in press) (DOI: 10.1016/j.jscs.2013.03.005),
2013.
74. Yan P., Sun W., Li G., Nie C., Gao T. and Yue Z., Synthesis,
characterisation and fluorescence of lanthanide Schiff-base
complexes, Journal of Coordination Chemistry, Vol. 60, No. 18, pp.
1973–1982, 2007.
75. Shakya P.R., Singh A.K. and Rao T.R., “Homo dinuclearlanthanide
(III) complexes of a mesogenic Schiff-base, N,N-di-(4-
decyloxysalicylidene)-1,6-diaminohexane: Synthesis and
Characterisation”, Spectrochim. Acta A, Vol.79, pp.1654-1659, 2011.
76. Yang T.-L. and Qin W.-W., “Synthesis and novel fluorescence
phenomenon of terbium complex with a new Schiff base ligand
derived from condensation of triaminotriethylamine and 3-
indolemethanal”, Spectrochim. Acta A, Vol.67, pp. 568–571, 2007.
233
77. Bunzli J.-C. G., Comby S., Chauvin A.-S. and Vandevyver C. D. B.,
“New Opportunities for Lanthanide Luminescence”, J. Rare Earths,
Vol.25, pp. 257-274, 2007.
78. Nabid M.R., Sedghi R., Jamaat P.R., Safari N. and Entezami A.A.,
“Catalytic oxidative polymerisation of aniline by using transition-metal
tetrasulfonatedphthalocyanine”, Appl. Catal. A: Gen., Vol.328,
pp.52–57, 2007.
79. Lu W. and Xi C., “CuCl-catalysed aerobic oxidative reaction of
primary aromatic amines”, Tetrahedron Letters, Vol.49, pp.4011–
4015, 2008.
80. Gawryszewska P. and Lisowski J., “Lanthanide(III) complexes of
N4O4 Schiff base macrocycle: luminescence and formation of
heterodinuclear d-f complexes”, Inorg. Chim. Acta, Vol.383,
pp. 220-229, 2012.
81. Friscic T., Kaitner B. and Mestrovic E., “Meštrovi , Synthesis and
structure of N,N'-butylene- and N,N'-hexylenebis(2-oxy-1-
naphthaldimine)”,Croat. Chem. Acta, Vol.71, pp. 87-98, 1998.
82. Mohanan K., Subhadrambika N., Selwin Joseyphus R., Swathy S.S.
and Nisha V.P. “Synthesis, spectroscopic characterisation, solid
state D.C. electrical conductivity and biological studies of some
lanthanide(III) chloride complexes with a heterocyclic Schiff base
ligand”, http://dx.doi.org/10.1016/j.jscs.2012.07.007
83. Sadana A.K., Miraza Y., Aneja K.R. and Prakash O., “Hypervalent
iodine mediated synthesis of 1-aryl/hetryl-1,2,4-triazolo[4,3-a]
pyridines and 1-aryl/hetryl 5-methyl-1,2,4-triazolo[4,3-a]quinolines as
antibacterial agents”, Eur. J. Med. Chem., Vol.38, pp. 533-536, 2003.
234
84. Greenwood D., Snack R. and Peurtherer J. “Medical microbiology, A
guide to microbial infections, Pathogensis, immunity, laboratory
diagnosis and control”, 15th ed., 1997.
85. Bilgari F., Alkarkhi A.F.M. and Easa A.M., “Antioxidant activity and
phenolic content of various date palm (phoenix dactylifera) fruits from
Iran”, Food Chem., Vol.107, pp. 1636-1641, 2008.
86. Abd El-halim H.F., Omar M.M. and Mohamed G.G., “Synthesis,
structural, thermal studies and biological activity of a tridentate Schiff
base ligand and their transition metal complexes”, Spectrochim.
Acta: A., Vol.78, pp. 36-44, 2011.
87. Ouyang X.M., Fei B.L., Okamuro T.A., Sun W.Y., Tang W.X. and
Ueyama N., “Synthesis, Crystal Structure and Superoxide Dismutase
(SOD) Activity of Novel Seven-Coordinated Manganese(II) Complex
with Multidentate Di-Schiff Base Ligands”, Chem. Lett., Vol.3, pp.
362-363, 2002.
88. Datta N.K., Karan S. Mitra G. and Rosair, Z. Naturforsch “Synthesis
and Structural Characterisation of [Cu(NH2CH2C6H4N = CHC5H5N)
Cl2]”, Vol.576, pp. 999-1005, 2002.
89. Jayabalakrishnan K. Natarajan, “Ruthenium(II) carbonyl complexes
with tridentate Schiff bases and their antibacterial activity“ Trans.
Met. Chem., Vol.27, pp. 75-79, 2002.
90. Sharghi H. and Nasseri M.A., “Schiff base metal (II) complexes as
new catalyst in efficient, mild and region selective conversion of
1,2epoxyethanes to 2 hydroxyethylthiocyanates with
ammoniymthiocyanate”, Bull. Chem. Soc. (Jpn.), Vol.76, pp. 137-142,
2003.
235
91. Przybylski P., Huczynski A., Pyta K., Brzezinski B. and Bartl F.,
“Biological properties of Schiff bases and azo derivatives of phenols”
Curr. Org. Chem., Vol.13, pp. 124-148, 2009.
92. Da Silva C.M., Da Silva D.L., Modolo L.V., Alves R.B., De Resende
M.A., Martins C.V.B. and de Fatima A., “Schiff bases: a short review
of their antimicrobial activities”, J. Adv. Res., Vol.2, pp. 1-8, 2011.
93. Maurya R.C. and Patel P., “Synthesis, magnetic and special studies
of some novel metal complexes of Cu(II), Ni(II), Co(II), Zn[II), Nd(III),
Th(IV), and UO2(VI) with Schiff bases derived from sulfa drugs, viz.,
Sulfanilamide/Sulfamerazine and o-vanillin”, Spectrosc. Lett., Vol.32,
pp. 213-236, 1999.
94. Ajlouni A.M., Taha Z.A., Al Momani W., Hijazi A.K. and Ebqa’ai M.,
“Synthesis, characterisation, biological activities, and luminescent
properties of lanthanide complexes with NN -bis (2-hydroxy-1-
naphthylidene)-1, 6-hexadiimine”, Inorg. Chim. Acta., Vol.388,
pp.120-126, 2012.
95. Ajlouni A.M., Taha Z.A., Al-Hassan K.A. and AbuAnzeh A.M.,
“Synthesis, characterisation, luminescence properties and
antioxidant activity of Ln (III) complexes with a new aryl amide
bridging ligand”, J. Lumin., Vol.132, pp. 1357-1360, 2012.
96. Singh G., Singh R., Girdhar N.K. and Ishar M., “A versatile route to 2-
alkyl-/aryl-amino-3-formyl- and hetero-annelated-chromones, through
a facile nucleophilic substitution at C2 in 2-(N-methylanilino)-3-
formylchromones”, Tetrahedron, Vol.58, pp. 2471-2480, 2002.
97. Schildcrout S.M., SriHari S. and Masnovi J., “Comparative Chemical-
Ionisation and Electron-Ionisation Mass-Spectra of SALEN
Complexes with Metals of the First Transition Series”, Inorg. Chem.
Vol.34, pp. 4117-4122, 1995.
236
98. Geary W., “The use of conductivity measurements in organic
solvents for the characterisation of coordination compounds”, Coord.
Chem. Rev., Vol.7, pp.81-122, 1971.
99. Cardoso M.C.C., Arau´ joMelo D.M., Schpector J. Z., Zinnera L.B.
and Vicentini G., “Spectroscopic, TG and DSC studies of lanthanide
picrate complexes with 1,4-pyrazine-dioxide (pyzDO): crystal
structure of the terbium complex”, J. Alloys Compd., Vol.344, pp. 83-
87, 2002.
100. Raman N., Pothiraj K. and Baskaran T., “DNA interaction,
antimicrobial, electrochemical and spectroscopic studies of metal(II)
complexes with tridentate heterocyclic Schiff base derived from 2 -
methylacetoacetanilide”, J. Mol. Struct., Vol.1000, pp. 135-144, 2011.
101. Bhattacharieea C.R., Goswami P., Pramanika H.A.R., Paula P.C.
and Mondal P., “Reactivity of tris(acetylacetonato) iron(III) with
tridentate [ONO] donor Schiff base as an access to newer mixed-
ligand iron(III) complexes”, Spectrochim. Acta A., Vol.78, pp.1408-
1413, 2011.
102. Shakya P.R., Singh A.K. and Rao T.R., “Homo
dinuclearlanthanide(III) complexes of a mesogenic Schiff-base, N,N -
di-(4-decyloxysalicylidene)-1 ,6 -diaminohexane: Synthesis and
characterisation”, Spectrochim. Acta A., Vol.79, pp.1654-1659, 2011.
103. Leniec G., Kaczmarek S.M., Typek J., Ko odziej B., Grech E. and
Schilf W., “Spectroscopic and magnetic properties of gadolinium
macrobicycliccryptate complex”, J. Phys. Condens. Matter, Vol.18,
pp. 9871-9880, 2006.
104. Kaczmarek S.M. and Leniec G., “EPR and IR investigations of some
chromium (III) phosphate (V) compounds”, J. Non-Cryst. Solids,
Vol.355, pp.1289-1438, 2009.
237
105. Shahawi M.S. El, Jahdali M.S. Al, Bashammakh A.S. Sibaai A.A. Al
and Nassef H.M., “Spectroscopic and electrochemical
characterization of some Schiff base metal complexes containing
benzoin moiety”, Spectrochim. Acta A, Vol.113, pp.459-465, 2013.
106. Paryzek W., Zankowska E. and Luks E., “Coordination compounds of
2,6-diacetylpyridinedihydrazone-II. Preparation and characterisation
of the complexes with heavier lanthanide chlorides, perchlorates and
nitrates”, Polyhedron, Vol.7, pp. 439-442, 1988.
107. Yan P., Sun W., Li G., Nei C., Gao T. and Yue Z., “Synthesis,
characterisation and fluorescence of lanthanide Schiff-base
complexes”, J. Coord. Chem., Vol.60, pp.1973-1979, 2007.
108. Wang W., Huang Y. and Tang N., “Synthesis and infrared and
fluorescence spectra of rare earth complexes with a novel amide-
based ligand”, Spectrochim. Acta, Vol.66, pp. 1058-1062, 2007.
109. Jadhav S.M., Shelke V.A., Shankarwar S.G., Munde A.S. and
Chandrashekar T.K., “Synthesis, spectral, thermal, potentiometric
and antimicrobial studies of transition metal complexes of tridentate
ligand’, J. Saudi Chem. Soc., Vol.18, pp. 27-34, 2014.
110. Shakir M., Shahid N., Sami N., Azam M. and Khan A.U., “Synthesis,
spectroscopic characterisation and comparative DNA binding studies
of Schiff base complexes derived from L-leucine and glyoxal”,
Spectrochim. Acta A: Biomol. Spectrosc, Vol.82, pp. 31-36, 2011.
111. Costes J. P., Laussac J.P. and Nicodeme F., “Complexation of
a Schiff base ligand having two coordination sites (N2O2and O2O2)
with lanthanide ions (Ln = La, Pr): an NMR study”, J. Chem. Soc.
Dalton. Trans, pp. 2731-2736, 2002.
238
112. Youssef T.A., “Reactions of chromium and molybdenum carbonyls
with bis-(salicylaldehyde)-1,3-propylenediimine Schiff base”, J.
Coord. Chem., Vol.61, pp. 816-819, 2008.
113. Guo L., Wu S., Zeng F. and Zhao J., “In situ synthesis of copper
nanoparticles and poly(o-toluidine): A metal–polymer composite
material“, Eur. Polym. J., Vol.42, pp. 670-675, 2006.
114. Felico R.C., Canalheiro E.T.G. and Dockal E.R., “Preparation,
characterisation and thermogravimetric studies of [N,N -cis-1,2-
cyclohexylene bis(salicylideneaminato)]cobalt(II) and [N,N -(±)-trans-
1,2-cyclo-hexylene bis(salicylideneaminato)]cobalt(II)”, Polyhedron.
Vol.20, pp.261-268, 2001.
115. Görller-Walrand C. and Binnemans K., Handbook on the Physics
Chemistry of Rare Earths, North-Holland Publishers, Amsterdam,
Vol. 25, pp. 101-110, 1998.
116. Ho Y., Yu W.Y., Cheung K.K. and Che C.M., “Blue luminescent
zinc(II) complexes with polypyridylamine ligands: crystal structures
and luminescence properties”, J. Chem. Soc. Dalton Trans., Vol.10,
pp.1581-1586, 1999.
117. Li J.X., Du Z.X., Zhou J., An H.Q., Wang S.R., Zhu B.L., Zhang S.M.,
Wu S.H. and Huang W.P., “Syntheses, crystal structures and
properties of Cd(II) and Co(II) complexes with 4,4 -dipyridylsulfide
ligand”, Inorg. Chim. Acta, Vol.362, pp. 4884-4890, 2009.
118. Zheng Y.X., Fu L.S., Zhou Y.H., Yu J.B., Yu Y.N., Wang S.B. and
Zhang H.J., “Electroluminescence based on a beta-diketonate
ternary samarium complex “, J. Mater. Chem., Vol.12, pp. 919-923,
2002.
239
119. Chohan Z.H. and Shad H.A., “Structural elucidation and biological
significance of 2-hydroxy-1-naphthaldehyde derived sulfonamides
and their first row d-transition metal chelates”, J. Enz. Inhib. Med.
Chem., Vol.23, pp.369-379, 2008.
120. Badwaik V.B. and Aswar A.S., “Synthesis, characterisation, and
biological studies of some Schiff base complexes”, Russ. J. Coord.
Chem., Vol.33, pp. 755-760, 2007.
121. Thangadurai D.T. and Natarajan K., “Synthesis and characterisation
of new ruthenium(III) complexes containing tetradentate Schiff
bases”, Synth. React. Inorg.Met. Org. Chem., Vol. 31, pp. 549-555,
2001.
122. Dhankar R.P., Rahatgaonkar A.M. and Chorghade M.S., “Spectral
and in vitro antimicrobial properties of 2-oxo-4-phenyl-6-styryl-
1,2,3,4-tetrahydro-pyrimidine-5-carboxylic acid transition metal
complexes”, Spectrochim. Acta, A, Vol.93, pp. 348-353, 2012.
123. Arish D. and Nair M.S., “Synthesis, characterisation, antimicrobial,
and nuclease activity studies of some metal Schiff-base complexes”,
J. Coord.Chem., Vol.63, pp.1619-1628, 2010.
124. Archer R.D. and Chen H., “Synthesis, Characterisation, and
Luminescence of Europium(III) Schiff Base Complexes”, Inorg.
Chem., Vol.37, pp. 2089-2095, 1998.
125. Danghui W., Yixin Y., Yiqin Y., Tiancheng Z., Xing W., Shaokang W.,
Yao H. and Weizong C., “Synthesis and properties of a Pr (III)
complex with 2-acetylbenzimidazoledehyde-glycine Schiff-base
ligand”, China. Sci. Bull., Vol.51, pp. 785-790, 2006.
240
126. Samir M.S. Zoromb and Hanan F.A.E., “Lanthanide amino acid Schiff
base complexes: synthesis, spectroscopic characterisation, physical
properties and in vitro antimicrobial studies”, J. Rare Earths, Vol.31,
pp. 715-721, 2013.
127. Kostova I., Petar G., Stefan B. and Tsvetanka S., “Synthesis,
characterisation and cytotoxicity of new Ho(III) and Er (III)
complexes”, Ind. J. Biotech., Vol.10, pp. 387-394, 2011.
128. Kostova I. and Georgi M., “Synthesis, spectral and pharmacological
studies on lanthanide(III) complexes of 3,5-pyrazoledicarboxylic
acid”, J. Coord. Chem., Vol.61, pp. 3776-3792, 2008.
129. Lekha L., Raja K.K., Rajagopal G. and Easwaramoorthy D.,
“Synthesis, spectroscopic characterisation and antibacterial studies
of lanthanide(III) Schiff base complexes containing N, O donor
atoms”, J. Mol. Struc., Vol.1056–1057, pp. 307–313, 2014.
130. Salehzadeh S., Nouri S.M., Keypour H. and Bagherzadeh M.,
“Synthesis of gadolinium(III) and samarium(III) complexes of new
potentially heptadentate (N4O3) tripodal Schiff base ligands, and a
theoretical study”, Polyhedron, Vol.24, pp. 1478-1486, 2005.
131. Andruh M., Tuna., In; M.A. Cato (Eds.), Focus on Organometallic
Chemistry Research, Nova Publishers, Hauppauge,2005.
132. Nawar N.A., Shallaby A.M., Hosny N.M. and Mostafa M., “Mono- and
binuclear Schiff base complexes derived from glycine, 3-
acetylpyridine and transition metal ions”, Trans. Met. Chem., Vol.26,
pp. 180-185, 2001.
133. Hosny N.M., “Synthesis, characterisation, theoretical calculations and
catalase-like activity of mixed ligand complexes derived from alanine
and 2-acetylpyridine”, Trans. Met.Chem., Vol.32, pp.117-124, 2007.
241
134. Tamboura F.B., Haba P.M., Gaye M., Sall A. S., Barry A.H. and
Jouini T., “Structural studies of bis-(2,6-diacetylpyridine-bis-(phenyl
hydrazone)) and X-ray structure of its Y(III), Pr (III), Sm (III) and Er
(III) complex”, Polyhedron., Vol.23, pp. 1191-1197, 2004.
135. Wang M.-F., Yang Z.-Y., Liu Z.-C., Li Y., Li T.-R., Yan M.-H. and
Cheng X.-Y., “Synthesis and crystal structure of a Schiff base
derived from two similar pyrazolone rings and its rare earth
complexes: DNA-binding and antioxidant activity”, J. Coord. Chem.,
Vol.65, pp.3805-3820, 2012.
136. Thunus L. and Lejeune R., “Overview of transition metal and
lanthanide complexes as diagnostic tools”, Coord.Chem. Rev.,
Vol.184, pp.125-155, 1999.
137. Cutler C.S., Smith C.J., Ehrhardt G.J., Tyler T.T., Jurisson S.S. and
Deutsch E., “ Current and Potential Therapeutic Uses of Lanthanide
Radioisotopes” , Cancer Biother. Radiopharm., Vol.15, pp. 531-545,
2000.
138. Li Z., Xue M., Yao H., Sun H., Zhang Y. and Shen Q., “Enol-
functionalised N-heterocyclic carbene lanthanide amide complexes:
Synthesis, molecular structures and catalytic activity for addition of
amines to carbodiimides”, J. Organomet. Chem., Vol.713, pp.27-34,
2012.
139. Yang T.-L. and Wu Qin W.-, “Synthesis and novel fluorescence
phenomenon of terbium complex with a new Schiff base ligand
derived from condensation of triaminotriethylamine and
3-indolemethanal”, Spectrochim. ActaA., Vol.67, pp. 568-571, 2007.
242
140. Wang M., Yang Z., Li Y. and Li H., “Lanthanide complex of 1-phenyl-
3-methyl-5-hydroxypyrazole-4-carbaldehyde-(isonicotinoyl) hydrazone:
crystal structure and DNA-binding properties”, J. Coord. Chem.,
Vol.64, pp. 2974-2983, 2011.
141. Reddy P.R., Shilpa A., Raju N. and Raghavaiah P., “Synthesis,
structure, DNA binding and cleavage properties of ternary amino acid
Schiff base-phen/bipy Cu(II) complexes”, J.Inorg. Biochem., Vol.
105, pp. 1603-1612, 2011.
142. Robinson M.R., O’Regan M.B. and Bazan G.C., “Synthesis,
morphology and optoelectronic properties of tris[(N-ethylcarbazolyl)
(3 ,5 -hexyloxybenzoyl)methane](phenanthroline)europium”,
Chem. Comm., Vol.17, pp. 1645-1646 , 2000.
143. Kanmani Raja K., Indira Gandhi N, Lekha L, Easwaramoorthy D and
Rajagopal G., “Synthesis, spectral, electrochemical and catalytic
properties of Ru(III) Schiff base complexes containing N, O donors”,
J. Mole. Struc., Vol.1060, pp. 49-57, 2014.
144. Leniec G., Kaczmarek S.M., Typek J., Ko odziej B., Przybylski P.,
Brzezi ski B. and Grech E., “FT-IR, ESI and EPR studies of a Dy(III)
Schiff base pod and complex”, J. Non-Cryst. Solids, Vol.355, pp.
1355-1359, 2009.
145. GuoL. and Yan B., “Photoluminescent rare earth inorganic–organic
hybrid systems with different metallic alkoxide components through
2-pyrazinecarboxylate linkage”, J. Photochem.Photobio. A:Chem.,
Vol.224, pp. 141-146, 2011.
146. Pui A., Malutan T., Tataru L., Mualtuan C., Humelnicu D. and Carja
G., “New complexes of lanthanide Ln (III), (Ln = La, Sm, Gd, Er) with
Schiff bases derived from 2-furaldehyde and phenylenediamines”,
Polyhedron., Vol.30, pp. 2127-2131, 2011.
243
147. Li X., Wang C.Y. and Hu H.-M., “The first example of tetranuclear
lanthanide complexes with 2-sulfobenzoate and 1,10-
phenanthroline”, Inorg. Chem. Commun., Vol.11, pp. 345-348, 2008.
148. Gansow O.A., Loeffler E., Davis R., Lenkinski M. and Wilcott R.,
“Contact vs. pseudocontact contributions to lanthanide-induced shifts
in the nuclear magnetic resonance spectra of isoquinoline and of
endo-norbornenol”, J. Am. Chem. Soc., Vol.98, pp. 4250-4258,
1976.
149. Carnall W., Siegel S., Ferrano J., Tani B. and Gebert E., “New series
of anhydrous double nitrate salts of the lanthanides. Structural and
spectral characterisation”, Inorg. Chem., Vol.12, pp. 560-564, 1973.
150. Shelke V.A., Jadhav S.M., Patharkar V.R., Shankarwar S.G.,
Munde A.S. and Chondhekar T.K., “Synthesis, spectroscopic
characterisation and thermal studies of some rare earth metal
complexes of unsymmetrical tetradentate Schiff base ligand”,
Arabian J. Chem., Vol. 5, pp.501-507, 2012.
151. Mohanan K. and Devi, S.N. “Synthesis, characterisation, thermal
stability, reactivity and antimicrobial properties of some novel
lanthanide(III) complexes of 2-(N-salicylideneamino)-3-carboxyethyl-
4,5,6,7-tetrahydrobenzo[b]thiophene”, Russ. J. Coord. Chem.,
Vol.32, pp. 600-610, 2006.
152. Shebl M., Seleem H.S. and El-Shetary B.A., 2010. “Ligational
behavior of thiosemicarbazone, semicarbazone and
thiocarbohydrazone ligands towards VO(IV), Ce(III), Th(IV) and
UO2(VI) ions: synthesis, structural characterisation and biological
studies”, Spectrochim. Acta A, Vol.75, pp. 428-433.
244
153. Salavati-Niasari M., SalimiZ., Bazarganipour M. and DavarF.,
“Synthesis, characterisation and catalytic oxidation of cyclohexane
using a novel host (zeolite-Y)/guest (binuclear transition metal
complexes) nanocomposite materials”, Inorg. Chim. Acta., Vol.362,
pp.3715-3716, 2009.
154. Kumar D.N. andGarg B.S., “Synthesis and spectroscopic studies of
complexes of zinc(II) with N2O2 donor groups”, Spectrochim. Acta
Part A., Vol.64, pp. 141-147, 2006.
155. Mohanan K., Athira C.J., Sindhu Y. and Sujamol, M.S., “Synthesis,
spectroscopic characterisation and thermal studies of some
lanthanide(III) nitrate complexes with a hydrazoderivative of 4-
aminoantipyrine”. J. Rare Earths, Vol.27, No.5, pp. 705-708, 2009.
156. E.S. Aazam, A.F. EL Husseiny and H.M. Al-Amri., “Synthesis and
photoluminescent properties of a Schiff-base ligand and its
mononuclear Zn(II), Cd(II), Cu(II), Ni(II) and Pd(II) metal complexes”,
Arab. J. Chem., Vol.5, pp. 45-53, 2012.
157. Deacon G. B. and Phillips R. J., “Relationships between the carbon-
oxygen stretching frequencies of carboxylato complexes and the type
of carboxylate coordination”, Coord.Chem. Rev., Vol.33, pp. 227-
250, 1980.
158. Bellamy L. J., “The infrared Spectra of complex Molecules”, J. Wiley,
NewYork, 1971.
159. Sun W.B., Yan P.F., Li G.M., Xu H. and Zhang J.W., “N,N -
bis(salicylidene) propane-1,2-diamine lanthanide(III) coordination
polymers: Synthesis, crystal structure and luminescence properties”,
J. Solid State Chem., Vol.182, pp. 381-388, 2009.
245
160. Wang W., Huang Y. and Tang N., “Synthesis and infrared and
fluorescence spectra of rare earth complexes with a novel amide-
based ligand”, Spectrochim. Acta., Vol.66, pp. 1058-1062, 2007.
161. TahaZ. A., AjlouniA. M., Al-Hassan K. A., HijaziA. K. andFaiqA. B.,
“Synthesis, characterisation, biological activity and fluorescence
properties of bis-(salicylaldehyde)-1,3-propylenediimine Schiff base
ligand and its lanthanide complexes”, Spectrochimica Acta A, Vol.81,
pp. 317-323, 2011.
162. Zolezzi S., Decinti A. and Spodine E., “Syntheses and
characterisation of copper(II) complexes with Schiff-base ligands
derived from ethylenediamine, diphenylethylenediamine and nitro,
bromo and methoxysalicylaldehyde”, Polyhedronl, Vol.18, pp.897-904,
1999.
163. Karaoglu K., Baran T., Serbest K. and De girmencio glu M. Er, I.,
“Two novel macroacyclic Schiff bases containing bis-N2O2 donor set
and their binuclear complexes: synthesis, spectroscopic and
magnetic properties”, J. Mol. Struct., Vol.922, pp.39–45, 2009.
164. Gorller-Walrand C. and Binnemans K., “Spectral intensities of f–f
transitions”, in: K.A. Gschneidner Jr., L. Eyring (Eds.), Handbook on
the Physics Chemistry of Rare Earths, vol. 25, North-Holland
Publishers, Amsterdam, pp. 101-264, Chapter 167, 1998.
165. Walrand C.G. and Binnemans K., Handbook on the Physics
Chemistry of Rare Earths, North-Holland Publishers, Amsterdam,
Vol. 25, pp. 101-2641998.
166. Xie W., Heeg M.J. and Wang P.G., “Formation and Crystal Structure
of a Polymeric La(H2salen) Complex”, Inorg. Chem., Vol.38, pp.
2541-2543, 1999.
246
167. Moawad M.M. and Hanna W.G., “Structural and Antimicrobial
Studies of Some Divalent Transition Metal Complexes with Some
New Symmetrical Bis (7-Formylanil Substituted-Sulfoxine) Schiff
Base Ligands”, J. Coord. Chem., Vol.55, pp. 439-457, 2002.
168. Sabbatini N., Guardigli M. andLehn J.M., “Luminescent lanthanide
complexes as photochemical supramolecular devices”, Coordi.
Chem. Rev., Vol.123, pp. 201-228, 1993.
169. Wu S., Zeng F., Wu S., Yao S., She W. and Luo D., “All-optical
switching properties of poly(methyl methyacrylate) azobenzene
composites”, J. Mat. Sci., Vol.38, pp. 401-405, 2003.
170. Dexter D.L., “A Theory of Sensitised Luminescence in Solids”, J.
Chem. Phys., Vol.21, pp. 836-837, 1953.
171. Kolchinski A.G., “Anhydrooligomers of o-aminobenzaldehydes—the
rich chemistry of the Busch macrocycles”, Coord.Chem. Rev.,
Vol.174, pp. 207-239, 1998.
172. Haynes A. V. and Drickamer H.G., “High pressure luminescence
studies of energy transfer in rare earth chelates “, J. Chem. Phys.,
Vol.76, pp. 114-118, 1982.
173. Inoue K., Sasaki Y. and ItayaT., “Polymerisation of styrenes with
pendant aminophosphazenes and fluorescence behaviors of their
Eu3+ complexes”, Eur. Polym. J., Vol. 33, pp. 841-847, 1997.
174. Du C.X., Ma L. and Xu Y., “Synthesis and photophysical
characterisation of terbium-polymer complexes containing salicylate
ligand”, Eur. Polym. J., Vol.34, pp. 23-29, 1998.
247
175. Kim D.H., Cho HI. And ZyungT., “New tetradentate Schiff-base
polymers: preparation of poly[2,5-(didodecyloxy)phenylene-1,
4-diyl-alt-N,N -(o-phenylene)-bis(salicylideneiminato-4,4 -diyl)] and
poly [2,5-(didodecyloxy)phenylene-1,4-diyl-alt-N,N -(alkylidene)-bis
(salicylideneiminato-4,4 -diyl)]s”, Eur. Polym. J., Vol.38, pp. 133-137,
2002.
176. Chohan Z.H., Supuran C.T. and Scozzafava A., “Metalloantibiotics:
Synthesis and Antibacterial Activity of Cobalt(II), Copper(II), Nickel(II)
and Zinc(II) Complexes of Kefzol”, J. Enzym. Inhib. Med. Chem.,
Vol.19, No.1, pp.79–84, 2004.
177. Chohan Z.H. and Praveen M., “Synthesis, characterisation,
coordination and antibacterial properties of novel asymmetric 1,1 -
disubstituted ferrocene-derived Schiff-base ligands and their Co(II),
Cu(II) Ni(II) and Zn(II) complexes”, Appl. Organomet. Chem., Vol.15,
pp. 617-625, 2001.
178. Chohan Z.H., Scozzafava A. and Supuran C.T., “Unsymmetrical 1,1 -
disubstituted Ferrocenes: Synthesis of Co(ii), Cu(ii), Ni(ii) and Zn(ii)
Chelates of Ferrocenyl -1-thiadiazolo-1 -tetrazole, -1-thiadiazolo-1 -
triazole and -1-tetrazolo-1 -triazole with Antimicrobial Properties”, J.
Enzym. Inhib. Med. Chem., Vol.17, pp. 261-266, 2002.
179. Hassan M.U., Chohan Z.H. and Supuran C.T., “Antibacterial Zn(II)
Compounds of Schiff Bases Derived from Some Benzothiazoles”,
Main Group Met Chem., Vol.25, pp. 291-297, 2002.
180. Shilov A.E. and Shul’pin G.B., “Activation of C H Bonds by Metal
Complexes”, Chem.Rev., Vol.97, pp. 2879-2932, 1997.
181. Hains A.H., Methods for the Oxidation of Organic Compounds,
Academic: London, 1985.
248
182. Mizuno N., Yamaguchi K. and Kamata K., “Epoxidation of olefins with
hydrogen peroxide catalysed by polyoxometalates”, Coord.Chem.
Rev., Vol.249, pp. 1944-1956, 2005.
183. Ramnauth R., Al-JuaidS.,Parkin B.C. and Sullivan A.C., “Synthesis,
Structure, and Catalytic Oxidation Chemistry from the First
Oxo Imido Schiff Base Metal Complexes”, Inorg. Chem., Vol.43, pp.
4072-4079, 2004.
184. AhluwaliaV.K., “ Organic Reaction Mechanisms”, Parashar Publisher
CRC Press: New Delhi, 2002.
185. Samec J. S.M., E´ ll A.H. and Ba¨ckvall J.-E., “Efficient Ruthenium-
Catalysed Aerobic Oxidation of Amines by Using a Biomimetic
Coupled Catalytic System”, Chem. Eur. J., Vol.11, pp. 2327-2334,
2005.
186. Satoru S., Miura M. and Nomura M., “Oxidation of 3- or 4-substituted
N,N-dimethylanilines with molecular oxygen in the presence of either
ferric chloride or [Fe(salen)]OAc”, J. Org. Chem., Vol.54, pp. 4700-
4702, 1989.
187. Wenchao Lu and Chanjuan Xi, “CuCl-catalysed aerobic oxidative
reaction of primary aromatic amines”, Tetrahedron Lett., Vol.49,
pp. 4011-4015, 2008.
188. Mansoor S. S. and Shafi S. S., , “Oxidation of aniline and some para-
substituted anilines by benzimidazolium fluorochromate in aqueous
acetic acid medium – A kinetic and mechanistic study”, Arabian J.
Chem., Vol. 7, pp. 171-176, 2014.
189. Wheeler O. H. and Gonzales D., “Oxidation of primary aromatic
amines with manganese dioxide”, Tetrahedron, Vol.20, pp. 189-193,
1964.
249
190. Nezhadali, M. Akbarpour, “Selective oxidation of primary substituted
aromatic amines to azoxy products using lacunary catalyses”, Chin.
Chem.Lett., Vol.21, pp. 43-46, 2010.
191. Zhao R., Tan C.,Xie Y.,Gao C., Liu H. andJiang Y., “One step
synthesis of azo compounds from nitroaromatics and anilines”,
TetrahedronLett., Vol.52, pp. 3805-3809, 2011.
192. White R.W. and Emmons W. D., “The chemistry of permaleic acid”,
Tetrahedron, Vol.17, pp. 31-34, 1962.
193. Baumgarten H. E., Staklis A. and Miller E. M., “Reactions of Amines.
XIII. The Oxidation of N-Acyl-N-arylhydroxylamines with Lead
Tetraacetate”, J. Org. Chem., Vol.30, pp. 1203-1206, 1965.
194. Emmons W.D., “The Oxidation of Amines with Peracetic Acid”, J. Am.
Chem. Soc., Vol.79, pp. 5528-5530, 1957.
195. Raja K.K., Easwaramoorthy D., Rani S.K., Rajesh J., Jorapur Y.,
Thambidurai S., Athappan P.R. and Rajagopal G., “Synthesis,
spectral, electrochemical and catalytic properties of Cu(II), Ni(II) and
Co(II) complexes containing N, O donors”, J. Mol. Catal. A: Chem.,
303, pp. 52-59, 2009.
250
LIST OF PUBLICATIONS
1. Lekha L, Kanmani Raja K, Rajagopal G. and Easwaramoorthy D,
“Synthesis, Spectroscopic characterisation and Antibacterial Studies
of Lanthanide(III) Schiff base complexes containing N, O donor
atoms”, J. Mol. Struct., Vol. 1056–1057, pp. 307–313, 2014.
2. Lekha L, Kanmani Raja K, Rajagopal G. and Easwaramoorthy D,
“Schiff Base Complexes of Rare Earth Metal ions: Synthesis,
Characterisation and Catalytic Activity for the Oxidation of Aniline and
substituted Anilines”, J. Organomet. Chem. Vol. 753, pp. 72-80,
2014.
3. Lekha L, Kanmani Raja K, Rajagopal G, Sivakumar D. and
Easwaramoorthy D, “Synthesis, spectral characterisation and
antimicrobial assessment of Schiff Base ligand derived from amino
acid and its transition metal complexes” – Int. J. chem. pharm. Sci.,
Vol. 4 (2), pp. 48-54, 2013.
4. Kanmani Raja K, Lekha L, Easwaramoorthi D. and Rajagopal G,
“Synthesis, Spectral, Electrochemical and Catalytic properties of
Ru(III) Schiff base complexes containing N, O donors”, Journal of
Molecular Structure, Vol. 1060, pp. 49-57, 2014.
5. Kanmaniraja K, Lekha L, Easwaramoorthi D. and Rajagopal G,
“Synthesis, Spectral, Electrochemical and Catalytic properties of
VO(IV) Schiff base complexes containing N, O donors”, Journal of
Molecular Structure, Vol. 1075, pp. 227-233, 2014.
251
PAPERS COMMUNICATED
1. Lekha L, Kanmani Raja K, Hariharan R, Sathish M, Rajagopal G.
and Easwaramoorthy D, “Synthesis, spectral characterisation,
antimicrobial and antioxidant assessment of Schiff Base ligand
derived from threonine and its rare earth metal complexes”,
J. Appl. Organomet. Chem.
252
TECHNICAL BIOGRAPHY
Mrs. L. Lekha was born on May 31st, 1981 in Chennai,
Tamilnadu, India. She did her schooling in St. Thereasa’s Girls Higher
Secondary School, Pallavaram, Chennai. She was graduated with distinction
in chemistry from Meenakshi College for Women (Affiliated to University of
Madras), Kodambakkam, Chennai and got her Master degree in Chemistry
from Queen Mary’s College (Affiliated to University of Madras), Mylapore,
Chennai. She obtained her Master of Philosophy in Chemistry from
Bharathidasan University, Thiruchirappalli.
She joined, Ph.D Programme in the Department of Chemistry,
B. S. Abdur Rahman University, Chennai, in January 2010. She carried out
her research in the thrust area of “Studies on the Synthesis, Characterisation
and Antimicrobial Applications of Rare Earth Metal Schiff Base Complexes”.
She has published four papers and communicated two papers in
international peer-reviewed journals. Also, she has presented a paper in
National Conference at Gurunanak College, Chennai.
She has about nine years of teaching experience at various levels
and presently she is working as Assistant Professor in the Department of
Chemistry, Saveetha School of Engineering, Chennai. Her e-mail ID is:
[email protected] and the contact number is: 9940611001.